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ABSTRACT 
EMOTIONAL DISTRESS AS A KEY CONSTRUCT IN THE PERSONAL 
MODEL OF DIABETES MANAGEMENT: ASSOCIATIONS OF FATIGUE, 
DIABETES-SPECIFIC DISTRESS, AND DEPRESSIVE SYMPTOMATOLOGY 
WITH QUALITY OF LIFE IN TYPE 2 DIABETES MELLITUS 
Chelsea L. Rothschild 
May 14,2010 
The importance of maximizing self-management and quality of life is well-
documented in the diabetes literature. Although maintaining self-care is known to be 
important for individuals with type 2 diabetes, this is often difficult to maintain over 
time. Emotional distress has also been shown to impact self-care behaviors in adults with 
type 2 diabetes. Glasgow et al (1997) introduced a model of key variables influencing 
diabetes self-management. This study examined specific emotional Personal Model 
constructs of diabetes management. Independent and converging lines of research have 
implicated several potentially overlapping constructs that may reflect emotional distress 
in persons living with diabetes including: fatigue, distress, and global depression that is 
specific to the demands of diabetes. These emotional distress constructs have all been 
linked to self-management behavior and quality of life in chronic disease. This study 
sought to explain the associations between these emotional constructs and their impact on 
self-management and quality of life. Questionnaire and medical chart review data were 
collected from adults (N=151) with type 2 diabetes at an outpatient diabetes clinic. 
Depressive symptomatology, diabetes-specific distress, and fatigue were found to be 
v 
moderately associated with one another. Fatigue and diabetes specific distress were 
found to be associated with diet, mental, and physical quality of life. Findings suggest 
the Problem Areas In Diabetes scale (PAID) had the strongest association with diet 
adherence. Depressive symptomatology, diabetes-specific distress, and fatigue have a 
significant negative impact physical and mental quality of life. Future research should 
include the impact of fatigue on quality of life in adults with type 2 diabetes. 
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INTRODUCTION 
Overview of Diabetes 
Prevalence of Diabetes 
Diabetes mellitus (diabetes) is a chronic disease affecting approximately 20.8 
million children and adults in the United States, 5 million of whom are undiagnosed 
[American Diabetes Association (ADA), 2007]. There are three major types of diabetes: 
(1) type 1 diabetes, which was previously known as insulin-dependent, or childhood 
onset diabetes, (2) type 2 diabetes, which was previously known as non-insulin 
dependent, or adult onset diabetes and comprises 95% of diabetes cases, and (3) 
gestational diabetes, which is characterized by hyperglycemia occurring during 
pregnancy and a return to a normal glucose levels after delivery (Report of the Expert 
Committee on the Diagnosis and Classification of Diabetes Mellitus, 1997). Symptoms 
of diabetes include excessive thirst and urination, fatigue, blurred vision, nausea, 
vomiting, increased appetite, and slow healing infections (National Institute of Health, 
2005). Diabetes is the main cause of kidney failure and adult onset blindness, and 
individuals with diabetes are at serious risk for cardiovascular disease, stroke, 
hypertension, central and peripheral neuropathy, retinopathy, foot ulcers, and amputation 
(ADA,2006). 
Internationally, increasing rates of type 2 diabetes have reached epidemic 
proportions. The World Health Organization anticipates prevalence rates of diabetes to 
double by the year 2030 (WHO, 2006). This trend is also occurring in the United States 
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(Engel au et aI, 2004). Rising rates of diabetes parallel rising obesity rates, increases in 
sedentary lifestyle, and a rapidly growing population of older adults (Visscher & Seidell, 
2001). Additionally, the prevalence rate of diabetes is higher among ethnic minorities 
(ADA, 2003). Prevalence rates indicate diabetes-related mortality will increase by more 
than 50% in the next 10 years. According to the International Classification of Diseases 
(loth Version), diabetes is the sixth leading cause of death in the United States. 
Economic Impact of Diabetes 
From an economic perspective, the cost of diabetes is increasing alongside 
prevalence rates. According to the ADA, in 2002 direct and indirect medical costs were 
estimated at $132 billion annually. This is a dramatic increase from the 1997 report, 
which indicated the national cost of diabetes was estimated to be $98 billion (ADA, 
1998). Per capita medical expenses totaled $13,243 for an individual with diabetes 
compared to $2,560 per individual without diabetes (ADA, 2006). Diabetes is often a 
result of a loss in productivity, resulting in an economic loss of $40 billion annually. 
These statistics only approximate the toll of diabetes as they exclude expenditures 
resulting from pain and suffering and impact on individuals and their families. 
Rationale for Studying Diabetes 
Due to the impact of diabetes on individuals, the healthcare system, and the 
economy, it is essential to identify strategies to optimize diabetes management. Diabetes 
is a unique chronic illness due to the fact approximately 95% of its treatment is based on 
self-management (Anderson, 1985). Diabetes is believed to be one of the most 
psychologically and behaviorally taxing of the chronic medical illnesses (Cox, Gonder-
Frederick, 1992). The key to successful diabetes management is to control blood glucose 
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levels and prevent additional complications. This is accomplished primarily by the 
patient adhering to an involved self-management regimen designed to stabilize blood 
glucose levels and prevent or delay further diabetic complications. 
Diabetes self-management 
Diabetes self-management is defined in the literature as "the various tasks in 
which patients must engage on a regular basis to manage their diabetes" (Glasgow & 
Eakin, 1998, p. 436). The Diabetes Control and Complications Trial (DCCT) concluded 
that extensive blood glucose management could prevent the onset of additional co-
morbidity and diabetes-related complications (DCCT and Research Group, 2003). 
Managing one's blood glucose is a complex daily regimen of self-management behaviors 
that include monitoring and decision making related to diet, exercise, recognizing 
hyperglycemia (high blood sugar) and hypoglycemia (low blood sugar), administering 
endogenous insulin/oral medications (i.e. oral agents), managing sick days, and testing 
and recording blood glucose levels (Elliott, Shewchuk, Miller & Richards, 2001). Self-
management regimen for diabetes was believed to be one of the main factors that 
distinguish diabetes from other chronic illnesses, which may require maintaining only a 
select few of these behaviors (ADA, 2006). However it has been demonstrated in the 
literature that this complex regimen is difficult to maintain over time (Hiss, Anderson, 
Hess, Stepien, & Davis 1994; Cramer, 2004; Harris & Eastman, 2001). 
Maintenance a/the Diabetes Self-management Regimen 
Maintenance of the complex self-management regimen is believed to be inversely 
related to the extent of behavioral modification required to adopt a new behavior 
(Meichenbaum & Turk, 1987). The more complicated or involved the regimen becomes, 
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the more difficult it is to maintain over time. People may be less inclined to change their 
behavior when the health behaviors are difficult to maintain, or when immediate results 
are not provided (Jacobsen, de Groot, & Samson, 1995). Individuals with type 2 diabetes 
often are required to make several changes to their routine, they are encouraged to 
incorporate exercise into their daily lives, monitor blood glucose, adhere to a medication 
regimen, and make changes to their diet. These changes are often implemented with a 
distal goal of delaying disease progression, and preventing the onset of comorbid health 
conditions. However, persons with diabetes mellitus frequently report difficulty adhering 
to their self-management regimen. This provides a unique opportunity for health 
psychologists, who have the skills to evaluate the etiology of such difficulties, such as 
environmental barriers or the psychosocial factors contributing to regimen non-
adherence. The section below will begin the discussion of barriers to engaging in a self-
management routine. 
Barriers to Self-Management: The Impact of Diabetes Burden 
There is a small literature available that suggests that the complex regimen 
individuals with diabetes must maintain can itself be perceived as a barrier to optimal 
diabetes self-management. The demands of the self-management regimen can directly 
contribute to decreased quality of life, suggesting quality of life is affected by the illness 
itself and the lifestyle changes that accompany diabetes (Glasgow, Ruggiero, Eakin, 
Dryfoos, & Chobanian, 1997). The burden of maintaining the self-management regimen 
often leads to diabetes-specific distress, and has been discussed in the literature as a risk 
factor for both poor glycemic control and poor adherence to the self-management 
regimen. This introduces the possibility of an affective component impacting this already 
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complex relationship, due to the distress associated with making these lifestyle changes 
(particularly adhering to the prescribed self-management regimen). This will be 
discussed in greater detail in the section below. Understanding the associations of affect, 
distress and self-management is important, it implies that this is a pathway by which 
affect contributes to the impact on both physical and psychological health in diabetes. 
Providing a Conceptual Framework/or Self-Management: Personal Models 0/ Diabetes 
Glasgow, Hampson, Strycker, and Ruggiero (1997) proposed a model of diabetes 
self-management that has been validated in the literature. This model suggests both 
personal models of diabetes and barriers to self-management are stronger predictors than 
a combination of demographic and other patient characteristics. Personal models of 
diabetes, according to Glasgow, Hampson, Strycker, and Ruggiero (1997) are "patient's 
representations of their illness, including disease-related beliefs, emotions, knowledge, 
and experiences" (p.556). This study included 2,056 adults with diabetes throughout the 
United States. Glasgow's model of Diabetes Self-Management (Figure 1) suggests these 
personal models influence the patient's ability to engage in self-management behaviors. 
The personal models were tested in this cross-sectional study using Glasgow's 
conceptualization, however only three components of the model were examined: (1) 
barriers, or challenges the individuals face with managing their diabetes, (2) treatment 
effectiveness, and (3) seriousness. Thus, while the authors' description of the Personal 
Model of diabetes self-management highlights the importance of emotion, their 
influential study did not integrate this key construct (emotion) into their actual research 
and figure depicting the model (i.e. Figure 1). Recent research highlights the importance 
of integrating emotion into conceptualization of disease and quality of life (Polonsky, 
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2000). This suggests that the omission of emotion in the studies examining living with 
diabetes self-management is meaningful, highlighting the importance of emotion as a 
core component of the Glasgow et al (1997) model. As will be discussed in subsequent 
sections of this paper, it is postulated that emotional distress may play an important role 
in diabetes by influencing not only disease management, but also quality of life. 
Emotion is conceptualized in the definition of "personal model", but studies 
focused on models of diabetes have repeatedly excluded analysis of emotion or 
symptoms associated with negative feelings. Due to the high comorbidity of depression 
and diabetes (discussed in subsequent sections of this paper), it is important that studies 
addressing self-management and Quality of Life examine the role of affect, as this could 
provide information to guide future interventions targeting specific symptoms of 
experiencing negative affect. This dissertation sought to address the emotion construct 
of the personal model of diabetes by examining specific components of depressive 
symptomatology that had previously been identified in the diabetes literature. Fatigue, 
diabetes-specific distress, and global depressive symptomatology were examined in the 
context of a personal model of diabetes framework, which is a modification of Glasgow 
et aI's (1997) model of self-management (see Figure 2). The affective components have 
been individually studied in the diabetes literature, but not in tandem within Glasgow's 
Personal Model self-management framework. 
Diabetes-specific Emotional Distress 
Due to both physical (e.g. changes to diet, exercise, blood glucose monitoring, 
administering medication) and psychological (e.g., problem solving ability, mental health 
status) demands of living with diabetes, researchers have documented the occurrence of 
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high levels of emotional distress and negative feelings in people with diabetes. Common 
emotions reported include: anger, reduced motivation, burnout, guilt, and discouragement 
(Welch, Jacobsen, & Polonsky, 1997). These emotions have been documented in the 
literature as diabetes-related distress and have been identified as an important risk factor 
for both poor adherence to diabetes regimen and poor glycemic control (Polonsky et aI., 
1995; Gary, Crum, Cooper-Patrick, Ford, and Brachati, 2000; Sultan and Heurtier-
Hartemann, 2001) . 
Measuring Diabetes-related Distress: The Problem Areas in Diabetes Scale 
Due to the importance of diabetes-related distress in people living with diabetes, 
the Problem Areas In Diabetes Scale (PAID) (Polonsky, Anderson, Lohrer, Welch, 
Jacobson, Aponte, & Schwartz, 1995) was created as a tool to assess the construct of 
diabetes-related distress both as a clinical tool and an outcome measure (Welch, Weinger, 
Anderson, & Polonsky, 2003). The PAID is a 20-item single-factor measure of diabetes 
related distress developed at the Joslin Diabetes Center and Harvard Medical School. 
This instrument has a 5-point item scaling, ranging from "Not a Problem" = 0 to "Serious 
Problem" = 4. Original scoring was a summed total; higher scores were indicative of 
higher levels of diabetes-specific distress. Original scoring has been simplified to a 
transformed scaled score ranging from 0-100, with higher scores demonstrating greater 
diabetes-specific distress. The main focus of the items surrounds feelings and moods 
associated with specific aspects of diabetes. The PAID has been found to be unrelated to 
age, duration of diabetes, education, ethnicity, and gender (Welch, Weinger, Anderson, & 
Polonsky, 2003). 
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The PAID is the most widely used instrument to assess diabetes-specific distress. 
A review of seven studies evaluating the utility of the PAID indicated internal reliability 
remained high (a = .90), and test-retest reliability was found to be adequate (r = .83). 
This study also found the PAID was correlated with a variety of theoretically relevant 
constructs such as general emotional distress, depression, diabetes self-management, 
diabetes coping, and health beliefs (Welch, Weinger, Anderson, and Polonsky, 2003). 
The next section will focus on studies that further elaborate upon the diabetes-
related distress construct by discussing the potential sources and consequences of 
diabetes distress. This section will also focus on the potential relationships between 
diabetes-specific emotional distress and possible overlapping constructs to further 
explore the relationships. 
Potential sources of Diabetes-related Distress 
One source of diabetes-specific emotional distress is thought to be the lifelong 
burdensome regimen patients with diabetes are required to maintain (Polonsky, 
Anderson, Lohrer, Welch, Jacobson, Aponte, & Schwartz, 1995). Recent studies have 
provided additional support for the role of the treatment regimen (injection of exogenous 
insulin vs. taking oral medication vs. diet-exercise regimen only) on diabetes-related 
distress in individuals with type 2 diabetes. Researchers reported individuals on an 
insulin regimen experienced greater diabetes-related distress than those on oral 
medications or diet and exercise only treatment regimens (Delahanty et aI., 2007). 
However, there is additional evidence that suggests patients with diabetes on high doses 
of oral agents may also report levels of distress similar to those on insulin regimens. This 
is believed to be due to a patient's heightened awareness that insulin injection therapy 
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will be prescribed next, if blood glucose levels do not decrease (Welch, Jacobsen, and 
Polonsky, 1997), or due to the complexity of the regimen itself. 
Another potential source of diabetes-related distress may be awareness of the 
necessity to adhere to self-management recommendations despite the knowledge that the 
onset of complications is often unavoidable (Welch, Jacobson, and Polonsky, 1997; 
Thomas, Jones, Scarinci, and Brantley, 2003). Changes in health status or adjusting to 
managing diabetes-related symptoms may activate thoughts and fears related to the 
progression of illness and the development of complications. Individuals with diabetes 
report worrying about the future and the development of additional complications as a 
primary source of diabetes specific distress regardless of type of diabetes and treatment 
regimen (Welch, Jacobsen, & Polonsky, 1997; Delahanty et aI., 2007). 
According to the literature presented above, the complexity of the treatment 
regimen and the worry associated with both fearing and experiencing increases in 
diabetic complications are potential sources of diabetes-related distress. Researchers 
have discussed the necessity for studies that evaluate the relationships between diabetic-
specific emotional distress and known overlapping constructs (e.g. depression and 
diabetes self-management behavior) (Welch, Jacobsen, and Polonsky, 1997). Diabetes-
related distress has emerged as a valuable construct related to the psychosocial impact of 
diabetes on both behavior and mental health. Depressive symptomatology may further 
influence an individual's experience of distress by enhancing diabetes-specific distress 
scores on the PAID, due to the overlapping emotional impact. 
In a recent meta-analysis by Stone, Peters, Davies, and Khunti (2006) 
psychological distress was described "as a natural and inevitable response" for 
9 
individuals with diabetes. The presence of depressive symptoms can be detrimental to 
diabetic outcomes. Diabetes-specific distress has been recently discussed in the literature 
as a construct that also may reflect more global depression, highlighting the overlap 
between these constructs. In a study comparing four measures of depressive 
symptomatology in persons with diabetes, the PAID was found to reflect both major and 
minor depression (Hermann, Kuzler, Krichbaum, Kubiak, & Haak, 2006). This study 
also provided support for the link between diabetes-related distress and depression. 
However, this is a relatively new area of research, and additional studies are needed to 
verify the validity of using the PAID in clinical samples of individuals with diabetes 
when screening for depression. 
The relationship between diabetes and depression as a comorbid condition is well 
established in the research literature. By examining this literature, additional information 
related to the psychological impact of depression on diabetes outcomes can be further 
evaluated to continue to explore existing relationships of the Personal Model emotional 
constructs. Ciechanowski, Katon, and Russo (2000) found that depression itself has 
detrimental influences on diabetes symptom burden. Depressed individuals with diabetes 
were more likely to experience a higher burden of disease-specific symptoms than non-
depressed individuals (Ciechanowski, Katon, and Russo, 2000). Given these depression-
diabetes burden associations, it seems highly plausible that depression would elevate 
diabetes-specific distress due to a shared affective component. The diabetes-depression 
literature will be examined in subsequent sections in order to address the potential 
overlap between diabetes-specific distress and global depression and their impact on 
diabetes self-management behaviors. 
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Depression and Diabetes 
Overview of Depression 
Depression (Major Depressive Disorder) is relatively common in the United 
States; the lifetime prevalence rate of major depression is approximately 16.2% (Kessler, 
Berglund, Demler, Jin, Koretz, Merikangas, Rush, Walters, & Wang, 2003). Depression 
manifests itself as a collection of both somatic (physical) and psychological (mental) 
symptoms. According to the Diagnostic and Statistical Manual of Mental Disorders-4th 
Edition-Text Revision (DSM-IV -TR), the diagnosis of Major Depressive Disorder is 
warranted if 5 or more of the following conditions are met over a 2-week period: the 
presence of a depressed mood or a loss of interest in once pleasurable activities, 
significant changes in appetite, hypersomnia or insomnia, psychomotor agitation or 
retardation, fatigue or loss of energy, feelings of worthlessness or inappropriate guilt, 
impaired concentration or indecisiveness, and recurrent thoughts of death (including 
suicidal ideation and/or intent) (APA, 2000). Depression can affect all areas of an 
individual's life; severity is often conceptualized in terms of functional distress and 
impairment. 
Depression in Diabetes 
The rates of depression are elevated in individuals with chronic medical disease 
(Katon & Sullivan, 1990) including diabetes (Lustman, Clouse, & Freedland, 1998). 
Recent research has indicated that adults with diabetes are twice as likely to have 
depression compared to individuals that do not have diabetes (e.g., Edege, Zheng, 
Simpson, 2002). Incidence rates of adults with diabetes in the United States are 
estimated to be 9.3% compared to 6.1 % for individuals without diabetes (Edege & 
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Zheng, 2003). Global depression has been extensively studied in the diabetes literature 
due to the implications of depression on physical and mental well-being. Depression has 
been found to be associated with poor glycemic control, increased functional impairment, 
poor diet and medication adherence, higher health care costs in diabetic patients 
(Ciechanowski, Katon, & Russo, 2000; Lin et aI., 2004) and has been found to have 
profound effects on quality of life (Goldney, Phillips, Fisher, & Wilson, 2004). 
Research in specific areas relevant to the complex relationship between diabetes 
self-management and depression will be reviewed below. This relationship is a central 
tenet of the framework of the model that will be introduced in this dissertation, modified 
from the Glasgow et. ai. (1997) diabetes-specific model of self-management described 
above. 
In a study conducted by the ADA (2006), specific gaps in diabetes self-
management education were identified as related to depression; specifically medication 
adherence, exercise, and diet. The literature on depression and diabetes and associations 
with health and well-being will be reviewed below. Potential areas of research that would 
inform these areas will be addressed. 
Prevalence of Diabetes and Depression and Associations with Health and Well-Being 
There is overwhelming evidence that comorbid depression in diabetes is 
associated with increased health problems, including increases in severity of diabetes 
symptoms, and an increase in risk of developing additional comorbid microvascular 
complications (e.g. retinopathy, nephropathy, peripheral neuropathy, cardiovascular 
disease) (Egede, 2006). Clinically relevant depression has been defined as "depression 
severe enough to warrant clinical intervention" (Anderson, Freedland, Clouse, and 
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Lustman, 2001). In a recent meta-analysis (Ali, Stone, Peters, Davies, and Khunti, 2006), 
prevalence rates of co-morbid depression in adults with type 2 diabetes were found to be 
significantly higher than in individuals without diabetes (17.6% vs. 9.8%). Another 
recent meta-analysis examined prevalence rates of depression among individuals with 
type 1 diabetes (Barnard, Skinner, and Peveler, 2006). In uncontrolled studies (the studies 
that did not have a comparison group) rates of depression were estimated to be 13.4%. Of 
the studies that had a control group, 12.0% of the diabetic population was depressed, 
compared to 3.2% of the healthy comparison groups. In a third recent meta-analysis 
(Anderson, Freedland, Clouse, & Lustman, 2001), a diagnosis of diabetes almost triples 
the odds of comorbid depression (OR=2.9, 95% CI 2.3-3.7), with no differences by type 
of diabetes, sex, subject source, or assessment method. 
The evidence from these meta-analyses suggests depression is significantly higher 
in individuals with diabetes compared to those without diabetes. The three studies 
mentioned above relied on cross-sectional data to reach their conclusions, which prevents 
causality or directionality from being determined. However, it is useful to examine this 
literature to determine specific health related targets that are affected by having both 
depression and diabetes. Due to the known benefit of maintaining optimal glucose levels 
among individuals with diabetes, the effects of depression on glycemic control will be 
reviewed below. 
The Impact of Depression on Glycemic Control 
A recent meta-analysis of studies conducted with individuals with type 1 and type 
2 diabetes found significant associations between depression and glycemic control 
(Lustman et aI., 2000). When comparing effect sizes between individuals with type 1 and 
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type 2 diabetes, there were no significant differences found in depression scores between 
groups, indicating that the effect of glycemic control on depression is similar in both 
populations. However, using diagnostic criteria for depression yielded a larger effect size 
(ES = 0.28) than when self-report measures were utilized (ES = 0.15) to assess for the 
presence of depression in both groups. The associations in both of these meta-analyses 
suggest there is an existing relationship between depression and glycemic control 
independent of type of diabetes, but that reported severity of depression may be a 
function of the method of assessment. 
Given the associations between depression and glycemic control and the impact 
of self-management behaviors on glycemic control, literature addressing the effects of 
depression on self-management behaviors will be reviewed below. 
The Impact of Depression on Diabetes Self management 
It has been well established that adoption of self-management behavior is crucial 
to optimal diabetes care. Evidence from large clinical trials has demonstrated that the 
effects of exercise, following dietary recommendations, and self-monitoring of blood 
glucose (SMBG) are essential to achieving optimal glycemic control, blood pressure, and 
lipid control (ADA, 2006). However, engaging and maintaining these recommendations 
frequently present challenges for persons with diabetes (Edege & Zheng, 2002; Nelson, 
Reiber, & Boyko, 2002; Harris, 2001). Co-morbid depression is believed to further 
complicate maintenance of adherence to diabetes self- management recommendations. A 
recent longitudinal study examined the relationship between depression and symptoms of 
diabetes and concluded depression influenced self-management behavior by affecting 
adherence to the self-management regimen (McKellar, Humphreys, & PIette, 2004). 
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Findings suggest that patient-initiated behaviors (e.g. exercise, dietary adherence, 
5MBG) are impacted by depression more than they are by physician-initiated services 
(e.g. HbAlc tests, physician visits) (Lin et aI., 2004). The above findings provide 
additional support for the impact of depression on the self-management component of 
successful diabetes management. Associations between depression and diabetes and 
other emotion-related outcomes will be further examined, as seen in the section below. 
The Relationship Between Depression, Diabetes, and Symptom Burden 
Ciechanowski, Katon, and Russo (2000) found that depression has a detrimental 
impact on diabetes symptom burden. In a sample of individuals with diabetes, those who 
were depressed were more likely to experience a higher burden of disease-specific 
symptoms than those who were not depressed. 
One possible explanation of the findings of the above studies could be the 
associations of the perceived burden of living with diabetic symptoms and complications, 
or the complexity of the regimen itself. Surwit, van Tilburg, Parekh, Lane and Feinglos 
(2005) demonstrated that the diabetes treatment regimen itself determined the 
relationship between depression and glycemic control. In individuals injecting insulin 3 
or more times a day (i.e. complex treatment regimen) depression was associated with 
glycemic control. The burden of diabetes has been found to be significantly associated 
with reporting more diabetic symptoms (Ludman et aI., 2004). This supports the 
influence of depression and diabetes-specific distress on both the perceived burden of 
living with diabetes symptoms and the demands of the treatment regimen itself. It 
appears that the complexity of the regimen that an individual is required to adhere to is 
associated with depression. However, there were no studies found that addressed the 
15 
impact of diabetes-specific depressive symptoms in relation to diabetes self-management. 
Such studies would be quite informative, due to the potential for shared heritability of the 
somatic component(s) of diabetes and depression. If symptoms overlap with both 
conditions, i.e. symptoms common to both diabetes and depression, it is important to 
identify the etiology of those symptoms to maintain accuracy of both diagnostic and self-
report measurement of these symptoms. The subsequent section will review the existing 
literature that link shared symptomatology of depression and diabetes, to explore 
potential overlap in greater detail. 
Possible Mechanisms Underlying Depression and Diabetes 
Recent literature lends support to two potential hypotheses linking depression and 
diabetes. One hypothesis suggests that depression precedes the onset of type 2 diabetes. 
There are several studies that support this hypothesis (e.g. Eaton, Armenian, Gallo, Pratt, 
and Ford, 1996; Golden et aI., 2004). However, this finding has not been universal, 
findings that depression precedes the onset type 2 diabetes has been inconsistent (e.g. 
Saydah, Brancati, Golden, Fradkin and Harris, 2003; Carnethon, Kinder, Fair, Stafford 
and Fortmann, 2003). When examining the mechanisms that could support this 
hypothesis, a recent literature review suggested that the increased risk of developing 
diabetes following the onset of depression stems from increased counterregulatory 
hormone release and action, mutations in glucose transporters, and increased 
immunoinflammatory activity. These physiological changes are believed to add to 
cellular insulin resistance, causing the onset of type 2 diabetes (Musselman, Betan, 
Larsen, & Phillips, 2003). The mechanisms of this process remain poorly understood, 
additional research in this area is needed to clarify these relationships (Edege, 2006). 
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A second hypothesis in the literature suggests depression in diabetes is caused by 
the psychosocial stressors related to having a medical condition. In one prospective 
study, youths who had Type 1 diabetes were followed over a lO-year period to assess for 
the onset of psychiatric conditions. Results indicated that after 10 years, 27.5% of 
participants developed major depression (Kovacs, Obrosky, Goldston, & Drash, 1997). 
In another large study of older adults with diabetes, results indicated there was a 3.7 fold 
increased odds of the onset of depression in type 2 diabetes (Palinkas, Barrett-Connor, & 
Wingard, 1991). This research suggests that regardless of age and type of diabetes, 
psychosocial factors playa role in the development of depression. 
A third possibility that must be considered and has not been explored thus far is 
that there may be symptoms that overlap both depression and the physical aspects of 
diabetes. The somatic component of depression is one area that provides considerable 
opportunity for symptom overlap between depression and diabetes. The next section will 
review the current literature examining the shared somatic symptoms between depression 
and diabetes. 
Shared Somatic Symptoms of Both Depression and Diabetes. 
The above section summarized the recent literature examining the relationship 
between depression and diabetes. However, the potential overlap of somatic symptoms 
of depression and symptoms of diabetes is virtually absent in the literature. In a recent 
review by Edege (2006), it was suggested the overlap between symptoms of suboptimal 
control of diabetes and depression are often overlooked in the medical community and in 
the literature. Somatic symptoms such as fatigue, changes in appetite, changes in 
weight, and sleep disturbance could share etiology from either illness (Edege, 2006). 
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A recent large study examining the relationship between diabetes and symptom 
burden highlights the relevance of examining the coexisting symptomatology between 
depression and diabetes (Ludman et aI., 2004). In this study of 487 patients with both 
diabetes and co-morbid depression, the association between depression-diabetes 
symptoms was stronger than the association between number of diabetes symptoms and 
glycemic control and diabetic complications. This study provides support for the strength 
of the association between depression and diabetes symptomatology. However, 
individual symptoms characterizing depression (e.g. fatigue, depressed mood, change in 
appetite, etc.) were not specifically examined. Additionally, because the study was cross-
sectional, causality cannot be determined. However, the significant results observed in 
this study remained significant after controlling for age, gender, marital status ethnicity, 
HbA1 c , number of complications, additional medical comorbidity, duration of diabetes, 
type of diabetes, and treatment intensity. 
This study also used well-validated measures to assess the somatic symptoms. 
Ludman et al (2004) used a self-report version of the PRIME-MD adapted from the 
Patient Health Questionnaire Study (Spitzer, Kroenke & Williams, 1999) to assess both 
prevalence and intensity of depression over time. Diabetes symptoms were measured 
using the Self-Completion Patient Outcome instrument (Whitty, Steen, Eccles, 1997). 
This instrument measures symptoms of diabetes including: cold hands and feet, numb 
hands and feet, polyuria, excessive hunger and/or thirst, shakiness, blurred vision, feeling 
faint and feeling sleepy. Items are scored on a Likert type scale that ranges from "never" 
to "every day". Symptoms are considered positive if they are experienced at least 
"several days" in the past month. Severity was identified via chart review. These 
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measures also demonstrated adequate internal consistency that strengthens the results of 
this study reviewed above. Ludman et al (2004) demonstrated that as the number of 
symptoms of depression an individual experiences increases, the number of symptoms of 
diabetes increase, even after controlling for complications and other potential 
confounding variables. 
Examining the somatic overlap between symptomatology shared by both 
depression and diabetes could provide a framework for examining diabetes emotions and 
symptom burden by providing additional information that could guide optimal medical 
care (e.g. mental health screening vs. additional medical diagnostic testing). 
Somatic Symptom Burden in Diabetes: The Potential Role of Fatigue 
Surridge et ai. (1984) found that fatigue was the most commonly reported 
diabetes physical demand including coping with fatigue by individuals with type 1 
diabetes. Out of the 50 individuals enrolled in this study, 31 of them reported 
experiencing an increase in fatigue, with 20 of them reporting considerable impairment as 
a result of this fatigue (Surridge et aI., 1984). This unique descriptive analysis provides 
preliminary evidence for the utility of examining fatigue in the diabetic population. 
Although this evidence for the role of fatigue in diabetes health and well-being is 
encouraging, the relatively small sample size in this study prohibits definitive conclusions 
from being drawn. It is also worth noting that it was the only study found that 
demonstrated the significance of this construct specifically in a diabetes sample. 
However, a large literature on fatigue and well-being is present in the larger behavioral 
medicine literature. 
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Additional support for the significance of fatigue impacting quality of life in 
individuals with chronic disease is demonstrated in a recent large longitudinal study that 
examined the validity of the DSM-IV criteria for depression among individuals with and 
without chronic co-morbid medical conditions (Simon & von Korff, 2006). There is an 
existing debate surrounding the inclusion of somatic symptoms when assessing for 
depression in a chronic disease population (Cavanaugh, Clark, & Gibbons, 1983). A 
recent study by Simon and von Korff (2006) demonstrated that of all of the somatic 
symptoms, the probability of reporting fatigue was greater in individuals with chronic 
disease when compared to a general medical clinic population (54% vs. 45% 
respectively). This suggests that health-related fatigue may be an independent construct 
in chronic disease and that assessment of fatigue could provide information above and 
beyond that of depression or other disease-specific distress measures alone. The results 
of Simon and von Korff (2006) provide support for the utility of independently 
examining fatigue and depression/disease specific distress, due to the increased 
prevalence of fatigue in chronic disease populations, particularly diabetes. 
The next section will focus on defining the construct of fatigue, in addition to 
highlighting the importance of fatigue as a symptom of both somatic function and distress 
in other chronic diseases. In addition, the utility of this construct in type 2 diabetes will 
be discussed. Initially, the larger chronic disease literature will be discussed, due to the 
limited representation of fatigue in the diabetes literature. Then, the smaller literature 
that is specific to fatigue in diabetes will be presented and the methodologies critiqued. 
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Fatigue in the Larger Chronic Disease Literature 
As previously presented, fatigue is an important construct in the chronic disease 
literature. Fatigue is considered to be one of the most commonly reported symptoms of 
chronic disease. Due to the commonality of this symptom, it has emerged as a useful 
construct relating to both functional status and quality of life. Fatigue has been identified 
in a variety of conditions, resulting from the illness itself, treatment, or psychological 
factors such as depression. Due to the complexity of this issue, the behavioral medicine 
literature has examined both the impact and causes of fatigue in several populations. 
Edege (2006) suggests an integrated approach to evaluating fatigue, which includes but is 
not limited to the fields of psychology, behavioral science, nursing, and medicine. 
One of the aims of this dissertation study was to examine self-reported fatigue as 
a potential emotional symptom of diabetes. Thus far, it has been identified as a 
potentially useful construct that has overlap with both physical (i.e. diabetes) and 
psychological (i.e. disease-specific distress, depression) illness. However, within the 
diabetes literature, there is limited evidence identifying definitions of fatigue and/or 
possible associations with other physical or psychological constructs. Therefore the 
section below will present the larger chronic disease literature to identify conceptual 
frameworks and existing theoretical models that provides support for examining this 
construct as a viable construct within the diabetes literature. 
Definitions of the Fatigue Construct 
Fatigue is a common complaint among patients suffering from a myriad of 
chronic diseases, including various forms of cancer and associated treatment, multiple 
sclerosis, and chronic fatigue syndrome. One of the greatest methodological challenges 
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in the fatigue literature centers on a consistent definition of the construct. In the existing 
literature, the definition of a symptom is often considered to be broadly defined as a 
manifestation of any illness. More specifically, symptoms are often discussed in terms of 
the individual's experience, and may not be directly observable (i.e. pain, nausea, fatigue, 
Rhodes, Watson, & Hanson, 1988). Fatigue is consistently operationalized as a 
subjective experience in the literature, which is consistent with the above description of 
symptom experience. Although fatigue is typically conceptualized as a subjective 
experience, the definitions of fatigue are inconsistent in the published literature. In a 
recent study, Richardson (1998) concluded that in the existing literature there are a 
variety of definitions that are ambiguous, numerous, and inconsistent across research 
studies. The absence of a comprehensive, consistent definition across studies prevents 
progress in the development of theoretical models that could potentially facilitate clinical 
practices related to chronic disease management. 
Defining Fatigue in Chronic Illness 
Definitions of fatigue have often been conceptualized as a decrease in physical 
performance or a loss of energy (Wu & McSweeny, 2001), but the debate over this 
construct continues in the literature. Piper (1986) was one of the pioneering researchers 
in operationalizing fatigue as an important symptom in cancer. Fatigue was described as 
"a subjective feeling of tiredness that is influenced by circadian rhythm; it can vary in 
unpleasantness, intensity, and duration" (Piper, 1986, p. 220). According to this 
definition, fatigue is conceptualized as serving as a protective function when it is 
experienced by the individual acutely. When fatigue becomes more chronic however, the 
protective function is no longer served. 
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In contrast, Rhodes, Watson, and Hanson (1988) suggested that fatigue in patients 
with cancer leads to distress when it is inconsistent and experienced less often. They 
report that when fatigue is experienced more frequently, cancer patients often do not 
experience high levels of distress. This finding was contingent upon patients developing 
appropriate self-management strategies to minimize their fatigue levels. Authors of this 
article suggested that individuals who experience fatigue intermittently may not have 
adequate self-management strategies in place to manage these symptoms, which may in 
turn lead to increased distress. Additionally, there was an observed association between 
engaging in appropriate self-management strategies and fatigue in patients with cancer. 
"Tiredness" was the symptom that interfered with self-management most frequently. 
Rhoten (1982) suggested intensity of symptoms differentiates fatigue from 
tiredness, per se. He defined fatigue as a state of general negative feeling that is 
associated with pain, discomfort, and pain medication. The sample studied was a 
postoperative patient population. Tiredness was defined as resulting from physical 
activity and was considered a normal physical phenomenon that could be relieved by 
adequate amounts of rest. Fatigue was defined as being experienced in longer duration 
and a more extreme state with both physical and mental aspects. This definitional 
approach suggests the possibility of a multidimensional aspect of this construct due to its 
impact on multiple areas of an individual's quality of life (i.e. physical, mental). This 
definition is in sharp contrast to the definition provided by Rhodes, Watson, and Hanson 
(1988), which defines the experience of fatigue as being associated with the frequency of 
symptom experience. Rhoten (1982) conceptualizes an increase in frequency and 
severity of the symptoms as differentiating fatigue from tiredness. These varied 
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definitions of fatigue highlight the differences and contradictions present in the literature 
that impede consistent results across studies. Without additional empirical support, 
progress toward gaining better understanding of fatigue is limited. 
As fatigue has gained increased attention from clinicians and researchers in 
behavioral medicine, many professionals have operationalized fatigue as a 
multidimensional construct. Individuals do not all share the same fatigue experience, it is 
subjective, multidimensional, and difficult to measure (Glaus, Crow, and Hammond, 
1996). One multidimensional definition proposes the development and establishment of 
cancer related fatigue (CRF). Cancer related fatigue defines a host of criteria that would 
standardize definition of fatigue for cancer patients (Cella, Peterman, Passik, Jacobsen, 
and Breitbart, 1998). For the full list of criteria for CRF, the reader is referred to Table 1. 
These proposed criteria were developed for inclusion in the International Classification of 
Diseases-10th Edition (lCD-lO). The ICD-IO is widely used for diagnosis in the medical 
community (World Health Organization, 1992), and the inclusion of CRF into this 
classification system would solve the problems associated with inconsistency. 
The majority of the information presented on fatigue thus far has been related to 
cancer. Fatigue is also a prevalent symptom in the Multiple Sclerosis literature, but 
literature is inconsistent when defining the construct. In a study examining the impact of 
fatigue and depression on quality of life in mUltiple sclerosis, fatigue was defined as "an 
abnormal sense of tiredness or lack of energy out of proportion to the degree of daily 
effort or degree of disability" (Janardhan & Bakshi, 2001, p.54). An earlier study 
conceptualized fatigue in terms of four distinct categories which supports a 
multidimensional approach (Schwartz, Coulthard-Morris, & Zeng, 1996). In a recent 
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study by Pittion-Vouyovitch et al. (2006) fatigue was defined as "a lack of physical or 
mental energy or a feeling of tiredness. [It is believed] to affect social relations, daily 
activities, cognitive and physical domains" (p.39). By comparing definitions used in 
these studies, similar inconsistencies that exist in defining the experience of fatigue in 
cancer are also found in the multiple sclerosis literature. There is a methodological 
debate that encompasses the enmeshment of measurement and definition inconsistencies 
in the existing literature for both cancer and Multiple Sclerosis. 
Summary o/Conceptual and Methodological Issues in the Chronic Illness Fatigue 
Literature. 
Inconsistencies in definitions presented above are intended to highlight the 
diverse definitions available in the chronic disease literature. This impedes progress in 
further research by prohibiting generalizable conclusions from being drawn. Recent 
research in this area presented in chronic disease suggests a multidimensional approach 
would best capture the experience of fatigue; however this is not always apparent when 
examining how fatigue is defined. Consistent factors of the definitions presented above 
suggest fatigue is a subjecti ve symptom that can vary in intensity, frequency, and 
duration. Additionally, fatigue is a symptom that surpasses "tiredness" in the sense it is 
chronic and not alleviated by adequate amounts of rest. Multidimensional definitions that 
capture the complexity of this issue are lacking consistency in the literatures reflecting 
the chronic disease populations presented above. It appears the cancer quality of life 
literature has examined this construct in greatest detail, and has developed criteria for 
defining and assessing cancer-related fatigue. The cancer literature provides a framework 
that may be applied to evaluating the diabetes literature. The complexities surrounding 
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measurement of fatigue largely seen in the cancer literature are demonstrated by a review 
of questionnaires that have been developed in this area, seen below. 
Fatigue Measurement 
Review of fatigue measurement instruments reflects inconsistencies in 
measurement approaches. There is a current debate centering on the dimensionality of 
fatigue that further complicates measurement approaches. The next section will explore 
this debate, discussing evidence for both unidimensional and multidimensional methods 
for assessment of fatigue in chronic disease. By exploring assessment measures of 
fatigue, this may further explain the complicated relationships observed between fatigue, 
physical symptom reports and distress/depression in persons living with chronic disease. 
Measuring Fatigue in the Cancer Literature 
Due to the definitional issues in the fatigue literature, it is not surprising that there 
is a debate in the literature pertaining to optimal methods of assessing this construct. The 
majority of current fatigue measures have been developed from a multidimensional 
model that includes general, cognitive, affective, somatic, and vigor dimensions of 
fatigue. Although theoretical foundations conceptualize fatigue as a multidimensional 
construct, measures of fatigue often display substantial subscale intercorrelations and 
lack sufficient discriminability from one another. An additional line of research suggests 
the most efficient method of evaluating fatigue is the parsimonious assessment of a single 
general fatigue construct or scale. This unidimensional approach is appealing when 
assessing medical populations in clinical settings, due to the timeliness and simplicity of 
this approach. Such approaches include fatigue by asking about it directly (i.e. using the 
word fatigue), or through visual analogue scales. For example, in a recent study by 
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Reyes-Gibby, Aday, Anderson, Mendoza, and Cleeland (2006) "Fatigue was defined by 
the response to the question "Have you had any of the following persistent or 
troublesome problems .... severe fatigue or exhaustion" (p.120). Some clinicians also 
report assessing fatigue by simply asking if the patient is tired, or if they feel impacted by 
fatigue, which eliminates the intensity dimension of fatigue has been examined and that is 
validated in both unidimensional and multidimensional approaches. 
The multidimensional vs. unidimensional debate regarding assessment of fatigue 
is unresolved in the current fatigue literature. It is widely accepted in the literature 
however, that due to the subjectivity of fatigue as a symptom, use of self-report 
questionnaires is a valid measurement technique (Jacobsen, 2004). The next section of 
this proposal will divide the discussion of fatigue assessment into two parts: 1) 
Unidimensional measures of fatigue and 2) Multidimensional measures of fatigue. For a 
complete list of measures including dimensional characteristics and psychometric 
information, the reader is referred to Table 2. The following discussion will focus on the 
conceptual frameworks that underlie these measurement approaches. Commonalities and 
differences across measures will be discussed in detail. The measures have been 
organized in terms of dimensionality, to illustrate both perspectives of this debate. 
Unidimensional Measures of Fatigue 
The majority of measures that unidimensionally assess fatigue focus on the 
severity or intensity of the symptom. One consistent limitation is cited in the 
methodological design of the studies using these measures. Frequently, researchers have 
used measures without providing validity information specific to the illness of the subject 
sample, or intention for the measurement tool selected. This can pose potential difficulty 
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in the consistency of measurement in the literature, as some measures are defined in 
terms of the medical population they are studying l e.g. Functional Assessment of Cancer 
Therapy (FACT) Yellen, et aI, (1997)]. This prohibits generalizability of the possible 
associations that could be uncovered by using a measure that is not specific to the disease 
itself. In contrast, the Fatigue Severity Scale (FSS) [Krupp et aI, (1989)] is a commonly 
used measure of fatigue that can be used across medical populations. Its name is 
somewhat of a misnomer however, because the FSS actually measures the impact and 
functional outcomes of fatigue rather than symptom severity. 
The majority of other unidimensional instruments measure the severity of fatigue 
on a single dimension. Close examination of these measures suggests that overall, the 
majority of instruments measure severity of fatigue itself, but lack operational definitions 
of the fatigue construct. The unidimensional measures do not provide consistency nor 
clarity in terms of definitions, instead these measures mostly focused on severity while 
ignoring individual factors that address some of the definitional confounds previously 
described. Consistent with unidimensional definitions of fatigue (e.g. Rhoten, 1982) these 
measures typically focus on the severity of the symptoms of fatigue. However little 
information is actually provided in terms of symptom operationalization, rather assume 
that the construct "fatigue" exists, and that it is often severe in chronic illness 
populations. 
Due to the limitations of the unidimensional approach, many researchers have 
advocated for a multidimensional approach. Multidimensional assessment may provide 
an opportunity to assess different aspects of the fatigue experience, while assessing for 
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severity of fatigue in each of the factors that contribute to the overall experience of 
fatigue (e.g. mental and physical fatigue). 
Multidimensional Measures of Fatigue 
Recent research reviewed in the cancer, multiple sclerosis, and chronic fatigue 
syndrome literatures suggests that chronic disease fatigue assessment would benefit from 
using a multidimensional approach to maximize understanding of experiencing fatigue, 
given its subjective nature (Jacobsen, 2004; Smets, Garssen, Bonke, & De Haes, 1995). 
When fatigue is measured in a multidimensional way, emotional, behavioral, and 
cognitive components are commonly assessed (Lewis & Wessely, 1992). Two reviews 
have discussed the multidimensional fatigue scales, and report them to be more 
comprehensive (Alberts, Vercoulen, and Bleijenberg, 1999; Friedberg and Jason, 1998), 
and due to the known differences between patients' experiences, essential to clarifying 
the ambiguity of fatigue as a construct. Severity of a poorly understood construct that 
remains ambiguous may not provide answers to more specific research questions. 
Research that incorporates multidimensional measures provides an opportunity to assess 
the actual experience of the individual in terms of which aspects of fatigue individuals are 
experiencing (i.e. physical symptoms and affective symptoms), and possibly distinguish 
differences in fatigue "profiles" across different chronic disease and working populations. 
The Multidimensional Fatigue Symptom Inventory-Short Form (MFSI-SF) is an 
excellent example of a multidimensional fatigue measure. Is was designed by researchers 
based on the existing literature suggesting fatigue is a multidimensional symptom that 
can be best captured by evaluating five dimensions: general (i.e. severity), affective, 
physical, mental, and vigor (Stein, Martin, Han, & Jacobsen, 1998). Additionally, it has 
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been argued that, due to the absence of disease-specific information, it is a flexible 
measure that can be used in a variety of populations (Dittner, Wessely, & Brown, 2004). 
The MFSI-SF is believed to have good psychometric properties, including excellent 
internal consistency, good diagnostic validity, good test-retest reliability, and sufficient 
ability to discriminate between fatigued and non-fatigued individuals (Wu & McSweeny, 
2001). 
The Checklist of Individual Strength (CIS) is another measure developed out of 
the multidimensional assessment trend (Vercoulen, Swanink, Fennis, Glalma, van der 
Meer, & Blegijenberg, 1994). The CIS was developed using CFS patients as a validation 
sample (Vercoulen, Swanink, Fennis, Glalma, van der Meer, & Blegijenberg, 1996), and 
has been validated in working populations (Beurskens, Bultmann, Kant, Vercoulen, 
Bleijenberg, & Swaen, 2000), and MS patients (van der Werf, Jongen, Nijeholt, Barkhof, 
Hommes, & Bleijenberg, 1998). 
Issues in Assessment Tools Measuring Fatigue 
One limitation in the multidimensional fatigue literature is the development of 
questionnaires on an ad hoc basis, which hinders the possibility to advance the construct 
and decreases the overall reliability of the results. Definitional confounds have also been 
observed in measurement studies. Jacobsen (2004) discussed an absence of a commonly 
agreed upon definition leading to a lack of a consensus regarding fatigue measurement. 
Different research groups utilize different instruments that are theoretically dissimilar, 
preventing a consensus regarding definition and measurement. In a review conducted by 
Dittner, Wessely, and Brown (2004), this issue was presented as a "Catch 22 ... before a 
concept can be measured, it must be defined, and before a definition can be agreed, there 
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must exist an instrument for assessing phenomenology" (p. 166). They suggest when 
considering dimensionality, research should address the purpose of the information they 
are attempting to collect. It is unlikely that one assessment measure will develop as the 
"gold standard" due to the complexity of fatigue measurement and the ambiguous issues 
surrounding definition (Dittner, Wessely, & Brown, 2004). 
Several unanswered questions in the multidimensional fatigue literature include 
influences of the course of fatigue which remains unknown due to the prevalence of cross 
sectional studies, and the lack of longitudinal information. Measurement approaches 
contribute to this by the lack of consistency in measuring the fatigue construct and in the 
study designs utilized. In addition, the measurement instruments themselves contribute 
to the issues, some tapping fatigue in the past two weeks, some discussing at present 
time, some relying on a 24-hour recall. Research could address these limitations by 
cross-validating instruments over time, to provide information that can explain temporal 
relationships of fatigue. 
One final issue that must be addressed concerns the potential for measurement 
overlap in assessing fatigue and chronic illness comorbidity. As previously discussed, 
treatment issues and diseases themselves may contribute to the experience of fatigue, and 
the overlap between the symptom of fatigue in depression and chronic disease also need 
to be adequately addressed. Due to the absence of a biological marker for fatigue, a 
heavy reliance is placed on self-report measures due to the subjectivity of the fatigue 
experience. Fatigue can be experienced as a physical symptom due to the physical (or 
somatic) dimension described by individuals that experience it. Additionally, chronicity 
and severity contribute to the physical manifestations of fatigue, including weakness and 
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tiredness that remain after rest. Studies that examine convergent and discriminant 
validity across fatigue instruments and between fatigue, disease-specific distress and 
global depression measures are currently non-existent in the chronic disease literature. 
Fatigue and Chronic Illness: Summary and Future Directions 
Thus far, this review has demonstrated the impact of depression and diabetes-
specific distress on diabetic outcomes. More specifically, the literature discussed has 
illustrated the impact of depression and diabetes-specific distress on diabetic symptoms, 
glycemic control, and self-management behaviors. Fatigue was introduced as a symptom 
that potentially shared an etiology with both depression and diabetes, and was found to be 
a commonly reported symptom in this population. However, the fatigue literature is very 
small within this population. Therefore, the existing current fatigue literature was 
reviewed in other chronic diseases, to illustrate the importance of this construct in other 
chronic disease populations. 
Fatigue has been discussed thus far in this review in the context of cancer, MS, 
and depression. However, measuring fatigue as a symptom of diabetes has not been well-
addressed in the literature; and the few studies that exist have been primarily conducted 
in working samples. The following section will review the studies on diabetes and 
fatigue, to inform the reader of the current status of the research in this area. A 
methodological critique will be presented. Results of the individual studies will be 
integrated to suggest a potential model that will guide future research examining the 
impact of fatigue on diabetes mellitus and the associations with measures of distress. 
Within diabetes, fatigue may have several possible etiologies (e.g. physical vs. 
psychological). This construct was selected for inclusion in this proposal due to the 
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prevalence of fatigue among individuals with diabetes (e.g. Surridge et aI., 1984), the 
overlap of fatigue and psychological distress, and the relative lack of data that addresses 
these specific symptoms in the diabetes-distress literature. 
Fatigue in Diabetes Mellitus 
Integrating fatigue into the diabetes-distress research can expand the current 
health psychology literature in behavioral diabetes. This integrative approach may guide 
future research in this area by exploring the overlap of depression and physical symptoms 
associated with diabetes and performance of self management behaviors. Thus far, this 
review has highlighted the existing evidence and methodological problems in both the 
definition of fatigue, and consistent measurement in this area of research. 
A Critique a/the Studies an Fatigue in Diabetes 
There were only five studies found in the literature that assessed fatigue as a 
symptom in the diabetes population in any context. Four of these studies were cross-
sectional, preventing determination of causality. These four studies included type 1 
diabetes, type 2 diabetes, diabetes with additional co-morbid chronic disease, and 
gestational diabetes populations, which prevents generalizability across studies. 
However, three of these studies used the Checklist of Individual Strength to measure 
fatigue (Weijman, Ros, Rutten, Schaufeli, Schabracq, & Winnbust, 2003; Weijman, Kant, 
Swaen, Ros, Rutten, & Schaufeli, et aI, 2004; Weijman, Ros, Rutten, Schaufeli, 
Schabracq, & Winnbust, 2005) which has been validated in healthy working populations 
(Beurskens, Bultmann, Kant, Vercoulen, Bleijenberg, & Swaen, 2000). This 
multidimensional measure assesses severity and behavioral consequences of fatigue using 
a 7-point Likert scale. All three studies reported a cut-score of 76 indicating prolonged 
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fatigue, which is consistent with previous empirical research in a working population 
(Bultmann, de Vries, Beurskens, Bleijenberg, Vercoulen, & Kant, 2000). Additionally, 
this facilitates generalizability in terms of a valid point of reference across studies, which 
has been lacking in previous research. 
Two of these studies included both type 1 and type 2 diabetes (Weijman, Ros, 
Rutten, Schaufeli, Schabracq, & Winnbust, 2003; Weijman, Ros, Rutten, Schaufeli, 
Schabracq, & Winnbust, 2005), the third included "diabetics" and compared them to four 
additional comparison groups that included both "healthy" individuals, individuals with 
diabetes with additional co-morbidity, and individuals with other chronic illnesses 
(Weijman, Kant, Swaen, Ros, Rutten, & Schaufeli, et aI, 2004). 
Diabetes-illness related variables accounted for 43.5% of the variance in fatigue 
in the Weijman et al (2003) study. An additional 16.3% of the variance in fatigue was 
explained by work characteristics. In a similar study, 30% of the population of insulin 
treated diabetics (type 1 and type 2 diabetes) reported CIS scores above 76, indicating 
they experienced prolonged fatigue (Weijman et aI., 2004). This finding is supported by 
two of the three studies described above (Weijman et aI., 2003; Weijman et aI., 2005), 
suggesting fatigue is consistently reported more frequently in diabetic working 
populations when compared to healthy controls without diabetes. It should be noted that 
the third study did not support these findings, and reported contrasting findings with 
results, indicating that individuals with diabetes and no other co-morbid conditions 
reported similar fatigue levels to a "healthy" population. However, once additional co-
morbidity was included in analyses, fatigue severity was significantly higher for diabetic 
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groups that also had additional physical illness (Weijman, Kant, Swaen, Ros, Rutten, & 
Schaufeli, et aI, 2004). 
An important consideration in the study of fatigue in diabetes is that associations 
with self management have been examined. With respect to fatigue and self-management 
behaviors, individuals who perceived insulin injections or dietary guidelines as a burden, 
reported higher levels of fatigue, and more depressive symptoms. Those who perceived 
diabetes self-management behaviors as less burdensome (i.e. less-diabetes-specific 
distress) were more likely to engage in that behavior, and reported lower levels of fatigue 
than if the behavior was perceived as more burdensome (Weijman, Kant, Swaen, Ros, 
Rutten, & Schaufeli, et aI, 2004). This provides preliminary evidence of a relationship 
between diabetes-specific distress, co-morbidity, and fatigue that warrants additional 
attention. The results of this study should be interpreted with caution, due to the 
inequality of sample size in the differing disease groupings (e.g. N = 8,946 in the healthy 
group vs. N = 76 in the DM only condition and N = 65 in the DM group with 
comorbidity). This is believed to be a significant finding in terms of building a 
conceptual framework, as research has indicated higher disease comorbidity to be 
associated with poorer diabetes outcomes. 
The fourth cross sectional study included in this critique attempted to understand 
exercise beliefs and behaviors in women with gestational diabetes (Downs & Ulbrecht, 
2006). Researchers conducted this study without a priori hypotheses, to prevent "biased" 
results. Furthermore, although fatigue was included as an outcome variable, it was not 
defined and specific information as to how fatigue was assessed was not included in the 
paper. Nonetheless, fatigue was reported as the strongest barrier preventing engaging in 
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exercise during pregnancy. This result was no longer significant in a post-partum 
assessment. These results are to be interpreted with caution due to associated 
methodological limitations in the manner in which fatigue was assessed. As this was a 
small descriptive study, there was a small sample size (N=28) and no comparison group. 
Due to these issues, it is unclear if fatigue as a barrier to exercise is specific and unique to 
a diabetic pregnant population or if this barrier is also relevant in healthy pregnant or 
non-pregnant diabetes populations as well. Due to the known benefits of exercise on 
diabetic outcomes, replication is warranted in both type 1 and type 2 diabetes 
populations, as fatigue could be identified as a potential target for intervention. Exercise 
has a known paradoxical impact on both fatigue and glycemic control. Continuing this 
line of research is recommended to further explore this relationship. 
One recent longitudinal study included in this review (conducted in 2005) 
examined a diabetes-screening program for type 2 diabetes. The Hoorn Screening study 
focused on the level of diabetes-specific symptom distress and its relationship to negative 
mood in individuals enrolled in a screening program for type 2 diabetes (Adriaanse et aI., 
2005). This Dutch study included 319 participants recruited from a pre-existing study of 
a screening program for type 2 diabetes (N=11 ,679). Questionnaires included the Type 2 
Diabetes Symptom Checklist (Grootenhuis, Snoek, Heine, & Bouter, 1994) and the 
Negative well-being subscale of the Well-being Questionnaire (Pouwer, van der Ploeg, 
Ader, Heine, Snoek, 1999). The sample was divided based on their screening results; 156 
of the participants received a diagnosis of type 2 diabetes, and the remaining 163 were 
identified as non-diabetic. The final sample included 116 participants who received a 
diagnosis and 130 who were non-diabetic. 
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Results of this study demonstrated that subjects with type 2 diabetes were 
significantly more burdened by fatigue symptoms in the first year post-diagnosis than 
were the individuals in the non-diabetic group. This group difference was also found to 
be stable over time. This provides longitudinal evidence that fatigue is a distressing 
symptom for individuals with type 2 diabetes for the first year post-diagnosis. It is also 
possible that the finding of greater psychological fatigue in the first year was due to 
diabetes-specific distress associated with diabetic symptoms and the new attempts to 
follow recommended self-management behaviors. This study provides evidence that 
within the first year after diagnosis, fatigue is not only perceived to be significantly 
different for individuals with type 2 diabetes compared to non-diabetic individuals, but 
that it is stable over time. Since this study only followed participants for one year it is 
unclear if this temporal relationship remains significantly longer than 12 months. 
Summary and Limitations of Literature on Fatigue in Diabetes 
The results of the five studies presented above suggest that fatigue is common in 
the diabetic population and warrants further attention. Diabetes-specific distress has been 
discussed above as a contributor to prolonged fatigue. Research has also linked diabetes-
specific distress to depression. Finally, fatigue has been identified as an exercise barrier 
for women with gestational diabetes. However, there were no studies identified in the 
literature examining fatigue among diabetes in medical settings (i.e. primary care, 
diabetes clinics) to gain additional insight into the impact of fatigue. Because these 
studies included working populations and pregnant women, it is possible that assessment 
within a medical setting would produce different results. 
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The above sections have illustrated the importance of measuring fatigue and 
depressive symptomatology in a diabetes population. Previous sections highlight the 
essential role of self-management for successful diabetes management. However, the 
impact of diabetes-specific distress, depressive symptomatology, and fatigue on quality 
of life, specifically health related quality of life has not yet been addressed in this 
proposal. Quality of life serves as an important outcome in the diabetes literature, as it 
has been shown to be an essential construct when discussing self-management. The 
following section will highlight the current literature focusing on what is known about 
the relationship between diabetes and health-related quality of life. 
Measuring Fatigue-related Outcomes in Diabetes 
Defining Quality of Life 
Quality of Life can be defined as the ways in which health, illness, and medical 
treatment effect an individual's perception of their daily functioning and well-being 
(Guyatt, Feeny, & Patrick, 1993). Recent literature suggests quality of life has 
increasingly been utilized as an outcome measure with individuals with chronic disease, 
including diabetes mellitus (Jacobson, de Groot, & Samson, 1997). Individuals with 
chronic illnesses often report decreased Quality of Life when compared to individuals 
without chronic illnesses (Stewart, Greenfield, Hays et aI, 1989). However, the reasons 
for these differences are often multi-factorial, and poorly understood. 
Quality of Life and Diabetes 
There is a large body of literature evaluating Quality of Life in diabetes mellitus. 
What is currently known about diabetes mellitus and Quality of Life is that Quality of 
Life is influenced by the number of secondary illnesses co-occurring (Rubin & Peyrot, 
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2002), and the frequency of serious metabolic complications that arise (Weinger & 
Jacobson, 2001). As previously mentioned, depressive symptomatology has been shown 
as an independent risk factor for decreased Quality of Life independent of physical 
complications or chronic illnesses individuals may also have (Barge-Schaapveld, 
Nicolson, Berkhow, and deVries, 1999). This has also been documented in the diabetes 
specific literature; individuals who experience depressive symptomatology often 
experience decreased Quality of Life, independent of number of secondary complications 
(Hanninen, Takala, and Keinanen-Kiukaanniemi, 1999). As previously reviewed in this 
paper, self-management is a key component of diabetes care and this plays an important 
role in health-related outcomes and well-being. The next section will review the existing 
Quality of Life literature to further explain what is known about this construct in 
relationship to diabetes self-management. 
Impact of Diabetes Self-Management on Quality of Life 
Recent literature has suggested successful management of diabetes improves 
quality of life. The inverse is also true; it has been suggested that suboptimal self-
management has been linked to decreased quality of life. Additionally, quality of life 
decreases as a function of increased number of diabetic complications (Jacobsen, de 
Groot, & Samson, 1995; Glasgow, Ruggiero, Eakin, Dryfoos, & Chobanian, 1997). 
There is also evidence to suggest individuals with type 2 diabetes who are required to 
adhere to a daily insulin regimen frequently report a decreased quality of life (Jacobsen, 
de Groot, & Samson, 1995). It appears the insulin regimen itself can be another potential 
source of distress for individuals with type 2 diabetes. However, there is limited 
literature in this area; additional research is needed to better understand this relationship. 
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Self-Management of Diabetes as an Outcome Variable. 
Self-management has been studied extensively in the diabetes literature. 
Research indicates diabetes is a unique disease due to the level of involvement of 
behavior in self-management and required regimen adherence. According to the 
American Association of Diabetes Educators (AADE), there are seven behaviors that 
together are seen as necessary for successful diabetes management. These behaviors 
include: being physically active, diet, medication taking, self-monitoring of blood 
glucose, problem solving (managing high and low levels, sick days, etc.), reducing risks 
of complications, and psychosocial adaptation to living with diabetes (AADE, 2003). 
Literature indicates these ongoing, multiple behavioral demands are the key factors that 
distinguish the demands of living with diabetes from those of other chronic illnesses, 
which may require maintaining only a select few of these behaviors (ADA, 2006). 
It is well-established that the seven self management behaviors components do 
not correlate highly with one another, suggesting individuals can be adherent to one 
behavior while ignoring another (Glasgow & Eakin, 1998; Rubin & Peyrot, 1992; Orme 
& Binik, 1989). This suggests there is a multidimensional component to self-
management. Due to the relative independence of the behaviors research suggests each 
component needs to be assessed separately when evaluating diabetes self-management 
outcomes (Johnson, 1992). This assessment of individual behavioral domains discussed 
in the behavioral diabetes literature as the preferred methodological approach to 
measuring self-management outcomes rather than creating a composite score summing 
all of the behaviors. For this dissertation project, blood glucose testing and diet are the 
individual self-management behaviors targeted for inclusion due to the impact of these 
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behaviors on maintaining optimal diabetes control. These two self-management 
behaviors will be discussed below. 
Blood Glucose Testing 
Blood Glucose testing is recommended for individuals with diabetes to assess 
glycemic control. The ADA (2007) recommends blood glucose testing for individuals 
with type 2 diabetes. Individuals prescribed an insulin regimen are recommended to test 
their blood glucose 3 or more times daily to achieve their glycemic goals. Individuals not 
on an insulin regimen are recommended to test their blood glucose levels less frequently 
than those on an insulin regimen. The frequency of self-monitoring of blood glucose 
should be determined based on maximizing blood glucose control. Research suggests 
individuals who maintain optimal glycemic control frequently report blood glucose 
testing as a key element in their self-management regimen thus highlighting its 
importance (ADA, 2007). Additionally, the negative impact of depression has also been 
identified in the self-monitoring of blood glucose literature. It is useful to examine the 
emotional impact of global depressive symptomatology, diabetes-specific distress, and 
fatigue on frequency of self-management of blood glucose to gain a better understanding 
of the impact of these constructs on blood glucose testing. 
Diet 
Diet was selected due to the importance of maintaining nutritional standards in 
addition to minimizing or delaying the onset of additional complications. Obesity is an 
independent risk factor for type 2 diabetes, and is often the result of poor nutritional 
habits. Due to the rising rates of type 2 diabetes and obesity, diet was selected as a 
behavior to assess, due to the health benefits of maintaining a healthy diet. Maintenance 
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of a healthy diet is important for many individuals with type 2 diabetes because it can 
lower blood sugar, triglycerides, blood pressure, cholesterol, and controlling weight 
(ADA, 2007). Research suggests maintaining a healthy diet is difficult for individuals to 
maintain (Toobert & Glasgow, 1994). This study sought to examine the frequency of 
dietary adherence. Additionally, due to the potential impact of depression on diet, this 
study examined the impact of global depressive symptomatology, diabetes-specific 
distress, and fatigue on the self-management of diet in individuals with type 2 diabetes. 
Purpose of Study 
This study sought to explore the frequency and intensity of diabetes-specific 
distress and depressive symptomatology, including fatigue in adults with type 2 diabetes 
mellitus. Glasgow's Personal Models of Diabetes Self-management was used as a 
conceptual framework for examining the associations between depressive 
symptomatology, diabetes-specific distress, fatigue (and its potential for overlap with 
depression), self-management behaviors, and health related quality of life. The results of 
this study informed the literature on personal models of diabetes management by 
including the emotion component and within this framework distinguishing global 
depressive symptomatology, diabetes specific distress, and fatigue. Additionally, this 
dissertation was designed to explore the associations between these constructs and self-
management behavior and quality of life. 
Specific Aims 
Aim! 
The primary aim of this study was to examine personal model constructs of 
diabetes management. Specifically, this study examined the individual levels of and 
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relationships between potential emotional aspects of diabetes (depressive 
symptomatology, diabetes-specific distress, and fatigue) using validated measures 
HI (Hypothesis #1): Hypothesized individual correlations between independent 
variables are listed in Table 3. It was believed the independent variables depressive 
symptomatology, diabetes specific-distress, and fatigue would be moderately associated 
with one another. 
Aim 11 
A second aim of this study was to examine the unique associations of emotional 
distress with diabetes self-management behavior, physical, and mental quality of life, 
controlling for demographic variables and diabetes regimen demand. Hypothesized 
individual correlations between independent and dependent variables are listed in Table 
4. Specifically, the following hypotheses were proposed: 
H2 (Hypothesis #2) 
Independent variable global depressive symptomatology (CESD-IO) controlling for 
demographic (age, gender, and BMI) and diabetes-related history (insulin, duration of 
diabetes, oral medication use), and anti-depressant use would be negatively and 
significantly associated with frequency of blood glucose testing on the SDSCA. It was 
hypothesized the variance accounted for by the independent variable would be beyond 
that of demographics and medical history. 
H3 (Hypothesis #3) 
Independent variable global depressive symptomatology (CESD-IO) controlling for 
demographic (age, gender, and BMI), diabetes-related history (insulin, duration of 
diabetes, oral medication use), and anti-depressant use would be negatively and 
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significantly associated with frequency of diet adherence on the SDSCA. It was 
hypothesized the variance accounted for by the independent variable would be beyond 
that of demographics and medical history. 
H4 (Hypothesis #4) 
Independent variable diabetes-specific distress (PAID) controlling for demographic (age, 
gender, and BMI) and diabetes-related history (insulin, duration of diabetes, oral 
medication use), and anti-depressant use would be negatively and significantly associated 
with frequency of blood glucose testing on the SDSCA. It was hypothesized the variance 
accounted for by the independent variable would be beyond that of demographics and 
medical history. 
H5 (Hypothesis #5) 
Independent variable diabetes specific distress (PAID) controlling for demographic (age, 
gender, and BMI) and diabetes-related history (insulin, duration of diabetes, oral 
medication use), and anti-depressant use would be negatively and significantly associated 
with frequency of diet adherence on the SDSCA. It was hypothesized the variance 
accounted for by the independent variable would be beyond that of demographics and 
medical history. 
H6 (Hypothesis #6) 
Independent variable fatigue (MFSI-SF) controlling for demographic (age, gender, and 
BMI) and diabetes-related history (insulin, duration of diabetes, oral medication use), and 
anti-depressant use would be negatively and significantly associated with frequency of 
blood glucose testing on the SDSCA. It was hypothesized the variance accounted for by 
the independent variable would be beyond that of demographics and medical history. 
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H7 (Hypothesis #7) 
Independent variable fatigue (MFSI-SF) controlling for demographic (age, gender, and 
BMI) and diabetes-related history (insulin, duration of diabetes, oral medication use), and 
anti-depressant use would be negatively and significantly associated with frequency of 
diet adherence on the SDSCA. It was hypothesized the variance accounted for by the 
independent variable would be beyond that of demographics and medical history. 
H8 (Hypothesis #8) 
Independent variable global depressive symptomatology (CESD-IO) controlling for 
demographic (age, gender, and BMI) and diabetes-related history (insulin, duration of 
diabetes, oral medication use), and anti-depressant use would be negatively and 
significantly associated with the physical function scores on the SF-12. It was 
hypothesized the variance accounted for by the independent variable would be beyond 
that of demographics and medical history. 
H9 (Hypothesis #9) 
Independent variable global depressive symptomatology (CESD-lO) controlling for 
demographic (age, gender, and BMI) and diabetes-related history (insulin, duration of 
diabetes, oral medication use), and anti-depressant use would be positively and 
significantly associated with mental well-being on the SF-12. It was hypothesized the 
variance accounted for by the independent variable would be beyond that of 
demographics and medical history. 
HIO (Hypothesis #10) 
Independent variable diabetes-specific distress (PAID) controlling for demographic (age, 
gender, and BMI) and diabetes-related history (insulin, duration of diabetes, oral 
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medication use), and anti-depressant use would be negatively and significantly associated 
with physical function scores on the SF-12. It was hypothesized the variance accounted 
for by the independent variable would be beyond that of demographics and medical 
history. 
H11 (Hypothesis #11) 
Independent variable diabetes-specific distress controlling for demographic (age, gender, 
and BMI) and diabetes-related history (insulin, duration of diabetes, oral medication use), 
and anti-depressant use would be positively and significantly associated with mental 
well-being on the SF-12. It was hypothesized the variance accounted for by the 
independent variable would be beyond that of demographics and medical history. 
H12 (Hypothesis #12) 
Independent variable fatigue (MFSI-SF) controlling for demographic (age, gender, and 
BMI) and diabetes-related history (insulin, duration of diabetes, oral medication use), and 
anti-depressant use would be negatively and significantly associated with physical 
function scores on the SF-12. It was hypothesized the variance accounted for by the 
independent variable would be beyond that of demographics and medical history. 
H13 (Hypothesis #13) 
Independent variable fatigue (MFSI-SF) controlling for demographic (age, gender, and 
BMI) and diabetes-related history (insulin, duration of diabetes, oral medication use), and 
anti-depressant use would be positively and significantly associated with mental well-
being on the SF-12. It was hypothesized the variance accounted for by the independent 
variable would be beyond that of demographics and medical history. 
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METHODS 
Description of Participants 
Participants were adults with diabetes receiving diabetes care at the Joslin 
Diabetes Center at Aoyd Memorial Hospital in New Albany, Indiana. Joslin Diabetes 
Center offers both inpatient and outpatient clinic that offers a variety of treatment, 
education, and exercise programs for adults with both type 1 and type 2 diabetes. 
Participants included in this study were men and women who met the following 
eligibility criteria: (1) must have received a diagnosis of type 2 diabetes mellitus, (2) be 
over the age of 21 , (3) are taking medication for their diabetes (e.g. oral agents, insulin, 
or both), (4) could successfully complete the Mini-Cog, and (5) read, write, and 
understand English. This protocol was approved by the Institutional Review Board(s) of 
both the University of Louisville, and Aoyd Memorial Hospital. 
Procedure 
Participant Recruitment 
Individuals presenting to the Joslin Diabetes Center to receive routine care were 
invited to participate in this study by research personnel. All research/project personnel 
completed both HIPAA and CITI training requirements. Participants were invited while 
waiting for routine clinic appointments. Research personnel determined eligibility of 
patients by receiving a list of eligible participants from the medical administrative staff. 
Individuals were invited to participate in one of two ways: (1) Research personnel called 
the patient into an exam room for screening, or (2) research personnel approached the 
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patient while already in an exam room. Both methods accommodated HIPAA 
requirements. Participants then received consent and HIPAA forms and completed them 
with the study personnel. 
Screening 
Screening approach consisted of the study personnel asking direct questions 
related to the eligibility criteria. Questions assessed for diabetes status, medication use, 
whether the participant was over the age of 21, and could read, write, and understand 
English. In addition, the research personnel administered the MINI-COG to screen for 
cognitive impairment. Participants were read three words then were asked to draw a 
clock with hands pointing to a specific time. Upon completion of the clock drawing task, 
participants were asked to recall the original three words they were read. If a participant 
incorrectly drew the clock and/or could not remember the words they were read, they 
were determined to be ineligible and were thanked for their time and participation. 
Eligible individuals were invited to participate in the study, and received the 
questionnaire packet. They were reminded their participation is voluntary, and that they 
would be asked to read and fill out a survey that would take approximately 30 minutes to 
complete. 
Data Collection 
Participants were given two options for questionnaire completion and return: (1) 
completing the questionnaire while waiting for their clinic appointment and returning it in 
the provided manila envelope directly to research staff, or (2) completing the 
questionnaire and returning it directly to the research personnel at the University of 
Louisville via mail, using a pre-stamped manila envelope. In addition to the self-report 
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questionnaire packet, a subsequent chart review was conducted to collect information 
regarding the participant's HbAlc value, height, weight, fasting glucose, duration of 
diabetes, and use of medication (exogenous insulin, oral diabetes agents, and 
antidepressants) corresponding to measurements made on the day on which they were 
enrolled is the study. Additionally, chart recorded information listing complications 
associated with diabetes and additional medical comorbidity information was recorded. 
Diabetes related co-morbidities were compiled into a database using only a subject 
identification number. 
Measures 
Table 5 and Table 6 summarize measures used for the independent and dependent 
variables respecti vel y. 
Sociodemographic Questionnaire. Data concerning background and 
socioeconomic characteristics was collected from each study participant. This 
questionnaire contains 12-items, which include age, gender, educational achievement, 
marital status, current living arrangement, employment status, race/ethnic background, 
height, and weight. 
The Mini-Cog. The Mini-Cog is a composite measure used as a screenerfor 
cognitive impairment (Borson, Scanlan, Brush, Vitaliano, & Dokmak, 2000). This test 
was designed to discriminate between individuals with and without cognitive impairment. 
This brief instrument includes a 3-item recall and a clock drawing task. Recent literature 
addressed the utility of the Mini-Cog in primary care clinics; results indicated the Mini-
Cog to be superior to the MMSE. This measure is believed to be easier to administer, 
and displays believed less bias with literacy and low-education issues (Ismail, Rajji, 
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Shulman, 2009). Screening criteria was consistent with the original scoring by Borson et 
al (2000). Individuals who were able to correctly identify all three items on the 3-item 
recall task were included in the study. If an individual correctly identified 1-2 items of 
the 3-item recall task, the clock drawing was analyzed for accuracy. If the clock was 
accurate (i.e. numbers accurately drawn, correct time, appropriate drawing and 
placement) the participant was included in this study. If an individual could not recall 
any of the 3-item recall items and/or could not produce an accurate clock, s/he was 
excluded from the study. 
Center for Epidemiological Studies of Depression Scale -10 (CESD-IO). The 
CESD-IO (Andersen, Malmgren, Carter, & Patrick, 1994) is a shortened version of the 
original 20-item measure designed to assess depressive symptomatology in a general 
popUlation. Individuals are asked about the frequency or duration of which they 
experience cognitive, affective, and behavioral symptoms of depression within the 
preceding week. This measure uses a four point rating scale that ranges from "rarely to 
none of the time (less than one day)' (0) to "most or all of the time (5-7 days)" (3). The 
range of possible scores is from 0-60, with higher scores indicating a higher frequency of 
depressive symptoms. The CESD-I0 has been used extensively in populations with 
chronic diseases, and is believed to be a valid measure of global depressive 
symptomatology. The CESD-IO has good psychometric properties, including a 
reliability coefficient of 0.85. 
Problem Areas In Diabetes Scale (PAID). Due to the importance of diabetes-
related distress, the Problem Areas In Diabetes Scale (PAID) (Polonsky, Anderson, 
Lohrer, Welch, Jacobson, Aponte, & Schwartz, 1995) was created as a tool to assess the 
50 
construct of diabetes related distress both as a clinical tool and an outcome measure 
(Welch, Weinger, Anderson, & Polonsky, 2003). The PAID is a 20-item single-factor 
measure of diabetes related distress developed by the Joslin Diabetes Center and Harvard 
Medical School. This instrument has a 5-point item scaling, ranging from "Not a 
problem" = 0 to "Serious Problem" = 4. Original scoring was a summed total; higher 
scores were indicative of higher levels of diabetes-specific distress. Original scoring has 
been simplified to a transformed scaled score ranging from 0-100, with higher scores 
demonstrating greater diabetes-specific distress. The main focus of the items surrounds 
feelings and moods associated with specific aspects of diabetes. The PAID has been 
found to be unrelated to age, duration of diabetes, education, ethnicity, and gender 
(Welch, Weinger, Anderson, & Polonsky, 2003). 
Multidimensional Fatigue Symptom Inventory-Short Form (MFSI-SF). The 
Multidimensional Fatigue Symptom Inventory-Short Form is an excellent example of a 
multidimensional fatigue measure. Is was designed by researchers based on the existing 
literature suggesting that fatigue is a multidimensional symptom that can be best captured 
by evaluating five dimensions: general (i.e. severity), affective, physical, mental, and 
vigor (Stein, Martin, Hann, & Jacobsen, 1998). Additionally, it has been argued due to 
the absence of disease-specific information, it is a flexible measure that can be used in a 
variety of populations (Dittner, Wessely, & Brown, 2004). The MFSI-SF is believed to 
have good psychometric properties, including excellent internal consistency, good 
diagnostic validity, good test-retest reliability, and sufficient ability to discriminate 
between fatigued and non-fatigued individuals (Wu & McSweeny, 2001). 
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Personal Illness Models Questionnaire. This questionnaire has been previously 
used in Glasgow et ai's (1997) study examining personal models of diabetes. This 
measure assesses beliefs about treatment effectiveness by asking two specific questions 
about individual areas of self-management (physical activity, glucose testing, recording 
glucose test results, taking medication, checking feet, and eating low fat foods). Each 
regimen area contains two personal model items: "How important do you believe __ _ 
is for controlling your diabetes?" and "How likely do you think it is that will 
prevent future complications?" Responses are provided on a five-point rating scale 
ranging from (1) not at all importantllikely to (5) very important/likely. These scores are 
averaged to produce a regimen-specific effectiveness score. This measure yielded 
sufficient internal consistency reliability (a = .89) as a measure of treatment 
effecti veness. 
Medical Outcomes Study Short Form 12 (SF-12). The SF-12 is an abbreviated 
version of the original SF-36, which was designed to measure global level of functioning 
(Ware, Kosinski, & Keller, 1996). This measure contains 12-items that measure physical 
function (physical) and well-being (mental), with higher scores indicating better 
functioning. Estimates of reliability for the physical and mental component scales are 
0.89 and 0.86 respectively. Normative data is also available for a diabetic population 
suggesting this instrument is both reliable and valid. 
The Summary of Diabetes Self-Care Activities Measure (SDSCA). The SDSCA is 
a brief self-report measure that measures levels of self-management across multiple 
diabetes self-management behaviors over the previous seven days using a 0-7 Likert scale 
(Toobert & Glasgow, 1994). The revised SDSCA contains II-items that assess the 
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frequency of performance of the following five self-management domains: (1) diet, (2) 
exercise, (3) blood glucose testing, (4) foot care, and (5) smoking (Toobert, Hampson, & 
Glasgow, 2000). Only the diet and blood glucose testing items will be administered in 
this study. A recent review article reported the SDSCA is the most widely used self-
report instrument for measuring diabetes self-management in adults. This measure 
demonstrates good inter-item reliability, test-retest reliability, and validity (Toobert, 
Hampson, & Glasgow, 2000). The majority of published studies using the SDSCA have 
focused on type 2 diabetes. 
Covariates: Several covariates were selected for inclusion in this dissertation. 
This study sought to explore the emotional component of Glasgow et ai's (1997) model 
of self-management. This influential study included age, gender, oral medication, and 
insulin use as covariates. This was replicated in this study due to the impact of these 
variables on both self-management and quality of life. Duration of diabetes and BMI 
were also selected for inclusion as covariates due to their potential impact on both 
physical and mental health. Finally, use of anti-depressant medication was selected for 
inclusion as a covariate due to the potential impact on self-reported emotional distress, 
self-management, and quality of life. 
Data Analysis 
Sample Size Calculation 
Cohen (1992) suggests a power analysis should be conducted to inform the 
number of participants needed to achieve a specified effect size between or within 
groups. This was conducted using the G* Power3 program adapted from Faul, Erdfelder, 
Lang & Buchner (2007). Cohen (1992) recommends .80 as sufficient power to detect a 
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moderate effect size (.30). Based on Cohen's recommendation, a minimum of 121 
subjects is needed to detect a moderate effect size at a significance level of .05 using 
multiple regression with 8 independent variables (including 3 demographic variables, 3 
diabetes-specific variables, and anti-depressant use to be examined as covariates). The 
number of participants providing valid data exceeded 121 for all hypotheses. This 
sample size provided adequate power to this study to detect a moderate effect size with 
95% confidence for the Primary and Secondary Aims at both the p < .05 and p <.01 
levels. 
Descriptive Statistics 
Descriptive statistics are provided for data from both self-report and chart review. 
This study focused on a clinical population of adults with type 2 diabetes who received 
their diabetes care at Joslin Center for Diabetes. Due to the heterogeneity of this 
population, demographic characteristics such as age, gender, level of education, 
occupation, ethnicity and body mass index were assessed to describe the characteristics 
of this sample with hopes to increase generalizability of this study to other populations of 
individuals with diabetes. Additionally, diabetes-related history such as use of insulin, 
duration of diabetes, and oral medication is described. Rates of current use of anti-
depressant medication are also presented. All questions reflecting independent and 
dependent variable constructs were scored and descriptive data is presented. Data was 
analyzed and reported in terms of frequencies, means standard deviations and ranges in 
table form. T-Tests were used to compare means across groups to test for group 
differences. 
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Statistical Plan for Hypothesis Analysis 
Hypothesis 1 was tested using Pearson correlations to explore the associations 
between the total scores of the CESD-lO, PAID, and MFSI-SF. A correlation matrix was 
formed to examine associations between these independent variables. 
The hypotheses for Aim 2 (Hypothesis 2-Hypothesis 13) were analyzed using 
hierarchical linear regression to test if independent variables predict dependent variables. 
Based upon Glasgow's conceptual framework of Personal Illness Models and the 
associations with both the independent and dependent variables included in this study, 
demographic characteristics, diabetes regimen characteristics, and antidepressant use 
were included as separate blocks in the regression analyses. Demographic variables age, 
BMI, and gender were entered into the first block, diabetes regimen characteristics 
(exogenous insulin use, duration of diabetes, and oral agent use) were entered into the 
second block, antidepressant use was entered into the third block and the predictor term 
(independent variable) was entered into the fourth block. The effects of the predictor 
variables (independent variables) were interpreted individually and the change in 
variance associated was used to evaluate the statistical significance of the predictor 




Figure 3 presents a summary of the study recruitment rates. A total of 246 adults 
with Type 2 Diabetes were invited to participate in this study. Of those invited, 18 (7%) 
declined participation, 21 (6%) were not eligible to participate due to screening (Mini-
Cog), and 207 (87%) were consented and given questionnaire packets. Of the 207 
consented participants 151 (73%) completed and returned the questionnaire packet. 
Fifty-six participants (27% of those consented) did not complete the questionnaire. 
Completion Rates for Measures 
Participants responded to measures at rates ranging from 94.7% to 98.7% per self-
report questionnaire. The SDSCA diet and blood glucose subscales were calculated 
individually; the percentages of subscale completion rates were noted to be equal 
(95.4%). The physical and mental component subscales of the Quality of Life measure 
(SF-12) were also calculated separately; both subscales yielded a response rate of98.7%. 
Study Completion Rate Group Differences 
In order to examine potential differences between individuals who provided 
consent but did and did not complete the study questionnaire packet, participants were 
grouped by completion status (i.e. those that completed vs. those who did not). Groups 
were compared on number of complications, Body Mass Index, and HbAl c using 
independent sample t-tests. Significant differences were observed for both duration of 
Diabetes and HbAl c. Those who completed the survey were more likely to have diabetes 
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longer than those who did not complete the survey t (190) = -2.35,p=.02 (two-tailed). 
When examining group differences based on HbAl c , those who completed the survey had 
lower HbAl c than those who did not complete the survey t (191) = 3.81,p=.000 (two-
tailed). There were no statistically significant differences observed in terms of number of 
complications and completion status. Means and Standard Deviations by completion 
status are reported in Table 7. 
Chi-square statistics were calculated to examine significant differences between 
completion status and several categorical variables including hypertension, 
hyperlipidemia, peripheral neuropathy, smoking status, antidepressant use, oral diabetes 
agent use, and exogenous insulin use. There were no significant group differences 
observed between completion status and oral agent use, insulin use, antidepressant use, 
smoking status, hyperlipidemia, and peripheral neuropathy. Comparisons of groups on 
presence of hypertension and completion status approached significance, with study 
completers having a trend of being more likely to be hypertensive than those that did not 
complete (p= .057). 
Demographics 
The demographic characteristics of participants (i.e. the study completers) are 
summarized in Table 8. Of the total sample of 151 adults, the mean age of participants 
was 60.7 years (SD=I1.2). Participants were comprised of 51.7% females, 93.2% 
Caucasian, 72.5% married, and 58.9% were retired/disabled. Thirty three percent of 
participants reported their education as completing high school. Over half of the sample 
of participants had additional partial college/specialized training (54.1 %) with 16.9% 
completing graduate or other professional training. Table 9 summarizes gender and 
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ethnicity characteristics of this sample as compared to both Louisville, KY and New 
Albany, IN (US Census Bureau, 2002). 
Descriptive Information on Study Measures and Subscales 
The means, standard deviations, and ranges of the total scores of the measures for 
the independent and dependent variables are presented in Table 10. 
With respect to the CESD-IO, the majority of this sample (93%) did not reach the 
empirically derived cutoff score of 10 (i.e. 7% had scores greater than or equal to 10) 
recommended by Andresen et al (Andresen, Malmgren, Carter, & Patrick, 1994) 




Differences between genders on subscale scores for measures assessing emotion 
(depressive symptomatology, diabetes-specific distress, and fatigue), self-management 
(diet and blood glucose testing), and quality of life (physical and mental) were assessed. 
Means, standard deviations and p-values for corresponding independent sample t-tests are 
presented in Table 11. Women reported higher depressive symptomatology scores on the 
CESD-IO, t (141) = 2.23,p=.03 (two-tailed). Women also reported lower scores on the 
SF-12 mental component subscale relative to men t (146) = -1.99,p=.048 (two-tailed). 
Medication Use 
Gender differences were also examined with respect to oral diabetes agent use, 
exogenous insulin use, and antidepressant use using Chi-square statistics. There were no 
significant differences observed between gender and oral agent use (p= .090) or 
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exogenous insulin use (p= .482). There were significant differences observed between 
gender and antidepressant use X2 (1, N = 143) = 4.19, p=.032, women were twice as likely 
to taking antidepressants when compared to men. 
Self-Management 
Gender differences were also examined with respect to diet and blood glucose 
testing. Women followed their diet recommendations more frequently according to the 
Diet subscale of the SDSCA, t (142) = 2.21,p= .02 (two-tailed). There were no gender 
differences observed with respect to blood glucose testing. 
Health Status 
Health Characteristics of participants was collected via-chart review at the time of 
consent. Of the 207 participants consented, chart data was available for 191 (92.3%) of 
the participants enrolled in this study. However, there were a number of participants who 
provided consent but did not return the survey. These cases were excluded from analyses 
including chart review, and the data is presented for 148 of the participants enrolled in 
this study. The mean duration of diabetes was 143.64 months (11.97 years, SD= 102.54; 
range = 2-554). In response to the SF-12 question "How would rate your present health 
condition?", 1 (0.7%) participant responded "Excellent", 25(17.0%) participants 
responded "Very Good", 68 (46.3%) "Good", 38 (25.9%) "Fair", and 15 (10.2%) "Poor", 
respectively. 
Most of the participants in this sample were non-smokers (88.8%), on diabetes 
oral agent medication (92.3%), and Obese (80%). Additional analyses were conducted to 
examine obesity rates by standard obesity classification. Four participants (2.7%) were 
classified as Normal weight, 24 participants (17.1 %) Overweight, 41 participants (27.7%) 
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Obesity Class 1,36 participants (24.3%) Obesity Class II, and 35 participants (23.6%) 
Obesity Class III (National Heart, Lung, and Blood Institutes of Health, 2000). 
Additionally, the mean number of co-morbid health conditions was 4.2 (SD=1.74) which 
included all medical diagnoses included in the chart; general medical and diabetes-
specific comorbidities were included in this calculation. All co-morbid health conditions 
were diagnosed by clinic physicians and recorded in patients' charts. Patient's medical 
diagnoses were collected from medical charts by research personnel. Diabetes-specific 
comorbidities were selected from the comorbidity information and percentages were 
calculated separately and presented in table 12. The majority of the sample had 
diagnoses of hypertension (78.2%) and hyperlipidemia (88.7%). Forty-two percent of the 
sample also had a diagnosis of Peripheral Neuropathy. 
The mean sample HbAl c was 7.32 (SD=1.45). Sixty-two participants had HbAl c 
below 7 (43.4%),29.4% of the sample had HbAl c between 7 and 7.9, 14.7% of the 
sample had HbAl c between 8 and 8.9, 8.4% had HbAl c between 9.0 and 9.9 and 4.2% 
had HbAl c greater than 10. Thirty-five percent of the sample was taking Exogenous 
Insulin, and 23% of the sample was currently taking antidepressant medication. A 
summary of participants' health characteristics including sub-groupings of age, HbA1 c , 
and Body Mass Index can be found in Table 12. Additionally, a chart depicting the 
participants' use of diabetes medications can be found in Figure 4. 
Medication Use Comparisons 
Insulin Use Status 
Participants were grouped and compared on blood glucose characteristics by 
insulin use status (Exogenous Insulin Use versus No Insulin Use) and compared on blood 
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glucose testing and health characteristics using independent sample t-tests. Means, 
standard deviations, and p-values for corresponding independent sample t-tests are 
reported in Table 13. Participants prescribed insulin were more likely to report that they 
tested their blood sugar than those who were not, t (130)= 2.25,p= .03 (two-tailed). The 
mean frequency of those on insulin testing their blood glucose levels was 5.46 (SD= 1.88) 
days per week. Those participants who were not prescribed insulin reported better 
physical quality of life on the SF-12, t (134) = -2.65,p= .009 (two-tailed). Participants 
who were prescribed insulin were more likely to have higher HbAl c than those who were 
not, t (133) = 5.30,p= .000 (two-tailed), indicating poorer metabolic control. There were 
no differences observed in subject age, BMI, or number of complications by insulin use 
status. 
Diabetes Oral Agent Use Status 
Participants were also grouped and compared by diabetes oral agent use status 
(i.e. those that took oral agents versus those that did not) using an independent sample t-
test. Comparisons were examined for self-management, quality of life, depressive 
symptomatology, diabetes specific distress and fatigue. No significant differences were 
observed. 
Anti-Depressant Medication Use Status 
Participants were also grouped and compared by antidepressant medication use 
status (i.e. those that took oral agents versus those that did not) using an independent 
sample t-test. Means, standard deviations, and p-values for corresponding independent 
sample t-tests are reported in Table 14. Comparisons were examined for self-
management, quality of life, depressive symptomatology, diabetes specific distress and 
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fatigue. Participants taking antidepressants reported higher depressive symptomatology 
scores t (135) = 2.87,p= .005 (two-tailed), higher diabetes specific distress t (140) = 2.54, 
p= .015 (two-tailed), and higher fatigue t (139) = 3.67, P < .001 (two-tailed) than those 
that do not. Additionally, participants who were not taking antidepressants reported 
lower physical t (141) = -2.53,p= .013 (two-tailed) and mental quality of life t (141) =-
3.79,p= .000 (two-tailed) scores relative to those not taking antidepressants. No 
significant differences were observed for diet or blood glucose monitoring SDSCA scores 
by anti-depressant medication use status. 
Hypothesis testing and analyses 
Analysis of individual aims and hypotheses are listed below. 
Aim! 
Hypothesis 1 Analysis 
Hypothesis one examined the associations between depressive symptomatology, 
diabetes specific-distress, and fatigue. It was hypothesized these variables would be 
moderately associated with one another. The individual correlations between the 
measures reflecting emotional distress are summarized in Table 15. Overall, correlations 
supported this hypothesis: depressive symptomatology, diabetes specific-distress, and 
fatigue were all moderately associated with one another. Table 16 summarizes the 
correlations between emotional distress measures (independent variables) and self-
management and quality of life (dependent variables). Table 17 summarizes the 
intercorrelations between the covariates, independent and dependent variables. 
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Depressive Symptomatology 
As seen in Table 17, depressive symptomatology was positively associated with 
fatigue and diabetes-specific distress as hypothesized. Depressive symptomatology was 
significantly negatively associated with gender, antidepressant use, physical quality of 
life, mental quality of life, and diet. Depressive symptomatology was not significantly 
associated with blood glucose testing, age, BMI, duration of diabetes, exogenous insulin 
use or diabetes oral agent use. 
Diabetes-Specific Distress 
As seen in Table 17, diabetes-specific distress (PAID) scores were significantly 
and positively associated with fatigue, depressive symptomatology, and HbAl c , and 
significantly and negatively associated with antidepressant use, physical quality of life, 
mental quality of life, and diet. Diabetes-specific distress was not significantly associated 
with blood glucose testing, age, gender, BMI, duration of diabetes, exogenous insulin use 
or diabetes oral agent use. 
Fatigue 
Fatigue (Total Score of the MFSI-SF) was positively associated with depressive 
symptomatology and diabetes-specific distress, and negatively associated with 
antidepressant use, physical quality of life, mental quality of life, and diet. Fatigue was 
not significantly associated with blood glucose testing, age, gender, BMI, duration of 
diabetes, exogenous insulin use or oral agent use. 
Aim II 
Self-Management Outcomes 
Depressive Symptomatology Predicting Blood Glucose Testing 
63 
Table 18 summarizes the findings of the hierarchical linear regression used to 
assess hypothesis 2, with blood glucose testing as the dependent variable and depressive 
symptomatology as the independent variable. The table includes R2, ~R2, and ~F for each 
step of the hierarchical regression analysis. The only step in the model that retained 
significance was the demographic step, which included BMI, gender, and age F (3, 119) 
= 6.17,p= .001 (R2= .135). The change in variance associated with the addition of the 
predictor was not significant (p=.102). No further analyses were conducted. 
Depressive Symptomatology Predicting Diet 
Table 19 summarizes the findings of the hierarchical linear regression used to 
assess hypothesis 3 with diet as the dependent variable and depressive symptomatology 
as the independent variable. The table includes R2, ~R2, and ~F for each step of the 
hierarchical regression analysis. The change in variance associated with the addition of 
the predictor was not significant (p=.107). Demographics, diabetes regimen demand, and 
antidepressant use were also non-significant. No further analyses were conducted, this 
hypothesis was not supported. 
Diabetes-Specific Distress Predicting Blood Glucose Testing 
Table 20 summarizes the findings of the hierarchical linear regression used to 
assess hypothesis 4 with blood glucose testing as the dependent variable and diabetes-
specific distress as the independent variable. The table includes R2, ~R2, and ~F for each 
step of the hierarchical regression analysis. The demographic step (block 1) retained 
significance in this model, which included BMI, gender, and age F (3,124) = 6.23,p= 
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.001 (R2 = .131). The change in variance associated with the addition of the predictor 
was not significant (p=.269). No additional analyses were completed. 
Diabetes-Specific Distress Predicts Diet 
Table 21 summarizes the findings of the hierarchical linear regression used to 
assess hypothesis 5 with diet as the dependent variable and diabetes-specific distress as 
the independent variable. The table includes R2, ~R2, and ~F for each step of the 
hierarchical regression analysis. Diabetes-specific distress retained statistical 
significance in this model, which included PAID total score, F (1,119) = 1O.23,p= .002 
(R2 = .131). The PAID total was significantly (negatively) correlated with diet (r= -.234, 
p=.004). Demographics, diabetes regimen demand, and antidepressant use were not 
significant in this model. 
Fatigue Predicts Blood Glucose Testing 
Table 22 summarizes the findings of the hierarchical linear regression used to 
assess hypothesis 6 with blood glucose testing as the dependent variable and fatigue as 
the independent variable. The table includes R2, ~R2, and ~F for each step of the 
hierarchical regression analysis. The demographic step (block 1) retained significance in 
this model, which included BMI, gender, and age F (3,122) = 6.38,p=.000 (R2 = .136). 
The change in variance associated with the addition of fatigue was not significant 
(p=.115). No additional analyses were completed. 
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Fatigue Predicts Diet 
Table 23 summarizes the findings of the hierarchical linear regression used to 
assess hypothesis 7 with diet as the dependent variable fatigue as the independent 
variable, and includes R2, ~R2, and ~F for each step of the hierarchical regression 
analysis. Fatigue retained statistical significance in this model, which included the 
MFSI-SF total score, F (1,117) = 6.37, p= .01 (R2 = .116). The MFSI-SF total was 
significantly negatively correlated with diet (r= -.221 ,p=.007). Demographics, diabetes 
regimen demand, and antidepressant use variables were not significant in this model. 
Quality of Life Outcomes 
Depressive Symptomatology Predicts Physical Quality of Life 
Table 24 summarizes the findings of the hierarchical linear regression used to 
assess hypothesis 8 with physical quality of life as the dependent variable (Physical 
Component Score of the SF-12) and depressive symptomatology as the independent 
variable, and includes R2, ~R2, and ~F for each step of the hierarchical regression 
analysis. With respect to Physical Component Score interpretation on the SF-12, a higher 
score is indicative of "better" quality of life. The demographic step (block 1) retained 
significance in this model, which included BMI, gender, and age F (3,122) = 3.94,p=.01 
(R2 = .088). Depressive symptomatology also retained statistical significance in this 
model, which included the CESD-IO total score, F (1,117) =13.28,p= .000, (R2 = .246). 
CESD-IO total was significantly negatively correlated with the Physical Component 
Score of the SF-12 (r = -.294,p=.000). Diabetes regimen demand and antidepressant use 
variables were not significant in this model. 
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Depressive Symptomatology Predicts Mental Quality of Life 
Table 25 summarizes the findings of the hierarchical linear regression used to 
assess hypothesis 9 with mental quality of life (Mental Component Score of the SF-12) as 
the dependent variable and depressive symptomatology as the independent variable, and 
includes R2, ~R2, and ~F for each step of the hierarchical regression analysis. With 
respect to Mental Component Score interpretation on the SF-12, a higher score is 
indicative of "better" quality of life. Demographics and diabetes regimen demand were 
not statistically significant in this model. Antidepressant use (block 3) retained 
significance in this model, F (1,118) = 6.97,p=.009 (R2 = .111). Depressive 
symptomatology also retained statistical significance in this model, which included the 
CESD-lO total score, F (1,117) = 68.58,p= .000 (R2 = .246). Antidepressant use was 
significantly (positively) correlated with the Mental Component Score of the SF-12 
(r=.259,p=.002). Depressive symptomatology was significantly (highly negatively) 
correlated with the Mental Component Score (r= -.622,p=.000). 
Diabetes-Specific Distress Predicts Physical Quality of Life 
Table 26 summarizes the findings of the hierarchical linear regression used to 
assess hypothesis 10 with physical quality of life as the dependent variable and diabetes-
specific distress as the independent variable, and includes R2, ~R2, and ~F for each step 
of the hierarchical regression analysis. The demographic step (block 1) retained 
significance in this model, which included BMI, gender, and age F (3,127) = 4.66,p 
=.046 (R2 = .099). Antidepressant use (block 3) retained significance in this model, F (1, 
123) = 4.08,p = .046 (R2 = .163). Diabetes-specific distress also retained statistical 
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significance in this model, which included the PAID total score, F (1,117) = 4.44, p = 
.037 (R2 = .192). Antidepressant use was significantly (positively) correlated with the 
Physical Component Score of the SF-12 (r =.163,p =.032). Diabetes-specific distress 
was significantly (negatively) correlated with the Physical Component Score (MCS) of 
the SF-12 (r = -.244,p = .002). Diabetes regimen demand variables were not significant 
in this model. 
Diabetes Specific Distress Predicts Mental Quality of Life 
Table 27 summarizes the findings of the hierarchical linear regression used to 
assess hypothesis 11 with mental quality of life as the dependent variable and diabetes-
specific distress as the independent variable, and includes R2, ~R2, and ~F for each step 
of the hierarchical regression analysis. The demographic step (block 1) retained 
significance in this model, which included BMI, gender, and age F (3,127) = 2.79,p 
=.043 (R2 = .062). Antidepressant use (block 3) retained significance in this model, F (1, 
123) = 7.24,p =.008 (R2 = .130). Diabetes-specific distress also retained statistical 
significance in this model, which included PAID total score, F (1,122) = 56.50,p = .000 
(R2 = .406). An independent sample t-test was calculated to assess for differences in 
Mental Component Score and antidepressant use. Those on antidepressants reported 
higher scores on the Mental Component Score than those not prescribed antidepressants t 
(141) = -3.80,p = .000 (two-tailed) A higher Mental Component Score is indicative of 
"better" quality of life, indicating that those on antidepressants self-reported higher 
quality of life scores than those that are not on antidepressants. The higher an individual's 
score on the PAID, the more diabetes-specific distress they endorsed. Diabetes-specific 
distress was significantly negatively correlated with the SF-12 Mental Component Score 
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(r = -.614,p =.000). Diabetes regimen demand variables were not significant in this 
model. 
Fatigue Predicts Physical Quality of Life 
Table 28 summarizes the findings of the hierarchical linear regression used to 
assess hypothesis 12 with physical quality of life as the dependent variable and fatigue as 
the independent variable, and includes R2, ~R2, and ~F for each step of the hierarchical 
regression analysis. The demographic step (block 1) retained significance in this model, 
which included BMI, gender, and age F (3,126) = 4.23,p =.007 (R2 = .092). 
Antidepressant use (block 3) retained significance in this model, F (1,122) = 5.04,p 
= .027 (R2 = .035). Fatigue (MFSI-SF total score) also retained statistical significance in 
this model F (1,121) =17.68,p = .000 (R2 = .107). Those on antidepressants reported 
higher scores on the Physical Component Score than those not prescribed antidepressants 
t (141) = -2.53,p = .013 (two-tailed). Fatigue was significantly and negatively correlated 
with the SF-12 Physical Component Score (r = -.374,p =.000). Diabetes regimen 
demand variables were not significant in this model. 
Fatigue Predicts Mental Quality of Life 
Table 29 summarizes the findings of the hierarchical linear regression used to 
assess hypothesis 13 with mental quality of life as the dependent variable and fatigue as 
the independent variable, and includes R2, ~R2, and ~F for each step of the hierarchical 
regression analysis. Demographics and diabetes regimen demand were not statistically 
significant in this model. Antidepressant use (block 3) retained significance in this 
model, F (1, 122) = 7.55, P = .007 (R2 = .112). Fatigue also retained statistical 
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significance in this model, which included MFSI-SF total score, F (l ,121) = 86.81,p = 
.000 (R2 = .483). Those on antidepressants reported higher scores on the SF-12 Mental 
Component Score than those that not prescribed antidepressants t (141) = -253,p = .013 
(two-tailed). Fatigue was significantly and highly negatively correlated with the SF-12 
Mental Component Score (r = -.669,p =.000) suggesting as fatigue scores increase, 
quality of life scores decrease. 
Supplemental Analyses Representing Emotional Distress 
Associations observed between measures indicate overlap in assessment 
approaches. This raises additional issues for consideration in relation to study aims. One 
of the aims of this study sought to evaluate the potential role of fatigue as a viable 
construct within the diabetes literature. Three of the four original hypotheses pertaining 
to fatigue were retained in the proposed analyses, suggesting fatigue plays an important 
role in diet and physical and mental quality of life for individuals with diabetes. Fatigue 
was not significantly associated with blood glucose testing. However, the associations 
among the three dependent variable constructs ranged from 581 to .657, indicating 
moderate to high associations with one another. A key question then remains, is fatigue 
uniquely contributing to as an independent construct or is this measurement error? An 
exploratory item analysis was conducted to explore this issue. 
Item overlap across emotional distress measures 
First, individual items were reviewed from the CESD-IO, PAID, and MFSI-SF to 
address similarities of these items across measures. Several items were determined to be 
similar in content and semantic structure and are presented in Table 30. 
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Item overlap was explained by examining the associations between the specific 
subscales of the MFSI-SF and the PAID, CESD-I0 to identify the possibility of 
measurement error. This extends the original aims and hypotheses that were focused on 
the utilization of the total scores on the MFSI-SF and the PAID. Second, the subscales of 
the MFSI-SF were included in analysis examining the Physical and Mental Component 
Scores of the SF-12 to examine convergence/divergence. Table 31 includes observed 
associations between the specific MFSI-SF subscales and the PAID, CESD-I0, and both 
SF-12 composite scores. These correlations ranged from -.091 to .657. Both the CESD-
10 and the PAID were positively associated with the general, emotional, physical, mental 
and total fatigue subscales, and negatively associated with the vigor subscale. All of 
these associations were in the moderate to high moderate range. The SF-12 physical 
component score was positively associated with the vigor subscale, and negatively 
associated with the general, physical, mental, and total fatigue subscales. Of note, the 
association between the emotional subscale of the MFSI-SF and the physical component 
score was not significant, suggesting minimal overlap between these items. The SF-12 
mental component score was negatively associated with general, physical, emotional, 
mental and total fatigue score and positively associated with the vigor subscale. 
Unique contributions of fatigue measurement beyond depressive symptomatology 
and diabetes distress. 
One of the main goals of this project was to determine the utility of fatigue as a 
viable construct in the diabetes literature. The overlap between emotional constructs (i.e. 
depressive symptomatology, diabetes-specific distress and fatigue) that exists was 
anticipated prior to the start of the study. Due to this overlap, an additional set of four 
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regressions were also performed to examine the variance fatigue accounted for in this 
model over and above that of depressive symptomatology and diabetes-specific distress. 
This was accomplished by including depressive symptomatology and diabetes-specific 
distress as an additional block in the regression equation. These variables were entered 
as follows: Demographic variables (Block 1), diabetes regimen demand (Block 2), 
antidepressant use (Block 3), depressive symptomatology and diabetes-specific distress 
(Block 4), and Fatigue (Block 5). This approach minimizes error and is a more 
conservative approach than comparing R2 across regression equations. The results of 
these regressions are presented below. 
Fatigue and Blood Glucose Testing 
Table 32 summarizes the findings of the hierarchical linear regression used to 
assess blood glucose testing as the dependent variable and fatigue as the independent 
variable, and includes R2, ~R2, and ~F for each step of the hierarchical regression 
analysis. The demographic step (block 1) retained significance in this model, which 
included BMI, gender, and age F (3,119) = 6.17,p = .001 (R2 = .135). Diabetes 
regimen demand, antidepressant use, depressive symptomatology/diabetes-specific 
distress, and fatigue were non-significant in this model. 
Fatigue and Diet 
Table 33 summarizes the findings of the hierarchical linear regression used to 
assess diet as the dependent variable and fatigue as the independent variable, and includes 
R2, ~R2, and ~F for each step of the hierarchical regression analysis. Demographic 
variables, diabetes regimen demand, and antidepressants did not reach statistical 
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significance in this model. The depressive symptomatology/diabetes-specific distress 
(block 4) did reach significance F (2,114) = 5.30,p =.006 (R2=.143). Fatigue did not 
significantly contribute to the model (p = .803). 
Fatigue and Physical Quality of Life 
Table 34 summarizes the findings of the hierarchical linear regression used to 
assess physical quality of life as the dependent variable and fatigue as the independent 
variable, and includes R2, ~R2, and ~F for each step of the hierarchical regression 
analysis. The demographic step (block 1) retained significance in this model, which 
included BMI, gender, and age F (3,121) = 4.30,p =.006 (R2 = .096). Diabetes regimen 
demand did not reach statistical significance in this model (p =.111). Antidepressant use 
was statistically significant in this model F (1, 117) = 3.87, p = .05 (R2 = .169). The 
depressive symptomatology/diabetes-specific distress (block 4) also did reach 
significance F (2, 115) = 5.98, p =.003 (R2 = .247). Of note, fatigue (block 5) was a 
significant predictor over and above the depressive symptomatology/diabetes specific-
distress block F (1,114) = 12.37, P =.001 (R2 = .321). This suggests fatigue may be 
contributing unique variance to the model when predicting physical quality of life. 
Fatigue and Mental Quality of Life 
Table 35 summarizes the findings of the hierarchical linear regression used to 
assess mental quality of life as the dependent variable and fatigue as the independent 
variable, and includes R2, ~R2, and ~F for each step of the hierarchical regression 
analysis. The demographic step (block 1) retained significance in this model, which 
included BMI, gender, and age F (3,121) = 2.90,p = .038 (R2 = .067). Diabetes regimen 
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demand did not reach statistical significance in this model (p = .759). Antidepressant use 
was statistically significant in this model F (1,117) = 6.19,p = .014 (R2 = .123). The 
depressive symptomatology/diabetes-specific distress (block 4) also did reach 
significance F (2, 115) = 52.46,p < .001 (R2 = .541). Of note, fatigue (block 5) was a 
significant predictor over and above the depressive symptomatology/diabetes specific-
distress block F (1, 114) = 22.78,p < .001 (R2 = .618). This suggests fatigue may be 




In this study, relationships between the emotional component of Glasgow's 
Personal Models of Diabetes Self-management, including blood glucose testing, diet, 
physical and mental quality of life were assessed. Global depressive symptomatology, 
diabetes-specific distress, and fatigue were used to examine the emotional construct 
within this model. An aim of this study was to collect descriptive data to better 
understand the extent of distress as assessed within each of these constructs and to 
examine their associations with one another. An additional aim was to examine the 
associations of each these constructs with key aspects of diabetes self-management and 
quality of life. 
To address the aims described above, a series of 13 specific hypotheses were 
developed. The analytic plan included conduction of a correlation matrix and 12 
individual hierarchical linear regressions. In addition, several supplemental analyses were 
conducted (individual item examination, an additional regression) to further explain the 
pattern of results observed. Given the relatively lengthy set 6f analyses, the discussion 
section below is organized to first provide a context for interpreting the study results, in 
order to guide the reader through the findings. This begins with a framework that 
addresses the study focus in the context of the existing published literature (study 
strengths, sample characteristics, scores on the key emotional constructs and outcome 
measures) then notes the gender differences that emerged in the analyses. Following this 
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contextual information, the discussion examines the findings for each individual aim and 
hypothesis. An overall summary and discussion of the pattern of results and their 
implications for the conceptual model and empirical literature follows the discussion 
of the individual hypotheses. 
Strengths of the Current Study 
This study makes a unique contribution to the existing diabetes literature across 
several domains. This study is the first study to explore the emotional component of 
Glasgow et aI's (1997) model of self-management by integrating literature (e.g., Fisher et 
aI, 2007) that addressed the impact of subclinical depressive symptomatology and 
diabetes-specific distress on diabetes related outcomes, specifically self-management and 
quality of life. Fatigue was introduced as a unique construct in the diabetes literature due 
to its importance as a potential overlapping symptom of both depression and diabetes. 
This study also contributes to the existing knowledge base by exploring the associations 
between the emotional constructs (depressive symptomatology, diabetes-specific distress, 
and fatigue) and self-management (blood glucose testing and diet) and quality of life 
(physical and mental quality of life). This study is the first to explore these associations in 
a clinic sample of adults; previously published research has examined the role of fatigue 
in a adults with diabetes specifically in a worksite setting. 
Chart review was conducted to gather relevant medical information including 
BMI, duration of diabetes, medication use, insulin use, comorbidity status and HbAlc. 
The chart review data collected in this study revealed the majority of this sample was 
overweight/obese. These individuals also reported high levels of cardiovascular disease 
(CVD) comorbidity; which has been cited as being a long-term complication of diabetes 
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itself. This comorbidity information in the present sample highlights the "real world" 
health issues of a clinical sample of adults with type 2 diabetes. 
The observed findings of this study present opportunities for future research to 
gain further understanding of the impact of fatigue on a population of adults with type 2 
diabetes by addressing the impact of the subscales of fatigue with both physical and 
mental quality of life. Some of the study's findings are consistent with current published 
studies and thus provides an opportunity to guide future research addressing the impact of 
fatigue on additional domains of self-management, specifically physical activity. Lastly, 
the hypotheses were addressed within a conceptual framework that has been empirically 
validated, which also greatly strengthens the opportunity for replication and future 
research. 
Representativeness of Sample 
Individuals who screened out the study due to their performance on the Mini-Cog 
were not included due to the cognitive capacity needed to complete questionnaire data. 
The Mini-Cog was included as a screening tool for cognitive impairment; those that 
completed this screener were included in the study and provided a questionnaire. Those 
that did not successfully complete this screening tool were excluded due to potential for 
cognitive impairment. Demographic and health-status information was not collected 
once an individual did not successfully complete the screening measure. Thus, the study 
sample was comprised of individuals whom were able to complete the cognitive screener 
(suggestive of absence of cognitive impairment) and meet eligibility criteria (i.e. a 
diagnosis of type 2 diabetes, currently prescribed medication, and can read, write, and 
understand English). 
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Those individuals who were eligible for participation and consented but did not 
complete the study measures had significantly higher chart-recorded HBA l-c levels 
relative to those who completed the study. This suggests that participants who completed 
the study had relatively good metabolic control relative to those who did not complete the 
study. 
The present study was comprised of 93% Caucasian participants; with African 
American participant representation considerably lower than the population of Metro 
Louisville. Of note, New Albany Indiana (the location of the clinic recruitment site), 
while in close proximity to Louisville KY, has a more rural catchment area and is more 
populated by Caucasians relative to Louisville (Metro Louisville's population is 
comprised of 62.9% Caucasians, 33.0% Black/African Americans, 1.4% Asians and 1.9% 
Hispanics; New Albany Indiana's population is comprised of 90.0% Caucasians, 6.9% 
Black/African Americans, 0.4% Asians and 1.4% Hispanics, U.S. Census Bureau, 2009). 
This reflects the ethnic/racial representation in this study sample. 
Health Characteristics and CVD Risk 
The majority of this sample was well controlled in terms of their blood glucose 
levels. Despite adequate blood glucose control (HbAl c < 8 = 29.4%; HbAl c < 7 = 
43.4%), the majority of this sample of participants were diagnosed with hypertension, 
hyperlipidemia, and obesity. These factors have all been identified in the literature as 
independent risk factors for cardiovascular disease (CYD), in addition to the diagnosis of 
diabetes itself. CYD has been shown in the literature to be the most prevalent 
complication of diabetes (Mooradian, 2003), and CYD accounts for approximately 65% 
of mortality rates among persons with diabetes (Grundy, Benjamin, Burke, Chait, Eckel, 
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et aI, 1999). Results from a meta-analysis indicate the rate ofCVD mortality for persons 
with diabetes was 2.2 times greater in men and 2.8 times greater in women compared to 
otherwise healthy controls (Kanaya, Grady, & Barrett-Connor, 2001). 
Recent research is indicative of the severity of consequences CVD risk can have 
on a population of individuals with diabetes. The UK Prospective Diabetes Study 
(UKPDS) showed that intensive blood glucose control did not cause a significant 
reduction in CVD risk or CVD complications (The UKPDS Prospective Diabetes Study 
(UKPDS) Group, 1998). More recently, there were two large trials completed 
examining the impact of intensive blood glucose control on reduction in CVD risk- the 
Action in Diabetes and Vascular Disease-Preterax and Diamicron Modified Release 
Controlled Evaluation (ADVANCE) and the Veterans Affairs Diabetes Trial (VADT). 
Results of the ADVANCE trial indicate there are no observed differences in 
cardiovascular mortality based on intensive blood glucose control (The ADVANCE 
Collaborative Group, 2008). The V ADT yielded similar results; individuals with poorly 
controlled blood glucose that began an intensive blood glucose regimen did not display 
reductions in CVD risk (Duckworth, Abraria, Mortiz, Reda, Emanuele, et aI, 2009). 
The majority of participants in this study maintained CVD risk factors similar to 
the studies mentioned above (i.e. hypertension, hyperlipidemia, and obesity). This 
information was collected via chart review. Of note, when participants were asked for 
their perceptions of their health status (an item on the SF-12), only 18.4% rated their 
health as Excellent or Very Good. It is believed CVD risk is an important factor to be 
considered to explain these subjective health ratings. Individual explanations are beyond 
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the scope of this study, however results suggest CVD risk may be contributing to 
participant's self-reported health status that warrants further exploration. 
Representativeness of Emotional Constructs 
Depressive Symptomatology 
The majority of this sample did not reach the empirically derived cutoff score of 
10 on the CES-D 10 recommended by Andresen et al (Andresen, Malmgren, Carter, & 
Patrick, 1994). This may suggests a positive clinical presentation of depressive 
symptomatology (93.0%), since 23.1 % of the sample is currently prescribed anti-
depressant medication. The CESD-lO is not intended to diagnose depression, rather it's 
function is to assess for the presence of depressive symptomatology. As discussed by 
Fisher et al (2007), persons with diabetes often do not meet criteria for a Major 
Depressive Disorder yet endorse symptoms of depression. Brown, Milburn, & Gary 
(1992) assessed depressive symptomatology using the CESD-20 with older African 
Americans and found that only 11 % of their sample met the cutoff score, consistent with 
current findings. Large scale studies of depression in diabetes samples indicate that such 
levels of endorsement are not uncommon; persons with diabetes have been shown to be 
twice as likely to endorse symptoms of depression relative to those without diabetes 
(Lustman & Clouse, 2002). 
Diabetes-Specific Distress 
The mean PAID score in the current study was 39.7, which is notably higher than 
the mean PAID scores observed among depressed individuals in the Kokoszka et al 
(2009) study. Findings of the present study suggest that despite overlap between 
constructs, the PAID appears to be addressing a separate construct than the CESD-I0 in 
80 
this study. This finding is consistent with recent literature, which also has indicated that 
depressive symptomatology and diabetes-specific distress are distinct constructs 
(Gonzalez, Delahanty, Safren, Meigs, & Grant, 2008). 
Fatigue 
Correlations observed in this study between the CESD-I0 and the MFSI-SF were 
comparable to associations observed in previous research (Stein, Martin, Hann, & 
Jacobsen, 1998; Stein, Jacobsen, Blanchard, & Thors, 2004). The mean of the total 
fatigue score observed in this study was comparable to fatigue levels observed in cancer 
patients (Prue, Rankin, Cramp, Allen, & Gracey, 2006). The MFSI-SF was developed 
for use in the cancer population; however, items are not illness-specific and this measure 
is increasingly being used in non-cancer populations (Stein, Jacobsen, Blanchard, & 
Thors,2004). The present study findings support the use of the MFSI-SF in diabetes 
populations. 
Antidepressant Use 
Despite individuals endorsing low levels of depressive symptomatology on the 
CESD-lO, 23.1 % of the study sample is currently prescribed anti-depressants. When 
comparing emotional distress across measures representing global and disease specific 
constructs, those taking antidepressant medications were found to have significantly 
higher distress scores --across depressive symptomatology, diabetes-specific distress, 
fatigue, and quality of life measures. This suggests despite the antidepressant therapy, a 
substantial percentage of participants continue to report higher scores on the CESD-I0, 
PAID, and MFSI-SF indicating higher levels of emotional distress and lower scores on 
both the Physical Component Score (PCS) and Mental Component Score (MCS) of the 
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SF-12, indicating poorer perceptions of mental and physical quality of life than those not 
taking antidepressants. This could be indicative of the benefits of antidepressant use on 
depressive symptomatology, or a false negative on the self report measures. Women were 
also more likely to be prescribed antidepressants compared to men. This is consistent 
with women's relatively higher rates of depressive symptomatology on the CESD-10 as 
mentioned above. 
Representativeness of Self-Management 
Self-management was measured using the SDSCA, which is often used in the 
literature to assess the frequency of engaging in self-management regimen in the past 7 
days. Blood glucose testing means available in the literature range from 4.31 to 5.80 
(Forjuoh, Reis, Couchman, & Ory, 2008; Rose, Harris, Ho, &Jayasinghe, 2009). With 
respect to diet, the mean SDSCA scores (expressed as days adhered to diet) in the 
published literature range from 3.4 to 4.9 (Lin, Katon, Rutter, Simon, Ludman, et aI, 
2006; Katon, Russo, Heckbert, Lin, Ciechanowski, et al 2010). Blood glucose testing 
and diet scores on the SDSCA observed in the present study are consistent with the 
findings in the current research literature. 
Representativeness of Quality of Life 
Mean scores observed for both the Physical and Mental Component Scores of the 
_ SF-12 were consistent with means observed with Ware, Kosinski, and Keller (1996). 
This study also provided normative information for this sample; the observed mean 
scores were comparable to a sample of individuals with physical limitations and mental 
difficulty. A recent study examined the quality of life scores related to health status and 
reported means for obese individuals with diabetes, hypertension, and hyperlipidemia 
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(Sullivan, Ghushchyan, & Ben-Joseph, 2008) that are comparable to the means observed 
in the current study. The findings of the studies presented are consistent with the current 
study suggesting obese individuals with type 2 diabetes report significant deficits in 
physical and mental quality of life. 
Gender Differences 
Depressive symptomatology was significantly negatively associated with gender. 
Females were more likely to have higher scores on the CESD-lO than males. This is 
consistent with the literature; Egede, Zheng, and Simpson (2003) also found that in a 
sample of adults with diabetes, women were more likely to maintain higher scores on 
measures of depression relative to men. 
Diabetes-specific distress was unrelated to gender, consistent with findings from 
Welch, Weinger, Anderson, & Polonsky (2003). Blood glucose testing, age, insulin use, 
oral agent use, and BMI were all unrelated to PAID scores in this study. Women have 
been cited in the literature as reporting higher levels of emotional distress than men 
(Edege, Zheng, and Simpson, 2003). Despite women scoring higher on depression 
constructs, they did not score differently than males with respect to diabetes-specific 
distress. This gender difference could provide evidence these distress constructs are 
independent constructs. 
With respect to quality of life, women were more likely to report lower Mental 
Component Summary scores compared to men. McCollum, Hansen, Ghushchyan, and 
Sullivan (2007) assessed quality of life using the SF-12 and found that women reported 
poorer Mental Component Scores than males, which provides support for the current 
study's findings. Women were also more likely to be prescribed antidepressants, which is 
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also consistent with reporting higher levels of depressive symptomatology and lower 
Mental Component Scores. 
There were significant group differences observed for men and women with 
respect to diet. Women had higher SDSCA diet scores, consistent with greater adherence 
to their recommended diet (approximately one half day per week more) than men. Over 
half of the sample was married, women could be preparing foods for their husbands. 
Additionally, women may also be feeding children and grandchildren in the home, which 
also could explain this finding. This was not formally assessed, future research could 
assess this issue by adding a single item inquiring who prepares the meals in the home. 
This could assess this explanation more directly. 
Aim 1: Examining the associations between depressive symptomatology, diabetes-
specific distress, and fatigue for adults with type 2 diabetes. 
Hypothesis 1 
The primary aim of this study was to examine the individual levels of and 
relationships between potential emotional aspects of diabetes, namely depressive 
symptomatology, diabetes-specific distress, and fatigue. This hypothesis was supported 
in this study, moderate associations were observed between depressive symptomatology, 
diabetes-specific distress, and fatigue in this sample of adults with type 2 diabetes. 
Depressive Symptomatology 
Depressive symptomatology was assessed in this study using the total score of the 
CESD-IO. Fisher et al (2007) discuss this measure and concluded the CESD-IO is more a 
measure of global depressive symptomatology and less a diagnostic measure of 
depressive disorder. Fatigue and diabetes-specific distress were significantly associated 
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with depressive symptomatology as hypothesized. Fisher et al (2007) discussed concern 
with potential overlap between depression and diabetes-specific distress and contended 
these are distinct constructs, but may be contributing to misdiagnosis of depression 
among individuals with diabetes due to the noted overlap between constructs and the 
likelihood for participants to endorse items on a depression measure that likely would be 
better explained by diabetes-specific distress. This may guide researchers and/or 
clinicians when selecting measures depending on the intended use of the information. 
Diabetes-Specific Distress 
Diabetes-specific distress was positively associated with fatigue and depressive 
symptomatology, as hypothesized. Diabetes-specific distress includes common emotions 
such as anger, reduced motivation, burnout, guilt, and discouragement related to specific 
aspects of diabetes. In a study comparing four measures of depressive symptomatology 
in persons with diabetes, the PAID was found to reflect both major and minor depression 
(Hermann, Kuzler, Krichbaum, Kubiak, & Haak, 2006). The Hermann et al (2006) study 
also provided support for overlap between diabetes-related distress and depression. The 
results of the current study replicate existing empirical support for the overlap between 
the independence of depressive symptomatology and diabetes-specific distress. In a 
recent study by Kokoszka, Pouwer, Jodko, Radzio, Mucko et al (2009), the PAID was 
used to evaluate diabetes-specific distress in a sample of patients with type 2 diabetes. 
This study concluded PAID scores are lower for individuals without depression than 
those with both depressive disorders and subclinical depression also supporting overlap 
between these emotional constructs. 
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Insulin regimens have been identified in the literature as burdensome for 
individuals (Makine, Karsidag, Kadioglu, Ilkova, Karsidag, et aI, 2009). Participants on 
an insulin regimen did not differ from those not on an insulin regimen with respect to 
PAID scores in this sample. The perceived burden of the insulin regimen discussed in 
recent literature suggested insulin regimens are burdensome and would likely contribute 
to higher diabetes-specific distress scores. Diabetes-specific distress scores were not 
associated with insulin use in this study, which is inconsistent with the current literature. 
Participants on an insulin regimen had higher HbAlc than those who were not 
prescribed insulin. Type 2 diabetes varies with respect to treatment options ranging from 
diet and exercise only, diabetic oral agent medication, an insulin regimen, or a 
combination of the above. Individuals are often prescribed an insulin regimen when their 
blood glucose is not optimally maintained with oral agent medication. 
Although the insulin regimen was not associated with PAID scores, HbAlc was 
positively associated with total PAID scores. Additionally, results of the current study 
found that diabetes-specific distress (PAID) was also negatively associated with SDSCA 
diet scores, suggesting higher levels of diabetes-specific distress are related to less 
frequent adherence to diet recommendations. Diabetes-specific distress may be a 
significant contributor to poor glycemic control and diet adherence that warrants 
additional attention. 
Fatigue 
Fatigue is one of the most commonly reported somatic symptoms associated with 
depression (Vaccarino, Sills, Evans, & Kalali, 2008) and is included in the diagnostic 
criteria for Major Depressive Disorder in the Diagnostic and Statistical Manual of Mental 
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Disorders, 4th Edition, Text Revision (American Psychiatric Association, 2000). Fatigue 
has also been identified as an overlapping symptom construct for both depression and 
diabetes. The present study was the first known to incorporate the construct of fatigue 
into emotion-based constructs with individuals with type 2 diabetes. Fatigue was found 
to be significantly and positively associated with both depressive symptomatology and 
diabetes-specific distress in this study. Fatigue was negatively associated with physical 
and mental quality of life, diet, and antidepressant use. This suggests that fatigue may 
impact an indi vidual's perception of their functional status and their mental quality of 
life. Fatigue is believed to interfere with an individual's ability to adhere to diet 
recommendations. Fatigue was unrelated to blood glucose testing, age, gender, BMI, 
duration of diabetes, exogenous insulin use, and oral agent use. 
Despite the overlap of fatigue, depressive symptomatology, and diabetes-specific 
distress, it appears fatigue is a useful construct to assess in adults with type 2 diabetes. 
Published research has examined the overlap of fatigue and psychological distress 
in a working population of adults with diabetes (Jansen, Kant, & van den Brandt, 2002). 
The present study found results similar to this previous research -- fatigue converged 
with depressive symptomatology, but it also appears to be an independent construct. 
Results of this study highlight the utility of fatigue in a clinical population of adults with 
type 2 diabetes. 
Aim 2: Examine the unique associations of emotional distress with diabetes self-
management behavior, physical, and mental quality of life, controlling for demographic 
variables and diabetes regimen demand. 
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Hypothesis 2 (H2): Global depressive symptomatology (CESD-IO) will be negatively and 
significantly associated with frequency of blood glucose testing on the SDSCA, 
controlling for demographic variables (age, gender, and BMl), diabetes-related history 
(insulin, duration of diabetes, oral medication use), and anti-depressant use. 
Hypothesis 2 tested the idea that depressive symptomatology decreases adherence 
to a blood glucose testing regimen in individuals with type 2 diabetes. Hypothesis 2 
explored depressive symptomatology as an independent variable used to predict scores on 
the blood glucose testing sub scale of the SDSCA. The results showed that scores on the 
CESD-lO did not significantly predict scores on the blood glucose testing subscale of the 
SDSCA. These results suggest that global depressive symptomatology was not a 
significant contributor to the frequency of blood glucose testing in this sample. This 
could be explained by participants' low scores on the depressive symptomatology 
measure. It was hypothesized the variance accounted for by the independent variable 
(depressive symptomatology) would be beyond that of demographics and medical 
history. This hypothesis was not supported. 
The negative impact depressive symptomatology has on one's ability to test their 
blood glucose has been identified in the self-monitoring of blood glucose literature but 
results are mixed. Evidence from large clinical trials have demonstrated that the effects of 
exercise, following dietary recommendations, and self-monitoring of blood glucose 
(SMBG) are essential to achieving optimal glycemic control, and blood pressure and lipid 
control (ADA, 2010). However, engaging and maintaining these recommendations 
frequently present challenges for persons with diabetes (Edege & Zheng, 2002; Nelson, 
Reiber, & Boyko, 2002; Harris, 2001). A recent meta-analysis indicated co-morbid 
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depression is believed to further complicate adherence to blood glucose testing 
recommendations (Lustman & Clouse, 2002). In contrast, Paschalides et al (2004) 
concluded that depression influences physical and mental functioning - not blood glucose 
testing in individuals with type 2 diabetes (Paschal ides et aI, 2004). These studies are 
presented to highlight the mixed findings present in the current literature. The present 
study differs from others in the published literature with respect to the relatively lower 
levels of depressive symptomology observed in the sample. The present study found that 
depressive symptomatology was not associated with blood glucose testing. The relatively 
low levels of depressive symptomatology likely influenced the ability to accurately detect 
the influence of symptomology on blood glucose testing. 
H3 (Hypothesis #3) 
Global depressive symptomatology (CESD-10) will be negatively and significantly 
a$sociated with frequency of diet adherence on the SDSCA, controlling for demographic 
variables (age, gender, and BM!), diabetes-related history (insulin, duration of diabetes , 
oral medication use), and anti-depressant use. 
Hypothesis 3 examined the impact of depressive symptomatology on diet 
adherence. It was proposed that diet would be negatively impacted by depressive 
symptomatology above and beyond the effects of demographic and diabetes-related 
history. This hypothesis was not supported. There were no significant findings observed. 
It is difficult to address the impact of depressive symptomatology on diet given the 
minimal depressive symptomology present in this sample. The CESD-lO is a screener for 
detecting the presence of depressive symptomatology, it is not intended to serve as a 
diagnostic tool. 
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Summary of impact of depressive symptomatology on self-management. 
The impact of depressive symptomatology on self-management of diabetes has 
been well documented in the research literature. Depressive symptomatology has been 
linked to poor glycemic control (Lustman et aI, 2000; Lustman & Clouse, 2005), a higher 
risk for diabetes complications (de Groot, Anderson, Freedland, Clouse, & Lustman, 
2001), and increased mortality (Ismail, Winkley, Stahl, Chalder, & Edmonds, 2007). 
Results of this study were unable to provide information related to the effects of 
depressive symptomatology on blood glucose testing and diet adherence largely due to 
the relatively low representation of depressive symptomology reported by this sample. 
Recent literature has addressed the issue of subclinical depression and identified this as a 
risk factor for later development of major depressive disorder (Cuijpers & Smit, 2004). 
Fisher et al (2007) discussed most patients with diabetes are reporting high levels of 
depression are not clinically depressed, rather these individuals often are experiencing 
subthreshold depressive symptomatology. 
H4 (Hypothesis #4) 
Independent variable diabetes-specific distress (PAID) controlling for demographic 
(age, gender, and BM/) and diabetes-related history (insulin, duration of diabetes , oral 
medication use), and anti-depressant use will be negatively and significantly associated 
with frequency of blood glucose testing on the SDSCA. It was hypothesized the variance 
accounted for by the independent variable will be beyond that of demographics and 
medical history. 
Hypothesis 4 explored the associations between diabetes-specific distress and 
blood glucose testing when controlling for demographic, diabetes-related history 
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variables and antidepressant use. Results of these findings failed to reject the null 
hypothesis, demographic variables were the only significant findings observed in this 
regression analysis. Age was the only variable to retain significance upon further review 
of the regression model. This suggests that as individuals get older, they are checking 
their blood glucose more often. This could be explained as a result of the trend for 
individuals with type 2 diabetes beginning an insulin regimen often as the result of onset 
of complications or long-standing suboptimal blood glucose control. 
Previous literature has established the PAID as a reliable and valid instrument for 
assessing disease-specific diabetes related distress (Welch, Weigner, Anderson, & 
Polonsky, 2003). One recent study examined depressive symptomatology and diabetes 
specific distress with respect to self-management outcomes using the SDSCA. Results 
were consistent with the observed findings in the current study; the PAID scores were not 
significantly associated with blood glucose testing (Gonzalez, Delahanty, Safren, Meigs, 
& Grant, 2008). The null findings for Hypothesis 4 support existing literature, diabetes-
specific distress was not found to be statistically significant, consistent with the findings 
of Gonzalez and colleagues (2008). 
H5 (Hypothesis #5) 
Independent variable diabetes specific distress (PAID) controlling for demographic (age, 
gender, and BMI) and diabetes-related history (insulin, duration o/diabetes, oral 
medication use), and anti-depressant use will be negatively and significantly associated 
with frequency 0/ diet adherence on the SDSCA. It was hypothesized the variance 
accounted/or by the independent variable will be beyond that o/demographics and 
medical history. 
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Hypothesis 5 explored the associations between diabetes-specific distress and diet 
when controlling for demographic/diabetes-related history variables and antidepressant 
use. It was hypothesized there would be a negative association observed between 
diabetes-specific distress and diet. Findings of this study provide support for this 
hypothesis. Diabetes-specific distress and diet were negatively correlated, suggesting that 
individuals who are currently experiencing more diabetes-specific distress are less likely 
to adhere to their diet recommendations. Due to the cross-sectional data collected in this 
study, causality cannot be determined. Results of this data would also suggest those with 
lower diabetes specific distress had higher frequency of diet adherence. Demographic 
variables, diabetes regimen demand, and antidepressant use were not statistically 
significant in this hypothesis consistent with previous literature. Diabetes specific-distress 
was also a significant predictor of diet adherence in the Gonzalez and colleagues (2008) 
study providing additional support for this hypothesis. The null hypothesis was rejected 
in this study, providing the evidence diabetes-specific distress has a negati ve impact on 
diet adherence in this sample of adults with type 2 diabetes mellitus. 
Summary of impact of diabetes-specific distress on self-management 
Fisher et al (2007) recently reported that diabetes-specific distress is a better 
indicator of self-management than depressive symptomatology. Gonzalez and colleagues 
(2008) concluded depressive symptomatology is a better indicator of self-management 
than diabetes specific distress. Further exploration revealed the studies presented above 
may not be producing conflicting results. These researchers both suggest that the 
variability in results can be explained by the measurements selected, and argue that 
depression measures do not assess etiology of symptoms, rather they provide information 
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related to presence or absence of symptoms. However etiology of depressive symptoms 
endorsed in the clinical interview have not been explored in diabetes samples. The 
authors suggested assessing content of depressive symptomatology collected via 
interview may have informed the nature of the symptoms, suggesting the overlap 
between these constructs would likely explain a subset of the sample of depressed 
individuals (Gonzalez, Delahanty, Saffron, Meigs, & Grant, 2008). 
In the present study, diabetes specific distress was found to predict diet scores on 
the SDSCA but not SDSCA blood glucose testing scores. These results replicated 
findings observed by Gonzales and colleagues (2008). Our results suggest diabetes 
specific distress is a better predictor of self-management than depressive 
symptomatology, but these findings should be interpreted with caution due to the low 
scores observed on the CESD-I0 in this study. Observed scores on the PAID were 
consistent with a population of depressed individuals with type 2 diabetes in the 
Kokoszka et al (2009) study. These authors concluded diabetes-specific emotional 
problems are equally likely with clinical depression and subclinical depression. This 
finding is consistent with the results of this study, diabetes-specific distress was a 
significant contributor to diet. Our study provided additional support for the existing 
literature, the PAID is a valid measure of diabetes-specific distress, and this disease-
specific distress is capable of predicting self-management behaviors in a population of 
individuals with type 2 diabetes. Additional research is needed to further explore the 
validity of the PAID with respect to individual domains of self-management (i.e. diet, 
medications, blood glucose testing) since these behaviors are believed to be mutually 
exclusive (Johnson, 1992). 
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Literature indicates these ongoing, multiple behavioral demands are the key 
factors that distinguish the demands of living with diabetes from those of other chronic 
illnesses, which may require maintaining only a select few of these behaviors (ADA, 
2006). It is well-established that the seven self management behavioral components of 
diabetes self-management do not correlate highly with one another, suggesting 
individuals can be adherent to one behavior while ignoring another (Glasgow & Eakin, 
1998; Rubin & Peyrot, 1992; Orme & Binik, 1989). Due to the relative independence of 
the behaviors research suggests each component needs to be assessed separately when 
evaluating diabetes self-management outcomes (Johnson, 1992). 
H6 (Hypothesis #6) 
Independent variable fatigue (MFSI-SF) controlling for demographic (age, gender, and 
BMf) and diabetes-related history (insulin, duration of diabetes, oral medication use), 
and anti-depressant use will be negatively and significantly associated with frequency of 
blood glucose testing on the SDSCA. It was hypothesized the variance accountedfor by 
the independent variable will be beyond that of demographics and medical history. 
Hypothesis 6 sought to assess the impact of fatigue on blood glucose testing 
recommendations. This study was the first known study to incorporate the construct of 
fatigue into the literature differentiating emotion-based constructs with individuals with 
diabetes. This study proposed there would be a negative association between fatigue 
levels and blood glucose testing behavior. This hypothesis was not supported. However, 
age and BMI retained significance in this regression suggesting those that are overweight 
and/or obese and those that are older check their blood glucose more frequently than 
those that are not. Observed correlations indicate older individuals in this sample are 
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heavier, have had diabetes longer, and check their blood sugar more often. It is believed 
these associations significantly contributed to the inability to reject the null hypothesis. 
There were no observed associations between fatigue and blood glucose observed in this 
study therefore no conclusions can be made. 
There was a significant difference observed in the frequency of blood glucose 
testing based on medication use. Individuals on insulin were more likely to test their 
blood glucose more frequently than those individuals on oral agents. This is likely 
explained by the health provider's recommendations for blood glucose testing. Blood 
glucose testing recommendations differ for individuals on oral agents and those on 
insulin. In the overall sample, individuals were testing their blood sugar on average 4.87 
days per week. Further exploration revealed there were significant differences noted 
based on types of medication prescribed. Those on insulin checked their blood sugar 5.42 
times per week vs. those on oral agents checked their blood glucose 4.57 times per week. 
Interestingly, those on Byetta tested their blood glucose more often; 5.95 times per week. 
ADA recommends those individuals on insulin should check their blood glucose up to 3 
times daily. This study did not inquire about frequency of daily blood glucose testing, 
rather how many times in the previous week had participants adhered to their physician 
recommendations for blood glucose testing. It is believed those on insulin should be 
checking their blood glucose daily; results reveal this is not the case. Rather findings 
from this study indicated individuals on insulin are not checking as often as they should 
according to the ADA recommendations. 
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H7 (Hypothesis #7) 
Independent variable fatigue (MFSI-SF) controlling for demographic (age, gender, and 
BM!) and diabetes-related history (insulin, duration of diabetes, oral medication use), 
and anti-depressant use will be negatively and significantly associated with frequency of 
diet adherence on the SDSCA. It was hypothesized the variance accounted for by the 
independent variable will be beyond that of demographics and medical history. 
Hypothesis 7 sought to assess the impact of fatigue on diet self-management. 
This study was the first known study to incorporate the construct of fatigue into the 
literature differentiating emotion-based constructs with individuals with diabetes. This 
study proposed there would be a negative association between fatigue levels and 
adherence to diet. This hypothesis was supported, fatigue was found to negatively impact 
an individual's ability to adhere to diet recommendations. Fatigue was the only 
significant predictor of diet observed in this regression. There were no significant 
demographic or diabetes-specific variables observed in this regression. 
There are several possible explanations for this finding. First, it is possible 
fatigue can be identified as a barrier for an individual to select, prepare, and consume 
foods that are consistent with a diabetes diet. This is the first known study that examined 
the relationship between fatigue and diet in diabetes independent of depression. The 
depression research has long suggested depression impacts an individual's self-
management ability; however specific symptoms of depression have often not been 
assessed to further explain specific symptoms of depression (i.e. fatigue) and its potential 
impact on an individual's ability to adhere to diet recommendations. 
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Summary of the impact of fatigue on self-management 
Fatigue has been identified in the literature as an overlapping symptom of both 
depression and diabetes, but the etiology of fatigue is less clear. This study sought to 
explore the impact of fatigue on self-management. Results provided preliminary 
evidence on the impact of fatigue on diet adherence. This relationship suggested 
individuals with higher fatigue were less likely to adhere to their diet recommendations 
than those with lower levels of fatigue. These findings may guide future research in this 
area by exploring the overlap of depression and physical symptoms associated with 
diabetes and performance of self management behaviors, due to fatigue being identified 
in both depression and diabetes. 
H8 (Hypothesis #8) 
Independent variable global depressive symptomatology (CESD-IO) controlling for 
demographic (age, gender, and BM/) and diabetes-related history (insulin, duration of 
diabetes, oral medication use), and anti-depressant use will be negatively and 
significantly associated with physical function scores on the SF-I2. It was hypothesized 
the variance accounted for by the independent variable will be beyond that of 
demographics and medical history. 
Hypothesis 8 was supported; but results should be interpreted with caution. 
Examination of this hypothesis was complicated by the low rates of depressive 
symptomatology endorsed in this sample. Findings suggest depressive symptomatology 
is predictive of the Physical Component Score of quality of life, in addition to the 
demographic variables included in this model (age, gender, and BMI). Results also 
revealed that age and BMI specifically predict higher scores on the Physical Component 
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Score of the SF-12, suggesting individuals who are older and have higher BMI report 
experiencing poor physical quality of life. An underlying assumption of this hypothesis 
is that participants' self-report of their physical well-being may be impacted by 
depressive symptomatology. This provides support for low levels of depressive 
symptomatology can also impact an individual's physical function. 
The results of this hypothesis are supported by Fisher et aI's (2007) contention 
that subclinical depression also affects an individual's perception of their physical quality 
of life. It has been established in the literature those with type 2 diabetes often report 
multisystem complications including poorer perceptions of their functional status. 
Studies have also implicated the progression of complications associated with diabetes is 
often associated with a sharp decline in self-report of functional status (Mayou, Bryant, & 
Turner, 1990). Although co-morbid diagnoses were not included in this study, obesity has 
been linked to increased co-morbidity among individuals with diabetes. Lopez-Garcia et 
al (2003) recently concluded that obesity was indicative of poorer perceptions of physical 
health regardless of age and gender compared to normal weight controls. These findings 
support this hypothesis -obesity was found to be associated with poor physical quality of 
life. 
Age was also found to be significant despite controlling for the effects of age in 
the regression analyses; suggesting that older adults often report poor physical 
functioning. The diabetes literature discussed the likelihood of developing complications 
increases as individuals get older. Aside from diabetes-related complications, other 
physical illness may impact an individual's functional status (i .e. arthritic conditions may 
impair someone's ability to function). This provides a platform for inclusion of all 
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physical complications when assessing physical quality of life. Qualitative information 
related to why individual's feel their functional status is poor may also inform future 
longitudinal research. For this sample, older obese individuals who reported higher 
levels of depressive symptomatology reported poor functional status. 
H9 (Hypothesis #9) 
Independent variable global depressive symptomatology (CESD-IO) controlling for 
demographic (age, gender, and BM/), diabetes-related history (insulin, duration of 
diabetes, oral medication use), and anti-depressant use will be positively and 
significantly associated with mental well-being on the SF-12. It was hypothesized the 
variance accounted for by the independent variable will be beyond that of demographics 
and medical history. 
Hypothesis 9 was largely supported; depressive symptomatology was negatively 
associated with the mental component score on the SF-12. This finding suggests 
consistency in terms of reporting; individuals are more likely to experience poor mental 
quality of life when they are also experiencing depression. Additionally, consistencies 
were also noted with respect to gender; women reported both higher depressive 
symptomatology and poorer mental quality of life relative to men. This hypothesis 
originally suggested a positive association, however the scoring criteria of the SF-12 
suggests higher scores indicate better quality of life, as with the CESD-IO higher scores 
are indicative of higher levels of depressive symptomatology. Taking the scoring into 
consideration, there was a negative association observed in this study, the higher an 
individual's depressive symptomatology, the lower their mental quality of life scores. 
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Consistent with findings on global depressive symptomatology, participants who 
were prescribed antidepressants reported a lower Mental Component Summary score than 
did those who were not prescribed antidepressants. This is an interesting finding worthy 
of discussion. Antidepressant therapy has been shown to be very effective for the 
treatment of depression, however recent literature suggests despite the effectiveness of 
antidepressant therapy, individuals may experience residual symptoms of depression 
(American Psychiatric Association, 2000). This may be contributing to this study's 
findings. Additional research can specifically address the effects of antidepressants on 
mental quality of life. 
An individual's perceptions of their quality of life may also be contributing to 
their scores on the quality of life measure in addition to the symptoms they may be 
experiencing. It is possible taking antidepressants may be linked to a perception of "doing 
worse" which could also be contributing to these findings. 
HIO (Hypothesis #10) 
Independent variable diabetes-specific distress (PAID) controlling for demographic 
(age, gender, and BM/) and diabetes-related history (insulin, duration of diabetes, oral 
medication use), and anti-depressant use will be negatively and significantly associated 
with physical function scores on the SF-I2. It was hypothesized the variance accounted 
for by the independent variable would be beyond that of demographics and medical 
history. 
Hypothesis 10 examined the construct of diabetes-specific distress having a 
negative impact on physical quality of life. This hypothesis suggested as PAID scores 
increased (higher levels of diabetes-specific distress), functional status (SF-12 Physical 
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Component Score) would decrease (poorer functional status). In testing hypothesis 10 
the association of diabetes-specific distress and physical quality of life was assessed 
using the PAID total score and the physical component score (PCS) of the SF-12 while 
controlling for demographics (age, gender, and BMI), diabetes related history (insulin, 
duration of diabetes, and oral medication use), and antidepressant use. 
The demographic variables, antidepressant use, and the PAID total score all 
retained statistical significance in this model, rejecting the null hypothesis that no 
conclusions can be made. With respect to the demographic variables, age and BMI were 
both statistically significant, suggesting individuals who are older and have higher BMI 
report poorer physical quality of life. This is consistent with obesity literature, which has 
identified obesity as a risk factor for decreased functional status (Wee, Wu, Thumboo, 
Lee, & Tai, 2010). Obesity has been identified in the literature as an independent risk 
factor for a host of physical illnesses. Disease comorbidity also may contribute to the 
observed findings in this study. 
Antidepressant use also retained statistical significance, accounting for 16.3% of 
the variance in this model. Results suggest participants who were prescribed 
antidepressants are more likely to report higher levels of functional impairment that those 
that are not. Interestingly, those who were currently taking antidepressants reported 
higher levels of diabetes-specific distress compared to those that were not taking 
antidepressants. This finding is believed to be related to the overlap between depressive 
symptomatology and diabetes-specific distress, however it is unknown if the emotional 
distress that initiated antidepressant therapy may have been related to the level of disease-
specific distress that the individual reported to their physician, rather than Major 
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Depressive Disorder. Current findings were consistent with Fisher et al (2007) study 
suggesting diabetes-specific distress is a better predictor of quality of life than major 
depression. 
Diabetes-specific distress has been identified in the literature as a reasonable 
construct to assess in clinical practice (Hermanns, Kulzer, Krichbaum, Kubiak, & Haak, 
2006). Patients with diabetes often report diabetes-related stressors, and these disease-
specific stressors have been cited in the literature as an independent risk factor for 
depression and reduced quality of life (Peyrot & Rubin, 1997; Hermanns, Kulzer, 
Krichbaum, Kubiak, & Haak, 2006; Snoek, Pouwer, Welch, & Polonsky, 2000). 
Diabetes-specific distress scores were shown to be elevated in this sample for individuals 
with poor diet adherence and higher HbAl c . Additionally, obesity has also been 
identified in this sample as a significant risk factor for decreased functional status. 
Additional comorbidity is also a potential contributor to Physical Component Scores, 
however, this was not addressed in the present study. 
The directionality of the relationship between diabetes-specific distress and 
physical quality of life remains poorly understood. It is likely this relationship is 
bidirectional. It is feasible an individual will experience higher levels of diabetes-
specific distress due to "feeling bad". On the other hand, an individual's physical health 
may cause disease-specific worry (i.e. diabetes-specific distress). Additional longitudinal 
research is needed to further explore the directionality of this relationship. 
HI I (Hypothesis # II) 
Independent variable diabetes-specific distress controlling for demo graphic (age, gender, 
and BM!) and diabetes-related history (insulin, duration of diabetes, oral medication 
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use), and anti-depressant use will be positively and significantly associated with mental 
quality of life on the SF-12. It was hypothesized the variance accounted for by the 
independent variable will be beyond that of demographics and medical history. 
Hypothesis 11 examined the construct of diabetes-specific distress having a 
negative impact on mental quality of life. This hypothesis suggested as PAID scores 
increased suggesting higher levels of diabetes-specific distress, mental quality of life (SF-
12 MCS) would decrease suggesting increased severity of the impact of psychological 
distress on an individual's quality of life. In testing hypothesis 11 the association of 
diabetes-specific distress and mental quality of life was assessed using the PAID total 
score and the mental component score (MCS) of the SF-12 while controlling for 
demographics (age, gender, and BMI), diabetes related history (insulin, duration of 
diabetes, and oral medication use), and antidepressant use. 
The demographic variables, antidepressant use, and the PAID total score all 
retained statistical significance in this model, rejecting the null hypothesis that no 
conclusions can be drawn. With respect to the demographic variables, age and BMI were 
both statistically significant, suggesting individuals who are older and have higher BMI 
report poorer mental quality of life. Recent literature suggests that obesity may be an 
independent risk factor for psychological distress, specifically depression (Sacco et ai, 
2007). The present findings are consistent with Sacco et al (2007), with BMI linked to 
higher levels of both diabetes-specific distress and decreased mental quality of life. 
Additionally, the association between diabetes-specific distress and mental quality 
of life is a logical finding. It was expected diabetes-specific distress would have a 
negative impact on mental quality of life, due to the distress associated with diabetes 
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impacting an individual's psychological functioning. Directionality of this relationship 
cannot be addressed due to the cross-sectional design of this study, but it appears this 
relationship could be bidirectional. Health status may be driving higher scores on the 
PAID, which is indicative of higher levels of diabetes-specific distress. High levels of 
distress may lead to a decreased psychological quality of life, as reflected by a decrease 
in scores on the Mental Component score of the SF-12 .. Alternatively, the inverse could 
also be true, having poor perceptions of mental quality of life may impair one's ability to 
view their illness rationally, which also would likely produce similar findings. 
Additional research is needed to further explore this relationship. 
H12 (Hypothesis #12) 
Independent variable fatigue (MFSI-SF) controlling for demographic (age, gender, and 
BM/) and diabetes-related history (insulin, duration of diabetes, oral medication use), 
and anti-depressant use will be negatively and significantly associated with physical 
function scores on the SF-12. It was hypothesized the variance accountedfor by the 
independent variable will be beyond that of demographics and medical history. 
Hypothesis 12 sought to assess the impact of fatigue on physical function scores 
on the SF-12. This study was the first known study to incorporate the construct of 
fatigue into the literature differentiating emotion-based constructs with individuals with 
diabetes. This study proposed there would be a negative association between fatigue 
levels and physical quality of life. Findings provided support for this hypothesis. 
However, age and BMI also retained significance in this regression suggesting those that 
are overweight and/or obese and those that are older subjectively report lower physical 
quality of life scores. Observed correlations indicate older individuals in this sample are 
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heavier, have had diabetes longer, and check their blood sugar more frequently; all which 
can potentially contribute to decreased quality of life. Additionally, co-morbid health 
conditions are more prevalent in older adults, but were not included as a covariate in this 
analysis. It is likely disease co-morbidity is also contributing to the decrease in physical 
function observed in this sample. Results revealed mean co-morbidity of 4.2 co-morbid 
health conditions. The impact of disease co-morbidity on quality of life has been well-
documented in the literature (Jacobson, de Groot, Samson, 1994). A recent study 
indicated obese individuals reported decreased physical quality of life compared to 
normal weight individuals even when controlling for the impact of diabetes and disease 
co-morbidity (Hlatky, Sheng-Chia, Escobedo, Hillegass, Melsop, et aI, 2010). 
Fatigue was also found to be contributing to an individual's Physical Component 
Score from the SF-12. As an individual's fatigue score increased their Physical 
Component Score score decreased, suggesting that fatigue is contributing to an 
individual's poor functional status. However, one cannot ignore the impact of obesity and 
age. Age and obesity likely contribute to an individual's fatigue level. Recent literature 
suggests fatigue and obesity are positively associated with one another and that these 
factors both contribute to an individual's decreased physical quality of life. 
Proinflammatory cytokines have been implicated as a contributor to the fatigue levels 
observed in obese individuals (V gontzas, Bixler, & Chousos, 2006), however this 
relationship is beyond the scope of this study. Results from this study suggested obesity 
and fatigue both contribute to increased fatigue levels, but how they are independently 
affecting quality of life is uncertain. 
HI3 (Hypothesis #13) 
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Independent variable fatigue (MFSI-SF) controlling for demographic (age, gender, and 
BMI) and diabetes-related history (insulin, duration of diabetes, oral medication use), 
and anti-depressant use will be negatively and significantly associated with mental 
component summary scores on the SF-I2. It was hypothesized the variance accounted 
for by the independent variable will be beyond that of demographics and medical history. 
Hypothesis 13 examined the construct of fatigue having a negative impact on 
mental quality of life. This hypothesis suggested as MFSI-SF scores increased suggesting 
higher levels of fatigue, mental quality of life (SF-12 MCS) would decrease suggesting 
fatigue has a negative impact on an individual's mental quality of life. The association of 
fatigue and mental quality of life was assessed using the MFSI-SF total score and the 
mental component score (MCS) of the SF-12 while controlling for demographics (age, 
gender, and BMI), diabetes related history (insulin, duration of diabetes, and oral 
medication use), and antidepressant use. This hypothesis was supported, suggesting 
higher fatigue levels significantly contribute to an individual's perception of their mental 
quality of life. 
The purpose of antidepressant therapy is to effectively treat symptoms of 
depression. The majority of participants in this sample reported low levels of depressive 
symptomatology, yet it is likely residual symptoms of depression remain. Recent 
literature suggests despite the efficacy of antidepressant treatment it is not uncommon for 
patient's to experience residual symptoms, most commonly to include fatigue, sleep 
disturbance, and apathy (Fava, 2006). These residual symptoms are often linked to 
increased risk of poor psychosocial functioning. Results indicate fatigue has a significant 
negative impact on mental quality of life scores. 
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Obesity has been linked to higher levels of self-reported fatigue in the literature. 
In one recent study examining the role of obesity and fatigue, fatigue was identified as a 
common symptom for obese individuals (V gontzas, Bixler, Chrousos, 2006). However, 
BMI was not significant in this model. This finding is inconsistent with V gontzas et al 
(2006) study, but may have important implications. The findings of this study suggest 
fatigue is a significant contributor to an individual's mental quality of life. This is likely 
multidimensional in terms of etiology; additional research is needed to clarify this 
relationship. 
Summary of Fatigue and Quality of Life findings 
Fatigue has been shown in this study to contribute to an individual's poor physical 
and mental quality of life. The relationship requires additional research to tease out the 
multiple factors that have been identified as significant contributors to causality. 
Additional analyses were performed to better understand this relationship. 
Additional Analyses 
Multidimensional Aspects of Fatigue 
The total score of the Multidimensional Fatigue Symptom Inventory-Short Form 
total score was used in this study to assess fatigue as a unidimensional construct. This 
was done because this is the first known study to specifically address the impact of 
fatigue on a population of clinic-based adults with diabetes. The results of this study 
indicated fatigue is a useful construct that warrants additional attention. Convergent 
validity across measures was assessed to explore the associations between depressive 
symptomatology, diabetes specific distress, and both physical and mental quality of life 
with the individual subscales of the MFSI-SF (general, physical, mental, and vigor). 
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Results revealed moderate to high associations among constructs, suggesting a moderate 
to high degree of overlap across measures. This overlap was anticipated prior to the start 
of the study. 
The subscales of the MFSI-SF were included in analysis examining the Physical 
and Mental Component Scores of the SF-12 to examine convergent/divergent validity. 
Both the CESD-lO and the PAID were positively associated with the general, emotional, 
physical, mental and total fatigue subscales, and negatively associated with the vigor 
subscale. This finding suggests moderate to high levels of convergent validity across 
measures. 
Fatigue and Blood Glucose Testing 
This analysis examined the relationship between fatigue and blood glucose testing 
while controlling for demographics, diabetes-related history, anti-depressant use, and 
emotion. Age and BMI retained significance in this model, which is consistent with the 
original hypothesis that explored the associations between fatigue and diet. This is 
consistent with the findings of this study presented thus far, the hypothesis that examined 
fatigue and blood glucose testing was not significant. 
Fatigue and Diet 
This hypothesis explored the associations of fatigue and diet while controlling for 
demographics, diabetes-related history, anti-depressant use, and emotion. Block 4 
included depressive symptomatology (CESD-IO). Diabetes-specific distress retained 
significance in this model. Depressive symptomatology was not significant in the 
original hypothesis examining the associations with diet. PAID total scores retained 
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significance in these analyses and the original analyses presented thus far, which is 
consistent with the current literature (Gonzalez et aI, 2008). 
Fatigue was found to be significant in the originally proposed, individual 
analyses, but did not remain significant when controlling for depressive symptomatology 
and diabetes-specific distress. Beta weights were examined to gain information related 
to which construct is believed to have the strongest associations with diet adherence; 
diabetes-specific distress accounted for a significant amount of the variance in this 
model. This suggests the total score of the PAID may be a stronger predictor of diet than 
is the total score of the MFSI-SF. In conclusion, diabetes-specific distress appears to be 
the strongest predictor of diet adherence across the measures included to assess emotion 
in this study. 
Fatigue and Physical Quality of Life 
This analysis explored the associations of fatigue and physical quality of life 
(functional status) while controlling for demographics, diabetes-related history, anti-
depressant use, and emotion. The demographic variables, antidepressant use, depressive 
symptomatology (CESD-IO) and diabetes-specific distress (PAID) retained significance 
in this model. As previously discussed, age and BMI were significant contributors to 
decreased physical quality of life in this sample. Those who are older and heavier 
reported decreased functional status. Antidepressant use was significant in both of the 
original analyses that examined the associations of diabetes-specific distress and fatigue 
and their impact on functional status. Antidepressant use retained significance in this 
model; however once fatigue was entered into the model the effect of antidepressant use 
was no longer significant. 
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Block 4 of this five-step regression included depressive symptomatology (CESD-
10) and diabetes-specific distress (PAID) to control for the impact of these constructs on 
the association between fatigue and physical quality of life. Diabetes-specific distress 
was a significant predictor of physical quality of life; depressive symptomatology was not 
significant. Diabetes-specific distress assessed an individual's level of distress related to 
their diabetes. Those who reported higher levels of diabetes specific distress also 
reported poorer physical quality of life. This is likely a bidirectional association, an 
individual may experience distress as a result of decreased functional status, or decreased 
functional status may cause an individual to experience diabetes-specific distress. 
In addition to the findings discussed above, fatigue was significant, suggesting as 
one's fatigue level goes up, their physical quality of life goes down. This finding 
remained significant when controlling for demographics, diabetes-related history, anti-
depressant use, and emotion. This analysis utilized the total score of the MFSI-SF which 
is a unidimensional summary score of an individual's fatigue level. This also provides 
support for the original question in this study, fatigue is a unique construct when 
assessing physical quality of life in a sample of adults with type 2 diabetes. Fatigue 
assumed 32% of the variance over and above depressive symptomatology and diabetes-
specific distress. 
Fatigue and Mental Quality of Life 
This analysis explored the associations of fatigue and mental quality of life while 
controlling for demographics (age, gender, and BMI), diabetes-related history (insulin, 
duration of diabetes, oral medication use), anti-depressant use, and emotion (depressive 
symptomatology and diabetes-specific distress). Body Mass Index retained significance 
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in this model, suggesting that heavier individuals report decreased mental quality of life. 
This is consistent with original hypotheses examining the associations between fatigue 
and mental quality of life. Antidepressant use also retained significance, consistent with 
original hypotheses. Depressive symptomatology and diabetes-specific distress also 
retained significance in this analysis. These variables were entered into a block in the 
regression equation to explore if fatigue provided a unique contribution to an individual's 
mental quality of live over and above the variance accounted for by the emotion 
constructs included. Fatigue retained significance in this model, suggesting fatigue is 
contributing something different to the model. 
The SF-12 mental component summary score reflects the frequency of 
endorsement of emotional difficulty as a barrier to accomplishing tasks, and doing things 
as carefully as usual. The mental component summary score also addressed the impact of 
feeling "downhearted and blue", "calm and peaceful", in addition to asking about an 
individual's energy level. These items are highly consistent with emotional items that are 
addressed in both the CESD-lO and the PAID. However, the unique contribution of the 
SF-12 highlights the impact of these emotional distress constructs on participant's ability 
to accomplish tasks and do work or activities. Literature suggests as an individual 
experiences emotional distress, this emotional distress acts as a barrier for an individual 
accomplishing things as often and as effectively as they would like (Ware, Kosinski, & 
Keller, 1996). When examining the specific contributions of the emotional constructs 
included in this analysis, depressive symptomatology was not significant. Rather 
diabetes-specific distress accounted for 41.6% of the variance accounted for with this 
model. This suggests an individual's disease-related distress has a significant impact on 
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their mental quality of life. Perceptions of diabetes likely impacted the mental of quality 
of life in this sample. Fatigue contributed an additional 7.6% of the variance accounted 
for. The differences across these emotional constructs suggest despite overlap between 
constructs, depressive symptomatology, diabetes-specific distress, and fatigue appear to 
be distinct but not mutually exclusive constructs. 
Limitations 
Limitations of the Current Study 
Conclusions from this study are limited by the cross-sectional design. Another 
limitation of this study is the retrospective recall of several constructs included in these 
analyses (depressive symptomatology, diabetes-specific distress, fatigue, quality of life, 
and blood glucose testing and diet) in addition to the nature of self-report measures. 
There is a possibility of the moderate to high correlations of self-report measures of 
distress being due to shared measurement variance. That is, the similar self-report 
approach of the measures could introduce bias and pose limitations for validity of 
associations among the proposed constructs. Studies may benefit from prospective 
assessment of these distress constructs and other indices of distress (e.g. physiological) to 
further assess the associations observed in this study. With respect to blood glucose 
testing, improved technology now affords the opportunity for the provider to download 
information from the meter directly into a data file to include time, date, and blood 
glucose reading. Additionally, use of ecological momentary analysis also would be a 
useful approach to collection of longitudinal data to address the issue of causality. 
The present study assessed fatigue using the total score of the MFSI-SF. This 
approach limits consideration of the multidimensionality of the fatigue construct. 
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However, this study did explore the overlap of the total score of fatigue with both 
depressive symptomatology and diabetes-specific distress. Examination of the individual 
subscales of fatigue with the overlapping emotional constructs was discussed, but 
additional research is needed to explore this relationship. 
Finally, there were demographic limitations in this study. African-Americans and 
other ethnic minorities, were under-represented compared to general Louisville, KY and 
greater United States population. Assessing an individual's emotional state while waiting 
for a physician appointment may also be a limitation, specifically if those people are 
experiencing health related difficulty, these scores may be inflated compared to a non-
clinic sample. Specifically, the effects of completing these questionnaires while waiting 
for their physician may increase their distress and that attending their doctor's 
appointments may have impacted their distress scores. Longitudinal assessment will also 
potentially remedy this issue by assessing these constructs over a period of time to 
strengthen the current findings. 
Recommendations for future research 
Research often struggles with the inherent limitations of self-report measurement 
methodologies. Clinical settings are pressured to assess for symptoms that are 
problematic for the patient and interfere with both the disease process and the 
individual's quality of life. This study addressed the utility of measures that assessed 
different domains of emotional distress to gain understanding into the utility of these 
measures and their associations with self-management and quality of life. Replication of 
this study with a longitudinal design would allow for examination of causality which 
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would further enhance the current level of understanding of the associations discussed in 
this study. 
With respect to gender, women were more likely to be more depressed and report 
lower mental quality of life when compared to men. Future research would benefit from 
a better understanding these gender differences in order to design interventions to best 
meet the needs of both women and men living with diabetes. 
This sample in this study was primarily Caucasian. Future research is needed to 
address the constructs examined in this study in minority populations. Additionally, 
further exploration of CVD risk factors would address the effects of comorbid conditions 
on an individual's emotional distress, fatigue, and quality of life. Obesity is another 
construct that should be included in future research, as the impact of obesity on physical 
quality of life and fatigue has been well documented in the literature. Specifically, the 
relationship between fatigue and obesity in adults with diabetes remains poorly 
understood. 
Recommendations for Use of Emotion Measures in Research and Clinical Practice 
The CESD-lO is a brief lO-item measure of global depressive symptomatology. 
Fisher et al (2007) discussed the impact of subthreshold depression impacting outcomes 
and often being misdiagnosed as depression. One could argue that diabetes-specific 
distress is a contributing factor to that misdiagnosis. If the emotional distress is related to 
a disease-specific etiology, the symptoms endorsed may be misattributed to depression. 
This study found a significant relationship between depressive symptomatology and 
quality of life - despite a relatively low level of depressive symptomology overall. 
Future research approaches could include a comparative study with two groups of 
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individuals; one that is clinically depressed and one that is not to examine potential 
differences between groups to further understand this relationship. Additionally, 
longitudinal research could provide information related to the change of the subthreshold 
depressive symptomatology over time. Results of this study indicate the CESD-lO is a 
useful screening tool for global depressive symptomatology. 
The PAID was used to assess diabetes-specific distress, which is a more disease-
specific representation of emotional distress. PAID total scores observed in this study 
were comparable to scores observed in previous research. Clinically, the PAID provides 
useful information for the treating provider to address specific concerns the patient may 
have with respect to their diabetes. From a research perspective, the PAID is a valid, 
useful measure to assess diabetes-specific distress. 
One of the major questions this study sought to address was the utility of fatigue-
specific measurement in a sample of adults with type 2 diabetes. Results from this study 
suggest that fatigue is an important construct to assess in diabetes. Fatigue was found to 
be associated with physical and mental quality of life, obesity, and diet. With respect to 
both physical and mental and quality of life outcomes, fatigue remained significant over 
and above the impact of diabetes-specific distress, suggesting fatigue is an independent 
construct. 
This study provides useful information related to the role of fatigue in a sample of 
individuals with diabetes. Additional support is needed for this finding, however these 
results provide a unique opportunity to explore a potentially useful construct. Analysis of 
the subscales may provide information about the ability of the MFSI-SF to accurately 
distinguish physical and mental dimensions of fatigue, which sets the stage for future 
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research. Of note, the vigor subscale of the MFSI was not associated with depressive 
symptomatology, diabetes-specific distress, or mental quality of life. This fatigue 
subscale may be a particularly useful in clinical evaluations, as it is brief and will provide 
information related to physical energy level, and possibly guide differentiating this from 
mental fatigue. 
Self Care Recommendations 
Self-management is often discussed in the diabetes research literature as a single 
construct despite the multitude of behaviors required to fully adhere to self-management 
recommendations. Johnson (1992) suggested these self-management behaviors are 
mutually exclusive and should be assessed separately. The present findings provide 
additional support for separating each self-management behavior, as diet was found to be 
impacted by diabetes-specific distress and fatigue. Assessment of self-management 
behaviors independently also provides useful information for a clinician to design a 
treatment plan targeting these behaviors independently. Future research should focus on 
specific self-management behaviors. They have been identified in the literature as 
constructs that should be addressed separately. This suggests outcome research should 
address this issue by utilizing specific self-management behaviors. Examining these 
behaviors independently will increase the understanding of what variables are actually 
impacting the adherence rates and the SDSCA is believed to be a valid instrument to 
assess this frequency. The SDSCA is a reliable measure of self-management that is brief 
and provides information to a clinician or researcher quickly to identify areas for 
intervention. 
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There were no significant differences observed between any of the emotional 
constructs and blood glucose testing in this study. The blood glucose testing and diet 
subscale scores observed in this study were consistent with scores observed in the 
literature, providing support for the representativeness of this sample with respect to self-
management. The new ADA (2010) Standards of Medical Care are less clear with regard 
to specific standards of blood glucose monitoring for individuals who have not been 
prescribed an insulin regimen, or who take insulin less frequently. Hence, specific 
prescriptions for blood glucose monitoring largely become the decision of the clinician. 
The SDSCA is recommended to assess behaviors for clinicians and healthcare providers, 
as this is a brief, valid measurement of self-management. With respect to diet, women in 
the present study reported adhering to diet recommendations more often than did men. 
Future research can further explore this relationship, focusing on both benefits and 
barriers to adhering to diet recommendations. Additionally, diet was found to be 
associated with both diabetes-specific distress and fatigue, additional research examining 
the subscales of these measures would provide additional information related to possible 
targets for intervention. 
Recommendations for Quality of Life Assessment 
The results of the current study highlight the poor quality of life scores observed 
in this sample. The SF-12 is a reliable and valid instrument that provides a substantial 
amount of information in a brief amount of time, minimizing both participant burden and 
clinical time. The Physical and Mental Component Scores are heavily utilized in the 
literature, which provides additional utility in terms of replication. Although there are 
additional subscales available for the SF-12, the Physical and Mental Component Scores 
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are most frequently used in research settings. Clinically, it provides qualitative 
information that target specific difficulties for an individual, and may guide interventions 
to address these concerns. 
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Proposed ICD-I0 Criterion of Cancer-Related Fatigue 
A. There are eleven symptoms within this criterion, one of these MUST be (1) 
significant fatigue. These are listed below: 
1. Significant fatigue, diminished energy, or increased need to rest disproportionate 
to any recent change in activity level. 
2. Complaints of generalized weakness or limb heaviness. 
3. Diminished concentration or attention. 
4. Decreased motivation or interest to engage in usual activities. 
5. Insomnia or hypersomnia. 
6. Experience of sleep as unrefreshing or nonrestorative. 
7. Perceived need to struggle to overcome inactivity. 
8. Marked emotional reactivity (e.g. sadness, frustration, or irritability) to feeling 
fatigued. 
9. Difficulty completing daily tasks attributed to feeling fatigued. 
10. Perceived problems with short- term memory. 
11. Postexertional malaise lasting several hours. 
B. The symptoms cause clinically significant distress or impairment in social, 
occupational, or other important areas of functioning. 
C. There is evidence from the history, physical examination, or laboratory findings that 
the symptoms are a consequence of cancer or cancer therapy. 
D. The symptoms are not primarily a consequence of comorbid psychiatric disorders 
such as major depression, somatization disorder, somatoform disorder, or delirium. 
*For a diagnosis of CRF to be warranted, six of the above criteria must be present for at 
least a 2-week period every day or nearly every day. 
Adapted from Cella, Peterman, Passik, Jacobsen, and Breitbart, 1998. 
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Table 2 
Summary of Fatigue Assessment Measures 
Author/ Instrument Population Definition Reliability/ Di-
Date Validity mensionali 
ty 
Hann et Fatigue N=107 women Fatigue was not Reliability: U 
aI., Symptom currently discussed in terms of Alpha = 0.94, 
1998 Inventory undergoing definition; it was 0.95,0.93 for 
(FSI) treatment for assessed due to its the three 
3 items; 0- breast cancer. impact on quality of groups 
10 numeric life 
scale N=113 women Test-retest 
that completed reliability was 
treatment for 0.35-0.75 was 
breast cancer. found in the 
active 
N=50women treatment 
with no history group and 
















Hazdi- Schedule of N=770 patients Fatigue was The only U 
Pavlovic Fatigue and with CFS. discussed in terms of validity 
et aI, Anergia N=1593 severity. information 
2000 (SOFA) pnmary care regarding 
scale and CFS discrimination 
10-items primary care between 
patients with 
5-point CFS/primary 
Likert scale care patients. 
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Krupp et Fatigue A large number This measure Internal U 
al,1989 Severity of patients with assesses the impact consistency: 
Scale (FSS) MS and and functional Alpha=0.88. 
systemic lupus outcomes affected by 
9-items erythematosus fatigue, rather than a Discriminative 







McNair Profile of Large Not defined; Fatigue Reliability: U 
et aI., Mood States psychiatric is addressed in terms Well-
1992 (POMS) populations and of intensity. examined in 
college the literature, 
37 items students Fatigue 
subscale has 
5-point not been 





Piper et Revised N=382 Breast Fatigue was defined Reliability: M 
aI.,1998 Piper cancer as a subjective Alpha=0.97 
Fatigue survivors feeling of tiredness (entire scale) 
Scale that is affected by and ranged 
(Revised circadian rhythm. from 0.92-0.96 
PFS) Four dimensions are for the four 
assessed: subscales. 
22 items behavioral/severity, 
affective meaning, Construct 
0-10 sensory, and validity: 
numerical cognitive mood. Demonstrated 
rating scale, due to four 




Rhoten, Rhoten N=5 adults Postoperative fatigue Reliability: U 
1982 Fatigue admitted for is defined as a not discussed 
Scale (RFS) abdominal general state of 
surgery negative feeling Validity: 
One item associated with pain, Patients' 
discomfort, and pain ratings on the 
II-point medication RFS are 




Schwartz Schwartz N=166 patients CRF is a subjective Reliability: M 
, 1998 Cancer with various state that is captured Alpha=0.96 for 
Fatigue forms of in four dimensions: the total scale, 
Scale cancer. physical, emotional, 0.82-0.93 for 









those who had 
completed 
treatment. 
Schwartz Fatigue N=235 Fatigue is measured Internal M 
et ai, Assessment individuals in terms of four consistency: 
1993 Instrument with Lyme subscales: Fatigue range from 
(FAI) disease, CFS, severity, situation 0.70-0.91 
SLE,MS, specificity, 
29 items dysthymia, and consequences of 
controls fatigue, and 
7-point responsiveness to 
Likert scale sleep. 
Smets et Multidimens N=111 patients Definition unclear, Reliability: M 
aI., 1995 ional with various fatigue is a Alpha=0.65-
Fatigue forms of cancer multidimensional 0.80 internal 
Inventory symptom with 5 consistency. 
(MFI) N=357 patients dimensions: general 
with CFS fatigue, physical Construct 
20-items fatigue, reduced Validity: 
activity, reduced Significant 
7-point motivation, and differences 









Stein et 1. 1. N=15 Fatigue was 1. Reliablity: Multidimen 
aI., 1998 Multidimens patients with conceptualized for Alphas were as sional 
ional breast cancer; both measures in follows: 
Fatigue N=lO with no terms of fi ve global= 0.92, 
Symptom history of dimensions: global affective=0.88, 
Inventory cancer, and experience, somatic, somatic=0.90, 
(MFSI) N=8 oncology cognitive, affective, cognitive=0.91 
care providers and behavioral. It is , and 
85-items 2. N=146 defined as a behavioral=0.8 
women subjective feeling of 7 
2. MFSI- currently tiredness and 
Short Form undergoing weariness both in 2. Reliability: . 
(MFSI-SF) treatment for association of Alphas were as 
breast cancer, activity and/or follows: 
30-item N=92 women independent of general= 0.96, 
that were post- physical effort, affective=0.93, 
Both treatment for decreased physical =0.85, 
measures cancer,and performance mental=0.90, 
use a 5-point N=54 with no motivation, and an and vigor=0.88 
Likert rating history of altered mood state. 
cancer. MFSI-SF included a 
vigor dimension 
rather than a 
behavioral 
dimension. 
Vercoule Checklist of N=298 CFS Fatigue is assessed in Internal Multidimen 
net aI, Individual patients terms of both Consistency: sional 
1994. Strength severity and Alpha=0.90 
(CIS). behavioral 
consequences using Test-retest 
20 items four subscales: reliability has 
subjective experience not been 
5-point of fatigue, demonstrated, 
Likert scale concentration, however this 
motivation, and measure is 





Yellen et Functional N=49 patients Fatigue was assessed Internal Unidimensi 
al,1997. Assessment receiving in terms of severity Consistency: onal 
of Cancer cancer and impact of the Alpha=0.93. 
























Moderate to High/+ Moderate/+ 







Hypothesized Relationships between Diabetes Emotional Distress Constructs and Self-
management and Quality of Life 




Diet Moderate/- Moderate/- Moderate/-
Blood 
Glucose 
Monitoring Moderate/- Moderate/- Moderate/-
Quality of Life (SF-12) 
Physical 
Component High/- Moderate/- High/-
Mental 
Component High/- High/+ High/-
Note. None = 0 to .10; Low = .11 to .30; Moderate = .31 to .50; High .51 and larger. 
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Table 5. 






Center for Epidemiological Studies of 
Depression Scale-lO (CESD-lO) 
Problem Areas In Diabetes Scale (PAID) 
Multidimensional Fatigue Symptom 
Inventory-Short Form (MFSI-SF) 





Measures Assessing Diabetes Self-Care Behavior and Quality of Life Constructs and Subscales. 
Observed Construct 
Diabetes Self-Care Behavior 
Quality of Life 
Measure 




Blood Glucose Testing 
Medical Outcomes Study Short Form 12 (SF-12) Physical Component Score 
Mental Component Score 
Table 7 
Diabetes Characteristics by Completion Status 
Observed Construct Completion Status n M SD 
Number of Complications Complete 143 4.23 1.74 
Non-Complete 49 4.12 1.88 
Duration of Diabetes in months Complete 143 143.64* 102.54 
(years presented in parenthesis) (11.97) (8.54) 
- Non-Complete 49 105.65 80.69 .j::>. 
tv (8.80) (6.72) 
HbAl c Complete 143 7.33** 1.45 
Non-Complete 50 8.29 1.79 
Body Mass Index Complete 143 35.38 6.83 
Non-Complete 50 36.82 8.59 
* p=.02; ** p=.OOO 
Table 8 
Demographic Characteristics of Participants 
Characteri sti c n % M SD 
(Total N=148) 
Age 60.68 11.24 
Age Under 40 5 3.4 
In 40's 16 10.8 
In 50's 45 30.4 
In 60's 51 34.5 
In 70's 24 16.2 
In 80's 7 4.7 
Gender 
Male 71 48.0 
Female 77 52.0 
Ethnicity 
Caucasian 137 93.2 
African American 7 4.8 
Hispanic 2 1.4 
Asian 1 0.7 
Marital Status 
Never Married 11 7.4 
Currently Married 107 72.3 
Separated 1 0.7 
Divorced 14 9.5 
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Characteristic n % M SD 
Widowed 15 10.1 
Living Arrangement 
Live Alone 27 18.l 
Live with spouse/partner 84 56.8 
Live w/spouse and children 26 17.6 
Live with children 3 2.0 
Live with roommate 3 2.0 
Live with parents 2 1.4 
Other 3 2.0 
Education 
Less than 7th Grade 1 0.7 
Junior High School 4 2.7 
Partial High School 13 8.8 
High School Graduate 49 33.3 
Partial college/specialized training 37 25.2 
College or University Graduate 18 12.2 
Graduate Professional Training 25 17.0 
Employment 
Full time 43 29.7 
Part time 8 5.5 
On Leave Without Pay 1 0.7 
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Characteristic n % M SD 
Disabled 21 14.5 
Retired 64 44.1 
Homemaker 8 5.5 
Income 
Less than $10,000 3 2.2 
$10,000-19,999 20 14.5 
$20,000-39,999 28 20.3 
$40,000-59,999 39 28.3 
$60,000-100,000 32 23.2 
Greater than $100,000 16 11.6 
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Table 9. 
Representativeness of study sample in comparison to U.S. Census demographic 
information. 
Characteristic Study Sample New Albany, IN Louisville, KY 
Gender 
Male 48.3% 46.9% 48.4% 
Female 51.7% 53.1% 51.6% 
Ethnicity 
Caucasian 93.2% 90.0% 82.8% 
African American 4.7% 6.9% 13.9% 
Hispanic 1.4% 1.4% 1.6% 
Asian 0.7% 0.4% 1.1% 
Note: Comparisons based on 2000 Census data 
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Table 10 
Means and Standard Deviations of Personal Illness Models Construct Measures (emotional distress, self-management, quality of life) 
Observed Construct Measure and Subscales n M(Range) SD 
Depressive Symptomatology CESD-IO 142 4.87 (0-13) 2.60 
Diabetes Specific-Distress PAID 147 39.69 (19-87) 14.36 
Fatigue MFSI-SF 147 13.90 [( -19)-78] 19.46 
Self-Management SDSCA 
Blood Glucose Testing 143 4.87 (0-7) 2.24 
:!:l Diet 143 3.67 (0-7) 1.40 
Quality of Life SF-12 
Physical 148 41.82 (12.9-63.4) 12.37 
Mental 148 43.89 (11.3-64.4) 12.73 
Table 11. 
Means and Standard Deviations between Insulin Use, Emotional Constructs, Diet, Blood Glucose, and Quality of Life Outcomes 
Gender 
Construct Male Female 
n M SD n M SD p 
Depressive Symptomatology (CESD-lO) 69 4.39 2.50 73 5.33 2.64 .032* 
Diabetes Specific Distress (PAID) 71 37.65 13.94 76 41.61 14.59 
Fatigue (MFSI-SF) 71 11.41 18.18 75 15.91 20.37 -.j:::. 
00 
Diabetes Self-Care Behavior (SDSCA) 
Diet 68 3.39 1.50 75 3.93 1.27 .020* 
Blood Glucose Monitoring 68 4.66 2.31 75 5.06 2.18 
Quality of Life (SF-12) 
Physical Component 71 41.68 11.82 77 41.94 12.93 
Mental Component 71 46.05 11.99 77 41.91 13.16 .048* 
Note: Exact p-values are reported for significant difference 
Table 12 
Health Characteristics of Participants 
Characteristic n % M SD 
Duration of DM (months) 143.64 102.54 
Body Mass Index 35.38 6.83 
Body Mass Index by Group 
Normal 4 2.9 
Overweight 24 17.1 
Obesity I 41 29.3 
Obesity II 36 25.7 
Obesity III 35 25.0 
HbAl c 7.33 1.45 
HbAl c by Group 
<7.0 62 43.4 
7.0-7.9 42 29.4 
8.0-8.9 21 14.7 
9.0-9.9 12 8.4 
>10 6 4.2 
Antidepressant Use 33 23.1 
DM Oral Agent Use 132 92.3 
Exogenous Insulin Use 47 34.8 
Byetta Use 10 7.4 
Medication Use 
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Orals Only 78 54.5 
Insulin Only 11 7.7 
Both Insulin and Oral Agents 54 37.8 
Smoking Status 
Tobacco User 16 11.2 
Non-Smoker 127 88.8 
How would you rate your present health condition? 
Excellent 1 0.7 
Very Good 25 17.0 
Good 68 46.3 
Fair 38 25.9 
Poor 15 10.2 
No. of Complications 4.23 1.74 
Hypertension 111 78.2 
Hyperlipidemia 126 88.7 
Peripheral Neuropathy 60 42.3 
Note: Data based on chart review 
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Table 13. 
Means and Standard Deviationsfor Personal Illness model Construct measures (Emotional Constructs, Self-Management, and 
Quality of Life Outcomes) by insulin use status 
Exogenous Insulin Use 
Construct YES NO 
n M SD n M SD p 
Depressive Symptomatology (CESD-lO) 44 4.93 2.67 85 4.78 2.57 
Diabetes Specific Distress (PAID) 46 42.28 15.32 88 38.63 14.09 
Fatigue (MFSI-SF) 46 13.63 19.00 87 12.28 18.72 
Diabetes Self-Care Behavior (SDSCA) 
VI 
Diet 45 3.74 1.26 86 3.70 1.50 
Blood Glucose Monitoring 46 5.24 1.89 85 4.57 2.32 .035* 
Quality of Life (SF-12) 
Physical Component 47 38.34 12.57 88 43.87 12.08 .014* 
Mental Component 47 41.99 12.56 88 45.09 12.53 
HbAlc 47 8.12 1.65 88 6.84 1.13 .000* 
Note: Exact p-values for independent sample t-tests are reported for significant differences by insulin use status 
Table 14. 
Means and Standard Deviations/or Personal Illness model Construct measures (Emotional Constructs, Self-Management, and 
Quality 0/ Life Outcomes) by antidepressant use status 
Antidepressant Use 
Construct YES NO 
n M SD n M SD l2 
Depressive Symptomatology (CESD-lO) 31 5.97 2.76 106 4.50 2.43 .005* 
Diabetes Specific Distress (PAID) 33 46.82 19.65 109 37.67 11.69 .015* 
VI 
Fatigue (MFSI-SF) 32 23.09 19.61 109 9.98 17.20 .000* 
N 
Diabetes Self-Care Behavior (SDSCA) 
Diet 32 3.67 1.32 106 3.69 1.45 
Blood Glucose Monitoring 33 4.76 2.19 105 4.92 2.23 
Quality of Life (SF-12) 
Physical Component 33 37.21 13.53 110 43.29 11.66* .013* 
Mental Component 33 37.20 12.84 110 46.27 11.79* .000* 













Note. p-values for Pearson Correlations are listed in parentheses. 











Associations between Personal Illness Model measures (emotional distress, diabetes self-management, and quality of life) 
Construct 
Diabetes Self-Care Behavior (SDSCA) 
Diet 
Blood Glucose Monitoring 









Note: Pearson correlations p-values are listed in parentheses, * denote significance 
Diabetes Specific Distress 
(PAID) 











Associations of primary study variables including independent variables, dependent variables and covariates. 
Construct 1 2 3 4 5 6 7 8 9 10 11 12 13 
1. OM-Specific Distress 
2. Fatigue .617** 
3. Depressive Sx. .579** .644** 
4. Gender -.136 -.105 -.184* 
...-
VI 
5. Age -.066 -.083 -.133 .024 
VI 
6. Body Mass Index .146 .086 .057 -.193* -.398** 
7. HbAl c .227** .040 .094 .008 -.082 .241 ** 
8. Duration of OM -.008 -.026 -.121 -.058 .353** -.106 -.044 
9. Antidepressant Use -.268** -.289** -.242** .174* .144 -.071 -.099 -.037 
10. Physical QOL -.262** -.392** -.290** -.020 -.138 -.112 -.126 -.162 .201 * 
11. Mental QOL -.574** -.685** -.612** .146 .046 -.096 -.130 -.035 .291 ** .361 ** 
12. Diet -.231 ** -.173* -.181* -.183 .033 -.073 -.232** .077 mo -.081 .169* 
13. Blood Glucose Testing -.015 -.066 -.140 -.081 .222** .055 -.021 .161 .035 -.158 .029 .203* 
Note: * p < .05; ** P < .01 Variables in italics are point bi-serial correlations 
Table 18. 
Summary of Hierarchical Linear Regression Analysis with Blood Glucose Testing 
(SDSCA Blood Glucose Testing) as Criterion (N=123) 
Step Predictor Variable ~F 
1 BMI, Gender, Age .135 .135 6.17* 
2 Insulin, Duration of DM, .174 .040 1.86 
Oral Agents 
3 Antidepressant Use .175 .001 .100 
4 Depressive Sx (CESD-lO) .194 .019 2.73 
* p = .001 
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Table 19. 
Summary of Hierarchical Linear Regression Analysis with Diet (SDSCA Diet) as 
Criterion (N=124) 
Step Predictor Variable ~F 
1 BMI, Gender, Age .037 .037 1.55 
2 Insulin, Duration of DM, .061 .023 0.975 
Oral Agents 
3 Antidepressant Use .063 .003 .320 
4 Depressive Sx (CESD-lO) .105 .042 5.4 
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Table 20. 
Summary of Hierarchical Linear Regression Analysis with Blood Glucose Testing 
(SDSCA Blood Glucose Testing) as Criterion (N=128) 
Step Predictor Variable llF 
1 BMI, Gender, Age .131 .131 6.23* 
2 Insulin, Duration of DM, .168 .037 1.81 
Oral Agents 
3 Antidepressant Use .169 .001 .164 
4 DM Specific Distress (PAID) .178 .009 1.23 
* p = .001 
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Table 21 
Summary of Hierarchical Linear Regression Analysis with Diet (SDSCA Diet) as 
Criterion (N=128) 
Step Predictor Variable ~F 
1 BMI, Gender, Age .042 .042 1.79 
2 Insulin, Duration of DM, .066 .024 1.05 
Oral Agents 
3 Antidepressant Use .069 .003 .375 




Summary of Hierarchical Linear Regression Analysis with Blood Glucose Testing 
(SDSCA Blood Glucose Testing) as Criterion (N=126) 
Step Predictor Variable ~F 
1 BMI, Gender, Age .136 .136 6.38* 
2 Insulin, Duration of DM, .172 .037 1.76 
Oral Agents 
3 Antidepressant Use .173 .001 .157 
4 Fatigue (MFSI-SF) .191 .017 2.52 
* p < .001 
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Table 23 
Summary of Hierarchical Linear Regression Analysis with Diet (SDSCA Diet) as 
Criterion (N=126) 
Step Predictor Variable ~F 
1 BMI, Gender, Age .040 .040 1.68 
2 Insulin, Duration of DM, .066 .026 1.11 
Oral Agents 
3 Antidepressant Use .068 .002 .293 




Summary of Hierarchical Linear Regression Analysis with Physical Quality of Life (SF-
12 Physical Component Score) as Criterion (N=126) 
Step Predictor Variable R2 ~R2 ~F 
1 BMI, Gender, Age .088 .088 3.94* 
2 Insulin, Duration of DM, .129 .040 1.83 
Oral Agents 
3 Antidepressant Use .160 .031 4.42 
4 Depressive Sx (CESD-I0) .246 .086 13.28** 




Summary of Hierarchical Linear Regression Analysis with Mental Quality of Life (SF-
12 Mental Component Score) as Criterion (N=126) 
Step Predictor Variable R2 ~R2 ~F 
1 BMI, Gender, Age .051 .051 2.18 
2 Insulin, Duration of DM, .058 .007 .312 
Oral Agents 
3 Antidepressant Use .111 .053 6.99* 
4 Depressive Sx (CESD-lO) .440 .329 68.58** 
*p <.05; **p<.OOI 
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Table 26 
Summary of Hierarchical Linear Regression Analysis with Physical Quality of Life (SF-
12 Physical Component Score) as Criterion (N=13l) 
Step Predictor Variable R2 L\R2 L\F 
1 BMI, Gender, Age .099 .099 4.66** 
2 Insulin, Duration of DM, .135 .036 1.70 
Oral Agents 
3 Antidepressant Use .163 .028 4.08* 
4 DM-Specific Distress (PAID) .192 .029 4.44* 
*p <.05; **p<.005 
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Table 27. 
Summary of Hierarchical Linear Regression Analysis with Mental Quality of Life (SF-
12 Mental Component Score) as Criterion (N=131) 
Step Predictor Variable ~F 
1 BMI, Gender, Age .062 .062 2.79* 
2 Insulin, Duration of DM, .079 .017 .771 
Oral Agents 
3 Antidepressant Use .130 .051 7.24* 
4 DM-Specific Distress (PAID).406 .275 56.50** 
*p <.05; **p<.OOl 
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Table 28. 
Summary of Hierarchical Linear Regression Analysis with Physical Quality of Life (SF-
12 Physical Component Score) as Criterion (N=130) 
Step Predictor Variable R2 ~R2 ~F 
1 BMI, Gender, Age .092 .092 4.23* 
2 Insulin, Duration of DM, .126 .034 1.60 
Oral Agents 
3 Antidepressant Use .160 .035 5.04* 
4 Fatigue (MFSI-SF) .267 .107 17.68** 
*p <.05; **p<.OOl 
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Table 29. 
Summary of Hierarchical Linear Regression Analysis with Mental Quality of Life (SF-
12 Mental Component Score) as Criterion (N=130) 
Step Predictor Variable ~F 
1 BMI, Gender, Age .047 .047 2.06 
2 Insulin, Duration of DM, .057 .011 .468 
Oral Agents 
3 Antidepressant Use .112 .055 7.55* 
4 Fatigue (MFSI-SF) .483 .371 86.81 ** 





















Item Wording Item Number 
I felt depressed. 3 
I feel depressed. 21 
Have you felt downhearted and depressed? 11 
Feeling depressed when you think about your diabetes? 11 
I had trouble keeping my mind on what I was doing. 2 
I am unable to concentrate. 20 
I have trouble paying attention. 15 
I feel energetic. 24 










Item Wording Item Number 
I feel calm. 29 
Have you felt calm and peaceful? 9 
--------.~-----------------------------------
Table 31. 
MFSI-SF subscales and their associations with CESD-lO, PAID, and SF-12 
component scores. 
MFSI-SF CESD-I0 PAID SF-12 SF-12 mental 
Subscale 
physical 
General .559 (.000) .492 (.000) -.385 (.000) -.489 (.000) 
Physical .539 (.000) .451 (.000) - .502 (.000) -.537 (.000) 
Emotional .624 (.000) .573 (.000) -.091 (.272) -.604 (.000) 
Vigor -.427 (.000) -.333 (.000) .300 (.000) .573 (.000) 
Mental .410 (.000) .553 (.000) -.218 (.008) -.396 (.000) 
Total .657 (.000) .619 (.000) -.384 (.000) -.680 (.000) 
Note: p-values are listed in parentheses. 
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Table 32 
Summary of Hierarchical Linear Regression Analysis with Blood Glucose Testing 
(SDSCA Blood Glucose Testing) as Criterion (N=122) 
Step Predictor Variable ~F 
1 BMI, Gender, Age .135 .135 6.17* 
2 Insulin, Duration of DM, .174 .040 1.86 
Oral Agents 
3 Antidepressant Use .175 .001 .100 
4 CESD-lO, PAID .195 .020 1.41 




Summary of Hierarchical Linear Regression Analysis with Diet (SDSCA Diet) as 
Criterion (N=123) 
Step Predictor Variable ~F 
1 BMI, Gender, Age .037 .037 1.55 
2 Insulin, Duration of DM, .061 .023 .975 
Oral Agents 
3 Antidepressant Use .063 .003 .320 
4 CESD-lO, PAID .143 .080 5.30* 
5 Fatigue (MFSI-SF) .144 .000 .062 
*p <.05 




Summary of Hierarchical Linear Regression Analysis with Physical Quality of Life 
(SF-
12 Physical Component Score) as Criterion (N=124) 
Step Predictor Variable R2 ~R2 ~F 
1 BMI, Gender, Age .096 .096 4.30* 
2 Insulin, Duration of OM, .141 .045 2.05 
Oral Agents 
3 Antidepressant Use .169 .027 3.87* 
4 CESD-lO, PAID .247 .078 5.98* 
5 Fatigue (MFSI-SF) .321 .074 12.37** 
*p ~.05; **p<.OOI 
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Table 35 
Summary of Hierarchical Linear Regression Analysis with Mental Quality of Life 
(SF-
12 Mental Component Score) as Criterion (N=124) 
Step Predictor Variable R2 ~R2 ~F 
1 BMI, Gender, Age .067 .067 2.90* 
2 Insulin, Duration of DM, .076 .009 .392 
Oral Agents 
3 Antidepressant Use .123 .046 6.19* 
4 CESD-lO, PAID .541 .419 52.46** 
5 Fatigue (MFSI-SF) .618 .076 22.80** 




Figure 1: Glasgow et ai's Model of key variables influencing diabetes self-management 
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Glasgow, Hampson, Strycker, & Ruggiero (1997). 













Figure 2: Proposed Revision of Glasgow's Model of Self-Management modified to include affect 
Personal Illness Models 




o depressive symptomatology 
o DM specific distress 
o fatigue 






Modified from Glasgow, Hampson, Strycker, & Ruggiero (1997). 
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Total Oral Agents 
N=132 (89.2%) 






Total Byetta Use 
N=lO (7.4%) 
Byetta and oral 
agents 
N=1O(7.4%) 
Note. Patients cannot be on Insulin and Byetta simultaneously, nor can they be on Byetta 
without Oral Agents. Additionally, 5 participants medicine regimen was not available 





GENERAL BACKGROUND INFORMATION 
1. Today's date: _________ (month/day/year) 
2. How old are you? __________ (years old) 
3. Gender 
D Female D Male 
4. How tall are you? 
feet inches 






Ethnic group (check one box): 
D 1 White (non-Hispanic) 
D 2 Black 
D 4 Asian 
D 3 Hispanic 
D 5 Other Specify Below 
( 
Marital status (check one box): 
D 1 Never married 
D 2 Currently married 
D 3 Separated 
D 4 Divorced 
D 5 Widowed 
Current living arrangement (check one box): 
D 1 Live alone D 5 
D 2 Live with spouse/partner D 6 
D 3 Live with spouse/partner and children 
D 4 Live with children (no spouse/partner) 
Level of school completed (check one box): 
D 1 Less than 7th grade 
D 2 Junior High School (7th, 8th, & 9th grade) 
D 3 Partial high school (10th or 11th grade) 
D 4 High School graduate (Includes G.E.D.) 
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Live with roommate 
who is not partner 
Live with parents 
D 7 Other 
D 5 Partial college 
or specialized training 
D 6 College or 
university graduate 
D 7 Graduate 
professional training 
(graduate degree) 
10. Approximate annual gross income for your household: (check one number) 
(Remember all information you provide will remain completely confidential) o 1 Less than $ 10,000 04 $40,000 - $59,999 o 2 $10,000 - $19,999 05 $60,000 - $100,000 o 3 $20,000 - $ 39,999 0 6 Greater than $100,000 
11. Which category best describes your usual occupation? If you are not currently 
employed, which category best describes your LAST job? (check one number) 
o 1 Professional (e.g., teachers/professors, nurses, lawyers, physicians, & 
engineers) 
02 Manager/Administrator (e.g., sales managers) 
03 Clerical (e.g., secretaries, clerks or mail carriers) 
04 Sales (e.g., sales persons, agents & brokers) 
o 5 Service (e.g., police, cooks, waitress, or hairdressers) 
06 Skilled Crafts, Repairer (e.g., carpenters) 
07 Equipment or Vehicle Operator (e.g., truck drivers) 
08 Laborer (e.g., maintenance factory workers) 
09 Farmer (e.g., owners, managers, operators or tenants) 
010 Member of the military 
011 Homemaker (with no job outside the home) 
012 Other (please 
describe) ________________________ _ 
12. Current employment situation (check all that apply): o 1 Full time at job 
o 2 Part time at job 
o 3 On leave with pay 
o 4 On leave without pay 
05 Disabled 
o 6 Seeking work 
07 Retired 
o 8 Homemaker 
09 Student 
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Below is a list of statements that describe how people sometimes feel. Please read each 
item carefully. Then circle the number next to each item which best describes how true 
each statement has been for you in the past 7 days. 
Not at all A little 










Below is a list of some of the ways you may have felt or behaved. Please indicate 
how often you have felt this way during the PAST WEEK by checking the 





1 da ) 
Occasion-




3-4 da s 
All of 
the 
These questions below are about your level of concern about your health, worries, and 
frustration, and how you feel about your diabetes. Please choose the answer that best 
describes how you FEEL about each question asked. 
1. How serious is your diabetes? 




5 Extremely Serious 
2. How worried are you about developing complications of diabetes (like eye problems, foot 
ulcers, or heart attacks)? 




5 Extremely worried 
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3. How important is following tour self-care recommendations (for example: diet, exercise, and 
glucose testing) for controlling your diabetes? 




5 Extremely important 
4. How frustrated do you feel when trying to take care of your diabetes (e.g., diet, exercise, 
glucose testing)? 




5 Extremely frustrated 
5. How important is controlling your blood glucose levels for avoiding complications from 
diabetes? 




5 Extremely important 
6. How much has having diabetes changed your activities (that is, your family and social events, 




4 A lot 
5 Completely 
7. How important do you believe healthy eating is for controlling your diabetes? 




5 Extremely important 
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8. How likely do you think it is that healthy eating will prevent future complications of your 
diabetes? 




5 Extremely likely 
Health and Well-Being 
The following items ask for your views about how you feel and how well you are able to 
do your usual activities. For each of the following questions, please mark an "X" in the 
one box? that best describes your answer. 
1. In general, would you say your health: 
Excellent Very Good Good Fair Poor 
o 0 o o o 
2. The following questions are about activities you might do during a typical day. Does 
your health now limit you in these activities? If so, how much? 
Moderate activities, such as moving 










bowling, or playing golf .............................. D ......................... 0 ...................... 0 
Climbing several flights of stairs .................. D ......................... 0 ...................... 0 
3. During the past 4 weeks, how much of the time have you had any of the following 












time time time time time 
Accomplished less than you 
would like .................... 0 ................ 0 .................. 0 ................. 0 ............... 0 
Were limited in the kind of work 
or other activities ........... 0 ................ 0 ................... 0 .................... 0 .................. 0 
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4. During the past 4 weeks, how much of the time have you had any of the following 
problems with your work or other regular daily activities as a result of any emotional 
problems (such as feeling depressed or anxious)? 
All of Most 







time time time time time 
Accomplished less than you 
would like .................. O ................. O ................. 0 ................. 0 ............... 0 
Did work or other activities less 
carefully than usual .... O ................ 0 .................. 0 ................... 0 ................... 0 
5. During the past 4 weeks, how much did pain interfere with your normal work 
(including both work outside the home and housework)? 
Not at all A little bit Moderately Quite a bit Extremely 
ODD o o 
6. These questions are about how you feel and how things have been with you during 
the past 4 weeks. For each question, please give the one answer that comes closest to 
the way you have been feeling. How much of the time during past 4 weeks ... 
All of Most Some A little None 
the of the of the of the of the 
time time time time time 
Have you felt calm and 
peaceful? ............ 0 ................ 0 ................. 0 ................. 0 ............... 0 
Did you have a lot of energy? 
0 ................ 0 .................. 0 ................... 0 .................. 0 
Have you felt downhearted 
and depressed? ..... O ......... '" .... 0 .................. 0 ................... 0 ................. 0 
7. During the past 4 weeks, how much of the time has your physical health or 
emotional problems interfered with your social activities (like visiting friends, relatives, 
etc.)? 
All of the time Most of the time Some of the time A little of the time None of the time 
















114~ Feeling alo(le with diabetelS, 
d 15. Feelings of deprivation regarding food and 
;:meals. 
!"='~""'·'C?~=",,,,,,,,,,.,,,=,,~c~,=,,, ... ,,"""""'"'' ," '" ,e:" ."'==""'== 
1
1116. Not having clear and concrete goals for 
\b2!'!~~~!'!"<::~!~;'~"""'.'''.''7'''''''''''''''' "N ','""",,,,,,,,,,,,,,,;',,,,,,',",,"<'" '''''1'i'=~ ," "=;;,;,';"~~"";;',,,,, 
:' 17. Uncomfortable interactions around diab 
Ii with family/friends. • 
II'''f8~''N~ta;;cepting''diabet;~''''''''''';;;;;;;;';'';;'''''~ ""·"'-T=r;==. r 
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19. Feeling that friends/family are not supportive; 
iabetes mana ement efforts. 
feeling' unsatisfied with your diabetes 




The questions below ask you about your diabetes self-care during the last 7 days. 
If you were sick during the past 7 days, please think back to the last 7 days that you 
were not sick. 
DIET 
How many of the last SEVEN DAYS have you followed a healthful eating plan? 
o 1 2 3 4 5 6 7 
On how many of the last SEVEN DAYS did you eat five or more servings of fruits and 
vegetables? 
o 1 2 3 4 5 6 7 
On how many of the last SEVEN DAYS did you eat high fat foods such as red meat or 
full-fat dairy products? 
o 1 23 4 5 6 7 
On how many of the last SEVEN DAYS did you space carbohydrates evenly through the 
day? 
o 1 2 3 4 5 6 7 
EXERCISE 
On how many of the last SEVEN DAYS did you participate in at least 30 minutes of 
physical 
activities? 
o 1 2 3 4 5 6 7 
On how many of the last SEVEN DAYS did you participate in a specific exercise session 
(such as swimming, walking, biking) other than what you do around the house or as part 
of your work: 
o 1 2 3 4 5 6 7 
BLOOD SUGAR TESTING 
On how many days of the last SEVEN DAYS did you test your blood sugar? 
o 1 2 3 4 5 6 7 
On how many of the last SEVEN DAYS did you test your blood sugar the number of 
times recommended by your health care provider? 
o 1 2 3 4 5 6 7 
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MEDICATIONS 
On how many of the last SEVEN DAYS did you take your recommended diabetes 
medications? 
o 1 2 3 4 5 6 7 
On how many of the last SEVEN DAYS did you take your recommended insulin 
injections? 
o 1 2 3 4 5 6 7 
On how many of the last SEVEN DAYS did you take your recommended number of 
diabetes pills? 
o 1 2 3 4 5 6 7 
SMOKING 
Have you smoked a cigarette (even one puff) during the past SEVEN DAYS? 
O. No 
1. Yes. If yes, how many cigarettes did you smoke on an average day? 
___ .....;Average Number of cigarettes 
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